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ABSTRACT

The t(4;9)(B3;E3.2)12Gso reciprocal translocation is an autosomal recessive
mouse mutation involving chromosome 4, band B3 (Mmu4B3) and chromosome 9, band
E3.2 (Mmu9E3.2). The most striking phenotype of the 12Gso homozygote involves
axial skeleton deformities, resulting in significant shortening of body length, scoliosis,
displaced hips and kinky tails. Homozygous animals are significantly smaller than
normal littermates and frequently exhibit early lethality, as many of the mutants perish
by 1 day postnatal, and many others do not survive the three weeks to weaning age.
Homozygous 12Gso mice also develop an unusual bone marrow defect that closely
resembles leukemia. The penetrance of the mutation is variable with significant
dependence on genetic background.
Fluorescent in situ hybridization and reverse transcription polymerase chain
reaction were used to localize the chromosome 4 breakpoint to a 600 base pair region
intrinsic to ATP-binding cassette 1 (Abca1), a gene that encodes a large transmembrane
protein involved in cholesterol efflux. The disruption of Abca1 results in a truncated
transcript. Aberrant expression of genes associated with lipid metabolism has been
detected in 12Gso homozygotes, and previous data by others describing the effects of
Abca1 null mutations in humans and mice indicate the likely involvement of this gene in
the early lethality of 12Gso homozygotes. Using polymerase chain reaction (PCR)based methods, we have cloned and sequenced DNA surrounding the 9;4 chromosome
junction in 12Gso/12Gso DNA. The chromosome 9 breakpoint maps to a relatively
gene-poor region, lying in the intergenic region between an uncharacterized T-box gene,
Tbx18, and a ras-like EST, Rock1. Both genes represent potential candidates for the
skeletal anomalies present in 12Gso homozygotes. These studies lay a firm foundation
for future studies with the unique model offered by the 12Gso mouse, aimed at
identification of novel genes and previously unknown pathways required for skeletal
development and associated with leukemia susceptibility in humans and mice.
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CHAPTER 1: INTRODUCTION

The origins of the t(4;9)12Gso mutation
The recessive t(4;9)12Gso mutation (hereafter referred to as 12Gso) arose in
studies designed to determine the mutagenic effects of radiological and chemical
clastogens on chromosome structure in mice. These studies were centered on the
heritable translocation tests (HTT). HTT are used to detect large chromosomal
rearrangements passed to viable offspring, specifically reciprocal translocations, based
on the reduction in the number of viable gametes produced by translocation carriers
(Generoso et al., 1980). Approximately 50% of the gametes produced by translocation
carriers carry partial duplications or deletions of chromosomal regions located telomeric
to the sites of reciprocal exchange because of the disjunctional activity of unbalanced
gametes in the first meiotic division.

The embryos carrying these unbalanced

chromosome complements die early in gestation. As a result, matings of translocation
carrier mice generate litters that are statistically half the size of that produced by normal
mice of similar genetic backgrounds, thus these carrier mice are termed “semisterile”.
Semisterility, as measured by the size of litters produced by a normal inbred or hybrid
female when mated to a translocation carrier relative to the litter size produced in
matings to a normal male, has been used extensively since the 1940s as a test for the
presence of reciprocal translocations in mutagenesis studies. The reliability of this
simple breeding test in establishing carrier genotype has been confirmed by cytogenetics
(Russell and Shelby, 1985; Generoso et al., 1980; refs. therein).

Litter-size

measurements have also been used in the maintenance of translocation stocks, as a
method for selecting carrier males and females that precludes the need for cytogenetics
(review, see Stubbs et al., 1997). Most of the Generoso (abbreviated Gso) collection of
translocation stocks have therefore been maintained by crossing tested heterozygous
carriers to normal inbred or hybrid mice, identifying translocation carriers for future
generations by semisterility rather than by association with any abnormal phenotype.
However, a small number of lines displayed dominant mutations that clearly
segregated with the inheritance of the translocation; one of these lines, 1Gso, was
1

described in an early publication (Rutledge et al., 1987). The discovery of dominant
phenotypes in translocation carriers inspired later studies in which the carrier animals
were bred to generate offspring homozygous for the translocation to examine potential
recessive phenotypes associated with the reciprocal exchange events. The recessively
inherited phenotypes that were identified included developmental anomalies,
neurological aberrations, and diseases such as cancer, leukemia, and polycystic kidney
disease (reviewed by Culiat et al., 1996; Stubbs, 1997).
One compound used in an HTT at Oak Ridge National Laboratory (ORNL) was
N,N’-methylene bisacrylamide (MBA), the chemical from whose application 12Gso was
derived. Dominant lethal (DLT) and HTT performed on males treated with this
chemical indicate that the maximum genetic effect is seen in maturing sperm (Rutledge
et al., 1990). MBA is a strong clastogen, and is unlikely to cause point mutations. For
this reason, the frequency of mutational events that are heritable is not expected to be
great. Indeed, very few specific locus mutations were generated in treatment with MBA,
as expected from the nature of the mutation and the cellular stage affected (unpublished;
W. Generoso, pers. comm.). However, because of the lack of available data on the
mutagenic ability of MBA, which could be identified in the specific locus test,
estimation of genomic mutation frequency induced by MBA is difficult to determine.

The nature of the 12Gso mutation and the associated homozygous phenotype
The 12Gso mutant phenotype was discovered in the early stages of the breeding
studies used to find recessive phenotypes in the Gso stocks. The balanced reciprocal
translocation associated with 12Gso was mapped to chromosome 4, band B3 (Mmu
4B3), and chromosome 9, band E3.2 by cytogenetic methods (Mmu 9E3.2; N. L. A.
Cacheiro, pers. comm.; Figure 1). All mice karyotyped as homozygous for the 12Gso
translocation exhibited clear vertebral deformities which resulted in significant
shortening of body length, scoliosis, displaced hips and kinked tails (Figure 2). Early
lethality has been common to 12Gso homozygotes; many of the mutants
have perished between 1 day postnatal and the three weeks to weaning

2

Figure 1. The 12Gso phenotype is associated with a t(4;9)(B3;E3.2) translocation.
A. 12Gso heterozygote karyotype. Arrows represent the location of the chromosomal
breakpoint on the normal mouse chromosomes. Normal chromosomes (left) and
translocation chromosomes (right) are boxed for size and banding pattern comparison.
B. Ideotype of mouse chromosomes 4 and 9, highlighting the band in which the
chromosomal translocation occurred.
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Figure 2. 12Gso homozygous mice. Skeletal malformations are visually identifiable
in newborn 12Gso homozygotes. A. One-day postnatal 12Gso/12Gso (bottom) with
sibling (top). B. One-day postnatal 12Gso/12Gso. Closed arrows indicate the curvature
of the backbone, and the open arrow points to a kink in the tail. C. Two week old litter
from a 12Gso/+ X 12Gso/+ mating. The two 12Gso/12Gso mice (arrows) are much
smaller than their siblings. D. Magnified picture of the two 12Gso/12Gso mice from C.,
with closed arrows indicating the curvature of the backbone. E. One month old 12Gso
homozygote. Note the bulging abdomen caused by the curvature of the spine (white
arrow). F. Two adult 12Gso/12Gso mice. The closed arrow indicates the bulging
appearance of the rear of the mouse from the displaced hips; the open arrow indicates the
severely kinked tail.
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age.

None of the matings between 12Gso/12Gso mice and normal, carrier,

or homozygous mutant mice have produced any litters, although it is still not
certain that the sterility is due to true reproductive defects rather than physical
limitations imposed by the skeletal malformations. Unpublished studies from this project
have also revealed that homozygous 12Gso mice have also developed an unusual bone
marrow defect that closely resembles leukemia (L. Chittenden, X. Lu, unpublished; see
details in chapter 3).
The 12Gso heterozygotes are semisterile, as are carriers of balanced translocation
in general due to production of genetically imbalanced gametes (Generoso, 1978).
However, reduced numbers of liveborn pups from heterozygote matings occurred at
rates greater than can be attributed to translocation-associated effects alone, which
suggested that the mutation may also be lethal in at least some fraction of the
homozygous mice. In accordance with this observation, anecdotal evidence obtained
during breeding experiments at ORNL suggested that a relatively low number of
homozygous mutants were being born live in 12Gso carrier crosses (on a BLH [C3H/Rl
x C57BL/10a] background; K.T. Cain and W.M. Generoso, unpublished data). The
number of liveborn offspring exhibiting the skeletal phenotype in 12Gso carrier crosses
was reduced significantly after the stock was moved to LLNL and transferred from the
BLH strains to an inbred C3Hf/Rl background, and later, to a pathogen-free B6C3
[(C3H/HeJ X C57BL/6J) hybrid; The Jackson Laboratory, Bar Harbor, ME] genetic
background. In later experiments, the hypothesis was tested by karyotyping all liveborn
pups from carrier crosses during a year-long period of breeding at Lawerence Livermore
National Laboratory (LLNL). During this period, experimental results indicated that
homozygous offspring were dying pre- or perinatally (discussed in Chapter 3), but were
generated in utero in expected ratios (1/6). Later experiments transferred the stock onto
two very different genetic backgrounds, C57BL/10J and 129x1/SvJ (The Jackson
Laboratory), both of which were more supportive of mutant production than either
C3Hf/Rl or B6C3 and provided a strong suggestion that both the survival of 12Gso
homozygotes and the severity of the skeletal defects expressed by the 12Gso/12Gso
mice was profoundly influenced by genetic background.
7

Two explanations could be offered for the variations in numbers of animals
expressing the skeletal disorder after transferal to these different backgrounds: (1) some
of the homozygotes were born without physical manifestations of the mutation, that is,
the 12Gso phenotype could be characterized by incomplete penetrance, or, (2)
homozygotes were affected with varying degrees of severity on the different genetic
backgrounds and the most severely affected may have been dying prematurely. Even in
the mice that exhibited an obvious skeletal malformation, the 12Gso skeletal phenotype
was expressed in a highly variable manner; for example, animals have been born with
slightly shortened spines and kinked tails, severely affected spinal columns but normal
tails, and many intermediate variations. This has also been observed in other skeletal
mouse mutations; mutations such as achondroplasia, snub-nose, meander tail, and
luxoid (Table 1) all exhibit variable penetrance. The mutation luxoid (Table 1) is
particularly notable, as the luxoid phenotype is almost completely absent on a C3H
background (Green, 1955). The phenotypic variation in these classical mouse mutations
suggest that the 12Gso homozygous skeletal phenotype is likely to be expressed with
variable penetrance and influenced by background genetic modifiers.

Normal skeletal development
The skeletal phenotype exhibited by 12Gso mice suggested a defect in the early
stages of skeletogenesis, and lead to the focus on potential candidate genes that are
known or implicated in the classical pathways involved in this complex developmental
process. Since the foundations of the skeletal system occur during the very early stages
of development, and bone development is essentially completed before birth, molecular
and genetic access to human conditions involving congenital skeletal abnormalities has
been extraordinarily difficult.

As a result, only a small number of genes had been

implicated as root causes in the etiology of skeletal anomalies until recent years.
Because of the accessibility of most developmental stages in mouse embryos, mouse
models have provided critical insights into the nature of human developmental
syndromes. By examining the expression patterns of genes at different stages of
development, as well as interpreting the fully developed adult mouse skeleton in the
8

Table 1. Mouse skeletal mutations mapping to Mmu4 and Mmu9
Mmu

Mutation

Symbol

4

meander
tail

mea

9

Map
Phenotype
position
44.8
ankylosis or fusion in the tail
cM
vertebrae; cerebellar disruption;
incomplete penetrance

skeletal
sks
fusions
with
sterility
Achondro- cn
plasia

54.6
cM

skeletal fusions occur in the ribs
and one or more vertebrae;
mutants are also sterile

55.4
cM

limited viability; a square body
shape, bulging a short tail and
domed skull; limited chondrocytes
vulnerable to regressive change

luxoid

lu

23 cM

Abnormal
feet and
tail

Aft

32 cM

polydactyly, kinked tails, an
increased number of vertebrae and
ribs; at E10.5 the number of
somites is increased; penetrance is
almost null in C3H strains, and is
close to 90% in C57Bl/10
heterozygotes exhibit syndactyly
and kinked tails; penetrance of the
mutation is very low in the 129
strain

tail-kinks

tk

48 cM

short, very kinked tails, and minor
aberrations in the vertebral
column; genetic background can
influence viability

kyphoscoliosis

Ky

56 cM

progressive kyphoscoliosis in the
thoracic and lumbar vertebrae,
preceded by musculature
aberrations; mutation in
transglutaminase-like musclespecific protein
9

Ref.
Hollander and
Waggie,
1977;
Fletcher
et al.,
1991
Handel
et al.,
1988
Konyukhov et
al.,
1970;
DiLeone
et al.,
1997
Green et
al.,
1955;
Burda et
al., 1969
Lane,
1987

Gruneberg,
1954;
Imai et
al., 1993
Blanco
et al.,
1998;
Blanco
et al.,
2001

context of the presence or absence of these genes, researchers have begun to elucidate
the mechanisms of normal and abnormal skeletal development in mammals.
Vertebrae and rib formation essentially begins at gastrulation with the production
of the primitive streak in the posterior of the developing mouse embryo. At
approximately 6.5 days post coitus (dpc; Theiler stage [TS] 9), the primitive streak arises
from the cells of the epiblast, which are laid down in a posterior to anterior direction.
From the anterior end of the primitive streak the mesoderm cells differentiate into the
notochord (Psychoyos and Stern, 1996). Fully developed, the notochord blocks the
progression of other mesodermal cells, also derived from the primitive streak, into the
midsagittal area of the embryo. This results in two sheets of mesoderm, which
accumulate on either side of the centrally located neural tube and notochord (Hall,
1977). The sheet adjacent to the neural tube, the paraxial mesoderm, will give rise to the
somitomeres (presomitic mesoderm) at 7.5 dpc (TS 11), which will undergo initial
segmentation to form the somites by 8 dpc (TS12). Somites are paired, segmental
structures, the first of which arises from the anterior end of the primitive streak, near the
head region. Each somite becomes epithelialized soon after formation. This epithelial
somite is subject to the dorsoventral patterning influence of the surrounding tissues
(Kaufman and Bard, 1999), and subsequently partitions into three zones: dermatome,
myotome, and sclerotome. The ventrally located sclerotome reverts to mesenchymal
tissue and separates from the dermomyotome. The rostrocaudal compartmentalization of
the sclerotome occurs in the presomitic mesoderm, prior to the initial segmentation of
this mesodermal sheet, and is separate from the epithelialization that is responsible for
dorsoventral specification of dermomyotome and sclerotome (Stern and Keynes, 1987;
Bronner-Fraser and Stern, 1991; Saga and Takeda, 2001). This compartmentalization
can be identified in the sclerotome by an area of dense mesoderm and an area of looser
mesoderm, demarcated by a cleft. Each vertebra derives from a rearrangement, or
resegmentation, of these mesodermal regions in the sclerotome of the somites. The areas
of loose and dense mesoderm in the sclerotome separate, and the loose rostral portion
rejoins with the dense caudal portion of the next posterior sclerotome. This results in the
prevertebrae being slightly offset from the dermomyotome and the segmental units of
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the neural tube, which remain in the original position of the somite. The dense rostral
portions give rise to the intervertebral discs, while the lower density caudal regions give
rise to the centra and processes of the vertebrae (Goldstein and Kalcheim, 1992;
Kaufman and Bard, 1999).
As the notochord disappears at approximately 11 dpc (TS 18), the centers of
chondrification appear and begin the formation of cartilage. Cartilage, the precursor of
ossified bone, is derived from the mesenchymal cells (embryonic connective tissue cells)
of the mesoderm. These cells differentiate from their branched formation to a more
spherical one and begin to secrete matrix, at which point they are termed chondrocytes
(Feduccia and McCrady, 1991). Eventually, the chondrocytes become trapped within
the lacunae (spaces) in the same matrix they have secreted (Romer, 1970). By 13 dpc
(TS 21/22), the cartilaginous axial skeleton of the embryo is almost completely
developed.
Vertebrae are considered endochondral bone; that is, they arise from the
replacement of cartilage by bone. While cartilage begins to degenerate centrally through
the action of chondroclasts, calcification occurs by deposition of a complex form of
calcium phosphate called apatite. Blood vessels break through into the degenerated
areas of cartilage, bringing with them the osteoblasts, which secrete the bone material
and aid in the calcification process (Romer, 1970). Ossification proceeds outward
toward either end as well as from the epiphyses, which are ossification centers located at
the ends of bones. In vertebrae, several primary ossification centers occur, causing the
irregular shape of the bone. During the first postnatal week in the mouse -- when bone
formation has replaced the cartilage formation -- the waves of ossification from the shaft
and the epiphyses unite to complete the bony skeleton (Kaufman and Bard, 1999).
Anatomically, vertebrae and ribs are considered to be members of the somitic
axial skeleton. The vertebrae have two principal parts: the centrum, which is the
replacement of the notochord, and the neural arch, which serves to protect the spinal
cord on either side.

Each vertebra is connected to those in front and behind by the

zygapophyses, which extend from the neural arch. Above the spinal cord two arches
fuse to form the neural spine, at the base of which is the transverse process
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(diapophysis), where rib attachment occurs. Rib formation occurs at approximately the
same time as sclerotome amasses around the notochord. The ribs, also derived from the
sclerotome, are attached dorsally to thoracic vertebrae and ventrally to a sternum, with
the exception of a few shorter, posterior “floating ribs”, which are only attached to the
vertebral column. These are the components of “typical” vertebrae, although vertebrae
vary regionally in functional morphology along the column (Weichert and Presch, 1975).
The vertebral column is fundamentally divided into five categories (anteriorly to
posteriorly): the cervical (7 vertebrae); the thoracic (13 vertebrae); the lumbar (6
vertebrae); the sacral (4 vertebrae); and the caudal (30 to 31 vertebrae).

The molecular basis of skeletal defects
Human developmental abnormalities involving the skeleton have been
documented extensively, ranging from complex heritable bone disorders to the simple
absence of one tiny phalanx. The genes responsible for many of these disorders have
been cloned, and encode such products as collagen matrix components, cellular signaling
molecules and receptors, and transcription factors. These defects can be grouped into
three categories: defects in collagen metabolism, aberrant differentiation or proliferation
of chondrocytes and osteoblasts, and abnormal mesenchymal condensation and its
associated incorrect cellular differentiation (Mundlos and Olsen, 1997a, b).
An example of a disease resulting from a defect in collagenous metabolism is
osteogenesis imperfecta. Osteogenesis imperfecta is more commonly known as brittle
bone disease, and is characterized by skeletal fragility. This fragility derives from
mutations within the genes for COL1A1 and COL1A2, which encode the α 1 and α2
chains of collagen, respectively (Byers and Steiner, 1992). The mutations can range
from mild anomalies caused by decreased collagen formation to lethal effects caused by
the inability to form the collagen triple helix (Cotran et al., 1999).
Achondroplasia results from an abnormal proliferation of chondrocytes within
the growth plate. The root cause of the disease is a point mutation in the cellular
signaling molecule FGFR3. The mutation hyperstimulates the receptor, leading to
constant inhibition of cartilage production and the resulting dwarfism (Mundlos and
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Olsen, 1997a). The homologous mouse mutation achondroplasia (cn) maps to 55.4 cM
on mouse chromosome 4 near Bmp8a and Bmp8b, members of the bone morphogenic
protein family (DiLeone et al., 1997). Mutants are clearly recognizable by the square
body shape and bulging abdomen, accompanied by a short tail and domed skull. The
major effect is seen in the chondrocytes, which are limited in number (Konyukhov and
Paschin, 1970) and are vulnerable to regressive change (Silberberg et al., 1976).
The majority of skeletal mutations manifest before cartilage is fully developed.
Since cartilage provides the template from which the bone of the axial skeleton derives,
the effects of mutations in this tissue persist in the fully developed skeleton.
Chondrification centers of the developing cartilage are not typically direct targets of
gene action, therefore effects of these mutations are generally displayed before cartilage
formation.

Mutations in somites, mesenchyme or sclerotome, the notochord, or the

primitive streak affect the cartilaginous skeleton, since these tissues are precursors to
cartilage development (Johnson, 1986). Defects in mesenchymal condensation, as well
as aberrant cellular differentiation, usually lead to congenital malformations. These
malformations are exceedingly difficult to study at a molecular level in humans, as
access to the developmental pathways is limited, and many of the affected genes from
which the defect derives are no longer expressed in adult tissues. It is also to this
category of aberrations that 12Gso bears the most resemblance, and will thus be the
category for which 12Gso represents the strongest model.
One of the most common vertebral malformations is scoliosis, particularly in the
form of kyphosis, in which the vertebral column arches dorsally. Scoliosis is generally
analyzed when present as a secondary condition of other skeletal syndromes, such as
Basal Cell Nevus Syndrome (BCNS; also called Gorlin Syndrome). As the name
implies, the most identifiable characteristic of this syndrome is the numerous basal cell
nevi. However, this syndrome also manifests severe skeletal deformities, including
kyphoscoliosis, bifid, fused, or missing ribs, and vertebral anomalies deriving from
improper segmentation (reviewed by Gorlin, 1987). This syndrome derives from
mutations in PTCH and PTCH2, vertebrate homologs of the Drosophila gene patched
(Hahn et al., 1996).
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Within the classification of congenital malformations is included a broad, generic
category termed spondylocostal dysostosis. This disease is characterized by shortened
stature; fused, block, and hemivertebrae; nonprogressive kyphosis; fused, missing, and
bifid ribs; shortened neck; apparent normal appearance of appendicular structures;
seemingly normal neurological function; and numerous cases of neonatal death
associated with respiratory infection (Jarcho and Levin, 1938; Lavy et al., 1966).
Mutations in delta-like 3 (DLL3), a mammalian homologue of the Drosophila gene
Delta, are associated with the autosomal recessive form of this disease (Bulman et al.,
2000). Mutations in the mouse homologue of this gene result in the classical mutation
pudgy (pu). pu arose from a spontaneous point mutation (Greenfield and Brown, 1987)
in Dll3, which maps to chromosome 7 in mouse (Kusumi et al., 1998). Dll3 is a member
of the Notch signaling pathway, which includes a cascade of pair-rule genes that control
positional effects during development.
The 12Gso mouse mutation became the central focus of this thesis work because
of its obvious effects on skeletal development. The mutation manifests as a profound
skeletal deformity, visually identifiable at one day postnatal (Figure 2). Before it was
mapped and characterized, the mutant was nicknamed “pudgy” by members of Dr.
Generoso’s group because of its outward morphological similarity to the previously
mentioned mutation of the same name. The gene associated with the pu phenotype has
been cloned and identified as the mouse delta-like 3 (Dll3) locus (Kusumi et al., 1998).
Phenotypically, 12Gso also strongly resembles targeted null mutations in the lunatic
fringe (Lfng) gene, which, like Dll3, participates in the Notch-Delta developmental
pathway. Because of the phenotypic similarities, a relationship between the12Gso
mutation and genes encoding members of this pathway was hypothesized. Dll3 and Lfng
mutant mice have severe vertebral and tail anomalies, including irregularly shaped
vertebrae and hemivertebrae that have been fused and jumbled extensively, rib and
sternum anomalies, and a kinked or missing tail (Figure 3). Abnormalities seem to be
restricted to the axial skeleton, since the appendicular structures appear normal. The
abnormalities in the tail have been attributed to lack of segmentation in the sclerotome
and/or somitic tissue; this could also be the source of the malformation in the vertebral
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Figure 3. The 12Gso homozygote skeletal phenotype strongly resembles that of
mutations in the genes from the Notch-Delta pathway. Orange arrows indicate
homozygotes from all three genotypes. Note the wedge-like shape, abnormal skeleton,
and shortened body length peculiar to all three mutations. Mutations: Lfng-/-, lunatic
fringe deficiency; Dll3pu, delta-like 3 deficiency. The Lfng-/- knockout mutation was
generated by Zhang and Gridley, and the D l lpu mutation was characterized by
Dunwoodie et al.
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column. In addition to the deficiency in segmentation, the somites present in p u
embryos do not extend as far caudally as the somites in a normal developing embryo,
thereby causing the shortening of the vertebral column. Like 12Gso homozygotes, pu
embryos have limited viability after the weaning stages (Gruneberg, 1961).

These

studies suggest that the skeletal malformations and limited viability of 12Gso might also
represent manifestations of a loss-of-function mutation in a single gene.

Aspects of hematopoiesis relevant to bone marrow components
As phenotypic studies have revealed, the 12Gso skeletal phenotype is
accompanied by aberrations in hematopoiesis within the bone marrow. To understand
the genetic factors that might contribute to this aspect of the phenotype, the basic stages
of normal hematopoietic development must first be considered. Hematopoiesis is the
generation of the cells of the hematopoietic system: blood cells, blood precursors in the
bone marrow, and cells of specific lineage in the spleen, lymph nodes, and other
lymphatic tissues. In normal progression, the first, or mesoblastic, phase occurs as early
as 7 dpc, and involves the production of primitive erythroblasts from the mesoderm of
the blood islands in the yolk sac and the splanchnopleura (TS 10; Kaufman, 1991; Godin
et al., 1993). The second, or hepatic, phase begins at early- to mid-gestation, peaks at
approximately mid-gestation, and subsides at birth. This phase takes place principally in
the fetal liver, but is also active in the spleen and lymph nodes. The third phase begins
at mid- to late-gestation and continues past birth, taking place in the bone marrow. The
rate of hematopoiesis in the bone marrow gradually decreases until puberty, at which
time approximately half of the marrow space is hematopoietically active, as indicated by
the presence of red marrow only in the skull, pelvis, vertebrae, ribs, sternum, and the
proximal epiphyseal regions of the humerus and femur (Cotran et al., 1999).
The precursors to the cells involved in hematopoiesis are undifferentiated
hematopoietic stem cells (HSCs). The HSCs are first found in the fetal liver and spleen,
and gradually move exclusively into bone marrow during the third phase of
hematopoiesis. From these HSCs derive two cell lineages: the lymphoid stem cells and
the trilineage myeloid stem cells. From the triliniage myeloid stem cells derive the
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erythrocytes, megakaryocytes, granulocytes, eosinophils, monocytes, and macrophages,
and from the lymphocytic line derive the B-cells, T-cells, and natural killer cells (Cotran
et al., 1999). In B-cell development, the HSC first differentiates into a lymphoid stem
cell, the precursor to both T- and B- cells, localized in the fetal liver or bone marrow.
The progeny of the lymphoid stem cell either migrate to the thymus to differentiate into
T-cells, or remain in the marrow to differentiate into B-cells. Differentiation of the
lymphoid stem cell into B-cells begins at approximately E14 in the mouse.
The morphology of the bone marrow structure can be broken down into bone
trabeculae and the medullary space. The medullary space contains adipose tissue, the
previously mentioned hematopoietic cells, and the connective and vascular tissue of the
stroma. The vascular tissue of the stroma is intricate; it consists of an artery that
branches into arterioles, which further branch into the capillaries that connect to a
system of sinusoids. While in earlier stages the marrow cellularity is approximately
80%, in the human adult, normal bone marrow composition is a one to one ratio of fat
cells to hematopoietic elements, of which approximately 60% are granulocytic and 10%
- 15% are lymphocytic in origin. Extreme alterations in these percentages are indicative
of disorder, such as the hyperproliferation that is associated with erythroid hyperplasia or
leukemia, or the hypocellularity associated with some forms of anemia (Litz et al., 1996;
Cotran et al., 1999).
Maturation of B-cells in the bone marrow occurs as the cells migrate towards the
central venous sinus of the marrow. That is, earlier progenitor cells would be located
near the endosteum, while the immature and mature B-cells surviving apoptosis and
phagocytosis would be closest to the central sinus and released into circulation. The
maturation of B-cells is dependent on a number of cytokines and growth factors, and is
thought to be maintained, at least in part, by the stromal and adventitial reticular cells
that line the interior of the cavity between the endosteum and central sinus. It is from
the adventitial cells that the fat cells of the marrow derive.
Because of the morphological similarity between stages in B-cell development,
classification
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deoxynucleotidyltransferase (Tdt), cell surface antigens, and immunoglobulin (Ig)
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expression (Loken et al., 1987). Lymphoid stem cells, which express Tdt but no cell
surface antigens, proliferate and differentiate, and those that are destined to be in the Bcell lineage undergo Ig heavy chain gene rearrangement. Ig gene rearrangement begins
with D-J rearrangement, and concludes with V-D rearrangement (Felix and Poplack,
1991). While undergoing recombination, the cells are termed pro-B-cells, and besides
Tdt, also express CD10, CD72, CD34, and progressively express CD19, CD20, and
CD21. Expression of CD10 ends when the cells emerge as pre-B-cells, which by this
time have assembled heavy chains of the m isoform. The µ heavy chains are at first
expressed in the cytoplasm, but as the stage progresses, are expressed at the surface,
associated with surrogate y light chains, and accompanied by Igα and Igβ, the remaining
components of the B-cell antigen receptor (Litz et al., 1996). At this time, the Ig light
chain genes rearrange to produce a κ or λ light chain, and cell surface expression of the
intact B-cell receptor, which could be either IgM-κ or λ + Igα/Igβ, commences. It is at
this time that the cell ceases to express Tdt, is classified as an immature B-cell, and is
committed to making a specific antibody based on the expressed antigen receptor (Felix
and Poplack, 1991; Litz et al., 1996). As the cell progresses into a mature B-cell, both
IgM and IgD are expressed as surface Ig. Expression of CD23 is present in immature
and mature B-cells, but is mostly found on activated B-cells. After activation by
antigen, the B-cells either differentiate into antibody-forming cells (which terminally
differentiate into plasma cells), or into memory cells.

Common forms and genetic causes of inherited bone marrow hyperplasia
Most neoplasms, or foci of excessive and aberrant cellular growth, are
somatically derived and associated with extensive DNA damage. This damage typically
involves genes that are classified as either oncogenes or tumor suppressor genes,
although other classes, such as those that regulate DNA repair and apoptosis, could also
contribute to abnormal proliferation (Cotran et al., 1999). In normal modes of action,
oncogenes should regulate cellular growth and differentiation, whereas tumor suppressor
genes usually encode products that have a negative influence on cellular growth. Due to
the roles of these genes in the induction of proliferation and/or differentiation, activation
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of only one copy of an oncogene can lead to neoplastic growth (Lebovitz, 1986; Muller,
1986). These oncogenes may encode growth factors, growth factor receptors, cell cycle
regulators, nuclear regulatory proteins, or proteins of a signal transduction pathway
(Cotran et al., 1999). However, as tumor suppressor genes inhibit cellular growth, two
“hits” are typically necessary to inactivate both copies of the gene, and thus, make that
locus ineffectual for growth inhibition (Levine, 1993). While the pathways through
which tumor suppressor genes contribute to neoplasms is less understood than those
pertaining to oncogenes, it is likely that the inhibitory signals are connected to cell cycle
or transcription regulation (Cotran et al., 1999). Oncogenes, in particular, have been well
studied in relation to immunological neoplasms, and it appears that different oncogenes
affect specific cell types with respect to growth stimulation, as exemplified by the c-myc
oncogene in B-cell lymphomas (Taub et al., 1982; Della-Favera et al., 1982). The genes
may be activated either by changes in structure or regulation, which may occur by
mechanisms such as gene amplification, point mutations, or chromosomal
rearrangements such as translocations (Cotran et al., 1999). All lymphoid and
myelocytic neoplasms are traditionally classified as malignant, but a distinct difference
lies between the hematopoietic neoplasms termed leukemia and lymphoma. While the
two may present overlapping clinical findings, they are distinct with respect to origin
and tissue distribution. Leukemia can be defined as neoplasms of lymphoid or
myelocytic origin with focused involvement of the bone marrow, and is usually
accompanied by infiltration of the peripheral blood by a large volume of tumor cells.
Lymphomas, on the other hand, are characterized by proliferations that have arisen in
separate tissue masses, and may later deposit tumor cells into the blood at leukemic
levels. However, all lymphoid neoplasms are monoclonal, that is, they derive from a
single cell, and are transformed after antigen receptor gene rearrangement. For this
reason, the diagnosis and classification of the type of lymphoid neoplasm is often based
on the cell type of origin (e.g. B lymphocyte, myelocyte) and differentiation stage that
appears to be amplified (Cotran et al., 1999).
Another term for bone marrow hyperplasia is leukemia, as it is defined as the
abnormal proliferation of hematopoietic cells whose initial locales are the blood and
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bone marrow.

Briefly, leukemias can be either lymphoproliferative or

myeloproliferative, and acute or chronic.

Acute leukemias are marked by a

predominance of blast cells, and often there is evidence of marrow failure. Chronic
leukemias, on the other hand, are marked by leukocytosis and predominantly mature
cells. Early marrow failure is rare (Litz et al., 1996). Occurrences of all forms of
leukemia in the United States averages approximately 9.5 cases per 100,000 individuals,
per year (Ries et al., 1991), and is usually more prevalent in males than females.
The four major forms of leukemia are acute myeloid leukemia, acute lymphoid
leukemia, chronic myeloid leukemia, and chronic lymphocytic leukemia. Acute myeloid
leukemias (AMLs) occur in the United States at a proportion of 2.2 individuals per
100,000, annually, and can be characterized by hyperproliferation of a precursor or
immature myeloid cell, principally located in the marrow. The proliferating cells can be
monoblasts, promonocytes, megakaryoblasts, promyelocyte, myeloblasts, or erythroid
precursors. The extensive proliferation of the immature cell type and the resulting lack
of normal myeloid cells is the principal cause of bone marrow failure in these patients.
Depending on which form of AML is present, different cellular antigens may be present
in the proliferative population; these markers include CD13, CD14, CD15, CD33, and
CD36. Common cytogenetic diagnostics for AML are also available, such as the
presence of t(15;17)(q11; q11-12) in over 90% of cases of promyelocytic leukemia
(Litz, et al., 1996).
Chronic myeloid leukemia (CML) occurs in the United States at a rate of 1.3 per
100,000, and is commonly diagnosed by use of the Philadelphia chromosome,
t(9;22)(q34;q11). The bone marrow in CML patients is almost 100% cellular, mostly
composed of granulocytic precursors (Cotran et al., 1999). In addition to neutrophilic
hyperplasia in the bone marrow, CML patients also present marked leukocytosis and
splenomegaly. The Philadelphia chromosome (Ph), present in 95% of cases, results in
the fusion of the major breakpoint cluster region gene (BCR) on chromosome 22 to the
c-abl oncogene (ABL) on chromosome 9 (Kutrzrock et al., 1988; Litz et al., 1996).
However, in the juvenile form of the disease, Ph is not present, but presenting findings
do include hepatosplenomegaly, lymphodenopathy, anemia, and skin rashes. Prognoses
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in these cases are typically poor; median survival is less than one year (Freedman et al.,
1988; Litz et al., 1996).
The precursor B-cell neoplasm acute lymphoblastic leukemia (ALL) is
manifested in the United States at a rate of 1.5 per 100,000, and is characterized by a
proliferation of lymphoblasts. The majority of cases are manifested during childhood.
Depending on the blast morphology, ALL may be classified as L1, L2, or the less
frequent L3, and can be either populous in B-cell precursor cells, T-cells, or B-cells
(Foon and Todd, 1986). A common marker for the B-cell form is CD10, also known as
CALLA (Cotran et al., 1999), although infantile forms of the disease typically lack this
antigen and are typed as “null”. ALL may also be identified cytogenetically. Almost all
cases present a translocation that disrupts the c-myc oncogene on HSA8 and an
immunoglobulin chain locus. The second disrupted locus may be a gene on HSA14
encoding the heavy chain, on HSA2 encoding the kappa light chain, or on HSA22
encoding the lambda light chain. The transposition of these loci facilitates the aberrant
transcription of c-myc. A small percentage of cases also present the Philadelphia
chromosome (Vogler et al., 1981; Ribeiro et al., 1987). Clinically, it is very similar to
AML. As in other leukemias, bone marrow failure is linked to the replacement of
normal marrow by the hyperproliferative lymphocytes, and the disease is often
accompanied by lymphadenopathy, splenomegaly, and hepatomegaly derived from
neoplastic infiltration of these particular organs (Litz et al., 1996).
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in
the United States, occurring at an incidence of 2.6 per 100,000 individuals. The disease
is a peripheral B-cell neoplasm that is characterized predominantly by hyperproliferation
of light chain-restricted mature B-cells (Bennett et al., 1989), and accordingly, most
neoplasms are found in patients over 50 years old (Cotran et al., 1999). It is always
observed in the bone marrow, and lymphadenopathy and/or hepatosplenomegaly is
present in 50-60% of cases.

Very often the disease is accompanied by

hypogammaglobulinemia, and occasionally, autoimmunehemolytic anemia derived from
neoplastic, self-reactive B-cells (Cotran et al., 1999). The bone marrow varies, and
diffuse patterns are associated with a poor prognosis. Besides the reduction in light
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chain-restricted surface immunoglobulin, the disease also presents CD5, a pan-T-cell
antigen that is normally expressed only on a small subset of circulating B-cells (Litz et
al., 1996).
Few spontaneous mouse models of leukemia exist, but there has been a
considerable amount of work done with respect to transgenics and gene knockout
models that target genes known to be involved in human leukemias. A recent example is
the mouse model of CLL generated by the insertion of a TCL1 transgene (Bichi et al.
2002). TCL1, an oncogene overexpressed in T prolymphocytic leukemia, exhibits
normal expression in immature T-cells, and a range of early B-cells. The mice carrying
a human transgene for TCL1 exhibited an expanded population of CD5+ B-cells,
indicative of B-CLL, and upon aging, developed all related symptoms of CLL. Another
of these mouse models was a targeted mutation of the Mll gene, which lies near the
luxoid mutation on mouse chromosome 9 and is homologous to the Drosophila gene
trithorax. The product of this gene exists in multiply spliced forms and has at least
partial similarity to DNA methyltransferases (Ma et al., 1993). The mutation is a
homozygous lethal, and heterozygotes exhibit not only hematopoietic abnormalities, but
also skeletal malformations.

These malformations are associated with aberrant

expression of the homeotic genes Hoxa7 and Hoxc9, which are regulated through a
conserved SET domain in the Mll sequence (Yu et al., 1995).

The role of genes for somitic development in both skeletal development and
hematopoiesis
Two major signaling pathways, one centered on the Notch-Delta receptor-ligand
pair and one involving the Sonic Hedgehog secreted morphogen, have been well
documented with regard to somitogenesis, and have implications in hematopoietic
development.

The components of the Notch-Delta pathway are conserved from

Drosophila to human, and maintain a similarity in basic function: to participate in the
specification of cellular fates by use of a signaling mechanism between adjacent cells.
However, the genes expressed in Drosophila are neurogenic, and probably not involved
in segmentation (Artavanis-Tsakonas et al., 1999), supporting the morphological data
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that indicate different mechanisms for segmentation are present in flies. In mammals,
however, this pathway is critical for the establishment of rostrocaudal polarity and
periodicity in the presomitic mesoderm (Saga and Takeda, 2001, and refs. therein).
Specific members of the Notch-Delta pathway are present in the presomitic
mesoderm, initially expressed in a cyclical fashion. In mouse, some of these include
Lfng and the hairy and enhancer of split-related genes Hes1, Hes5, Hes7, and Hey1
(Aulehla and Johnson, 1999; Leimeister et al., 1999; Bessho et al., 2000; Jouve et al.,
2000; Dunwoodie et al., 2002). The suggested role of Notch signaling has been to
maintain the oscillating expression patterns of these genes by cellular communication
through its own wave-like activity which traverses the presomitic mesoderm for each
somite formed (Jiang et al., 2000).
Expression of Notch1 and some of its ligands have also been identified in
hematopoietic precursors, developing B-cells, T-cells, and myeloblasts (Jones et al.,
1998; Varnum-Finney et al., 1998; Osborne and Miele, 1999; Walker et al., 2001;
Kawamata et al., 2002). Indeed, it has been speculated that although Notch1 appears to
be particularly responsible for early T-cell development, as indicated by expression in
fluorescence-activated cell sorter analysis (e.g., Kawamata et al., 2002) and genetic
overexpression that resulted in T cell lymphoma/leukemia (Pear et al., 1996; Pui et al.,
1999; Wilson et al., 2001). However, it has been indicated that this T-cell development
occurs at the expense of B-cell development, because of suppression of B-cell
development in Notch1 overexpression and the proliferation of B-cells upon inhibition of
Notch1, presumably through ligands such as Deltex and Jagged1 (Pui et al., 1999;
Bertrand et al., 2000; Izon et al., 2002). This role of Notch1 in hematopoiesis seems to
be in accordance with its role in segmentation: regulation of cell fate through a complex
series of interactions. Two Delta-like genes, Dll1 and Dll4, and a Serrate-like gene,
Jagged1, are expressed in the bone marrow stroma and endothelium and have also been
implicated in the control of Notch signaling within the bone marrow. As in somitic
tissue, these two ligands appear to differentially regulate Notch1, in a manner similar to
lateral inhibition (Bertrand et al., 2000).
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The Hedgehog pathway, particularly the members that interact with Sonic
hedgehog (Shh), is also evolutionarily conserved and has dual roles in both
somitogenesis and hematopoiesis. The expression of Shh and its progenitors in
mesodermal tissue induces dorsoventral polarity. Shh is expressed at sites of epithelialmesenchymal interaction (Bitgood and McMahon, 1995). Its relevance to somitogenesis
lies in its secretion as a morphogen gradient extending from the notochord which
induces the ventral somite to revert to mesenchymal tissue, thus becoming the
sclerotome from which the somites derive (Pourquie et al., 1993; Fan and TessierLavigne, 1994). Shh functions through the activation of the transcription of patched
(Ptc/Ptch), wingless (wg) or its homologs (e.g., Wnt3), and decapentaplegic (dpp) or its
homologs (e.g.Bmp4), often by the release of repression of associated complexes
(Hidalgo and Ingham, 1990; Ingham et al., 1991; Capdevila et al., 1994). The binding
of Shh to the Ptch-smoothened (Smo) receptor complex relieves the repression of Smo,
which in turn activates the transcription of cubitus interruptus (ci) homologs, the Gli
genes (Hui et al., 1994; Nusse et al., 1999; Stone et al., 1996; Kalderon et al., 1997).
Shh is also thought to be involved in epithelial proliferation, as overexpression
contributes to the expression of both Ptch and Gli1 in mesenchyme, leading to rapid
proliferation of both tissues (Grindley et al., 1997).
A role for Shh in hematopoiesis has also been implied. Shh, which induces the
proliferation of HSCs, acts through Ptch, Smo, and the downstream Gli genes to activate
a Bmp4-inhibitor, Noggin. Bmp4 has been previously documented in its role of
hematopoietic cell maintenance and survival (Maeno et al., 1996; Dale and Jones, 1999),
but this role for Shh has only recently been elucidated (Bhardwaj et al., 2001).
As embryonic hematopoietic cells derive from mesodermal tissue, the finding
that both pathways involve the same signaling members is not a novel idea and has been
studied in nonmammalian systems (Zon, 1995; Dosch et al., 1997). However, in light of
the fact that the associated skeletal phenotype closely resembles mutations within the
somitogenesis pathway, the finding of the lymphocyte hyperproliferation only further
solidifies the relationship between the genetic mutation(s) of 12Gso and those within
these developmental pathways.
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The genetic relationship between translocation breakpoints and gene(s) associated
with the mutant phenotypes
Many of the experiments described in this study proceed according to a basic
hypothesis, that is, that the 4;9 translocation inherited by 12Gso homozygous mice
disrupts either the structure or the regulation of transcription unit(s) that are directly
associated with the skeletal abnormalities, bone marrow defects, and low survival rates
of the mutant mice. This hypothesis is based on several lines of evidence, the strongest
of which has been provided by genotype-phenotype correlations that have been
documented before and during the course of this study. First and most importantly, strict
concordance has been observed between expression of the skeletal/early death
phenotype and homozygosity for the 12Gso translocation. These data, which will be
described in further detail in chapter 3, suggest that the chromosome break has disturbed
the structure. These data suggest that the chromosome break has disturbed the structure
or expression regulation of a gene or genes that are directly associated with the skeletal
defects and early lethality. The breeding methods employed for maintenance of the
12Gso stock have been based primarily on selection for the translocation, and not for
presence/absence of the phenotype (L. Stubbs, K.T. Cain, and W. Generoso, pers.
comm.). Because of this fact, we would expect that after many generations of selection
for the translocation, segregation between the translocation and the mutation associated
with the phenotype would have occurred if the two were not coinciding or very closely
linked. If the translocation were not associated with the phenotype, the aberrations seen
in the mutants would have disappeared after generations of stock maintenance. At the
very least, we would expect to document the expression of the skeletal and/or leukemic
phenotype among animals that did not inherit the translocation in homozygous form.
This has never been documented despite more than 10 years of maintenance breeding of
this mutant stock.
The phenotype could, however, be explained by a second mutation closely linked
to the translocation site. The a priori argument against involvement of a linked mutation
is based on two pieces of evidence: (1) the mutagenesis load expected from the
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treatment that produced the 12Gso line, which though relatively unknown, is unlikely to
be highly mutagenic, and (2) the amount of founder DNA [JH stock; (C3Hf/Rl X
101/Rl) F1] remaining in current mouse stocks after years of selective outbreeding.
Although 12Gso was maintained at Oak Ridge on a BLH [(C3Hf/Rl x C57BL/10a) F1]
hybrid background, we know from molecular evidence that the lesion occurred on the
C3Hf/Rl chromosome 4. It is therefore possible to estimate how much founder DNA, in
centimorgans (cM), remains after each generation based on calculations used for the
generation of congenic strains (Silver, 1995), that is, [200 (1-2-N)/N], where N
represents the generation number. To simplify this further, after the fifth generation, the
calculation [200/N] may be used. Because the mutation/allele of interest, in this case the
translocation breakpoint, is the selection reference for each generation, the genetic
region surrounding this mutation/allele decreases the amount of donor DNA much more
slowly. That said, it must be noted that 12Gso is already at F20 for several mice, and the
regions surrounding the chromosomal breakpoints in these mice can be calculated to
have retained an average10 cM, or 20 Mb, of founder DNA. While this number is an
estimate, and would certainly be subject to genetic variation in the region, it is still
useful in determining the likelihood of a second mutation linked to the site where the
lesion generating the translocation occurred. While a true estimate of the presence of a
second mutation is not possible with the data currently available, it is known that the
nature of MBA is to generate large lesions which lead to chromosomal rearrangements.
The presence of a second lesion in the form of another translocation may be ruled out;
gametes with this cytology would not be viable. Large deletions and inversions can also
be ruled out using mapping data generated for 12Gso in this 20 Mb region. The
elimination of these categories of lesions further reduces the chances of a mutation event
within the calculated 20 Mb. Since the likelihood of a linked mutation, though reduced,
cannot be ignored, experiments were designed to address the link between inheritance of
the translocations and the 12Gso mutant phenotype. Tests included genetic mapping,
breeding, and the use of microsatellite markers surrounding the breakpoints to determine
both the strain on which the mutagenic lesion occurred, and how much of this original
DNA is maintained in current stocks. A more in-depth analysis of the likelihood of non27

concordance will be addressed in later chapters. This analysis will be centered on an
estimate of the maximum possible distance existing between the map locations of the
translocation and the mutation causing the phenotype, without making the assumption
that the two are coextensive. While these calculations can not prove or disprove the role
of the translocation in the mutant phenotype, the data can be used to strengthen the
argument for concordance.

Chromosome rearrangements as a tool for identifying genes associated with human
disease
Localization of genes associated with inherited disorders can be an extremely
lengthy process, involving years of pedigree analysis or extensive animal breeding and
genotyping. Although localization of candidate genes has been streamlined significantly
with the recent advent of human and mouse genome sequence, making a link between
genes in a candidate interval and mutant phenotypes can still be an overwhelming task.
The use of a genetic approach for gene mapping in humans is difficult, therefore large
chromosomal rearrangements such as deletions, inversions, duplications and insertions
have assumed a prominent role in the discovery of genes associated with human disease.
A classic example that illustrates the usefulness of chromosomal rearrangements in
linking candidate genes to phenotypes is the story behind the cloning of the autosomal
dominant polycystic kidney disease gene, PKD1. The 1 megabase (Mb) critical region
to which the PKD1 gene had been localized was searched exhaustively for many years
(Reeders et al., 1985; Germano et al., 1992), and although many different genes were
discovered and analyzed, none could be clearly associated with the disease. The critical
breakthrough finally came when a second group of researchers identified a PKD1 patient
carrying a balanced translocation that disrupted the candidate region. Disrupted in the
breakpoint interval was a 14-kb transcript, which was confirmed as the causative agent
of ADPKD when deletions within this gene were also discovered in PKD1 patients
(European Polycystic Kidney Consortium, 1994).
Another prominent example is the DMD gene. The locus for Duchenne
muscular dystrophy had been localized to Xp21 by a linkage analysis (Davies et al.,
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1983), deletions in male subjects (e.g. Clarke et al., 1986; Greenburg et al., 1987) and by
numerous translocations (e.g. Lindenbaum et al., 1979; Jacobs et al., 1981; Boyd et al.,
1988). The DMD locus was finally cloned and confirmed through the use of an array of
deletions, most of which were contained within a 2 kb region of the cloned transcript
(Koenig et al., 1987). The use of translocations in isolation of the NF1 gene for
neurofibromatosis type I narrowed the region to under 1 Mb (Fountain et al., 1989;
O’Connell et al., 1989) before the gene was cloned by three separate groups, again with
the aid of deletions and translocations (Cawthon et al., 1990; Viskochil et al., 1990;
Wallace et al., 1990). Numerous other examples of genes associated with human
disease identified as a result of their disruption by chromosomal rearrangements can be
found in recent literature. Prominent examples include the FMR1 for Fragile X mental
retardation (Verkerk et al., 1991); the genes BRCA1 and BRCA2 involved in familial
breast cancer (Miki et al., 1994; Tavtigian et al., 1996); WT1 for Wilm’s tumor/aniridia
(Call et al., 1990); the TBX5 gene in Holt-Oram syndrome (Li et al., 1997); the SOX9
gene for autosomal sex reversal/campomelic dysplasia (Wagner et al., 1994); and the
RIEG gene for Rieger syndrome (Semina et al., 1996).
In addition to these inherited disease phenotypes, the use of somatic
rearrangements -- especially translocations -- in the cloning of genes associated with
leukemic phenotypes is widespread, and has been well reviewed by many sources
(Rowley, 1990; Rabbitts, 1994; Heim and Mitelman, 1986; Look, 1997; Rowley, 1998;
Rabbitts, 2001). Some of the more notable examples of leukemia-associated genes
cloned by use of translocations are MLL/ALL/HRX, which is disrupted in cases of acute
myeloid leukemia and acute lymphocytic leukemia (Zieman-van der Poel et al., 1991;
Djabali et al., 1992; Gu et al., 1992; Tkachuk et al., 1992), the AML1/CBFA2 gene,
which is disrupted by translocations in acute myeloid leukemia and acute lymphoblastic
leukemia (Myoshi et al., 1991), and the familiar Philadelphia chromosome, which fuses
the BCR and ABL genes in approximately 95% of chronic myeloid leukemia cases and
5% - 30% of acute lymphoblastic leukemia (de Klein et al., 1982). The discovery of
these genes would have been much delayed without the aid of a cytological marker such
as a translocation.
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Human geneticists have therefore learned to exploit the information given by
disease-associated balanced chromosome rearrangements, as a study done by a
consortium in Sweden and Denmark has indicated (Bugge et al., 2000). Even excluding
the most frequently seen cytogenetic aberrations, Robertsonian translocations and
chromosome 9 inversions, these laboratories found de novo rearrangements at a
frequency of six times the normal population in their cytogenetic archives, the data of
which was collected during diagnosis of an aberrant phenotype in an observed patient.
Of the rearrangements the group found, several disorders were either cloned or localized
within a finite interval as a direct result of cytogenetic anomalies. These include PraderWilli Syndrome (SNRPN; Schulze et al., 1996; Sun et al., 1996; Conroy et al., 1997;
Kuslich et al., 1999), Nail-patella syndrome (LMX1B; Duba et al., 1988; Silahtaroglu et
al., 1999), Beckwith-Wiedemann Syndrome (Tommerup et al., 1993), Grieg
cephalopolysyndactyly syndrome (Tommerup and Nielsen, 1983), Diamond-Blackfan
anemia (Gustavsson et al., 1997), Duchenne muscular dystrophy (Nielsen and Nielsen,
1984), and Trichorhinophalangeal syndrome type I (TRPS; Brandt et al., 1997). Other
disorders, e.g., Smidt syndrome, Noonan syndrome, ulna aplasia, polydactyly, atypical
ataxia, and various forms of mental retardation, were localized to candidate regions
using the chromosomal abnormalities (e.g., Skovby and Niebuhr, 1974; Kristoffersen et
al., 1974; Rasmussen et al., 1982; Friedrich et al., 1982). Eleven of the 14 wellcharacterized disorders that were documented in this analysis presented evidence that
linked the chromosomal breakage event and the phenotype by independent verification
of involvement of the disrupted locus in the disease. The translocations in the remaining
3 diseases did disrupt genes, but not the genes later proven to be associated with the
disease phenotype. While results of this study are preliminary, they contribute to an
overwhelming body of solid evidence that exists to support the usefulness of cytogenetic
abnormalities, such as translocations, as tools for cloning the genes responsible for
aberrant phenotypes.

30

Chromosome rearrangements and inherited disorders in mice
Because of anatomical, physiological and developmental similarities between
mice and humans, and because of the facility of maintenance and breeding, mice have
long been used for analysis of human development and disease. With regard to gross
chromosomal abnormalities, mice have been an ideal source of study. While the study
of human inversions, deletions, and translocations usually relies initially on a subject or
descendant of a subject with a spontaneous rearrangement presenting an obvious
phenotype, this is not the case for mice. By subjecting mice to specific mutagenesis
schemes, chromosomal rearrangements can be easily induced and studied. A few studies
have used chromosome rearrangements to identify genes associated with mutant
phenotypes in mice.
One of the most notable studies directly related to the 12Gso project is that of
cloning the gene associated with the non-agouti coat color phenotype. Although the
Agouti (A) locus had been a research subject for a number of years, it was not until 1990,
when an γ-radiation induced mutation caused a deletion, an insertion and an inversion,
placing the A gene adjacent to the previously characterized limb deformity (ld) locus,
which maps approximately 20 cM away in normal mice (Woychik et al., 1990). This
inversion (Bultman et al., 1991) enabled initial characterization of the region, ultimately
leading to the cloning of the A locus (Bultman et al., 1992).
Deletions and deletion complexes have been used extensively as tools for cloning
mouse genes. A large collection of deletion mutations exist for loci associated with
markers used in the specific locus test (Russell, 1951; Russell et al., 1982; Lyon et al.,
1992; Metallinos et al., 1994; Rinchik, 1994; Rinchik et al., 1994; Bell et al., 1995;
Johnson et al., 1995; Russell et al., 1995;O’Brien et al., 1996 reviewed by Rinchik,
2000). These deletion complexes permitted the use of hemizygosity as a method to
identify the functions of numerous loci linked to the region of mutation (e.g., Johnson et
al., 1995; Rinchik et al., 1999; Rinchik et al., 2002). The deletion complexes have also
led to the cloning of several genes in these regions, including the cp1/Gabrb3 gene for
cleft palate (Culiat et al., 1993; Culiat et al., 1995); juvenile fitness, growth, and sterility
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(jdf2; Walkowicz et al., 1999); fumarylacetoacetate hydrolase (Fah; Klebig et al., 1992);
extra embryonic mesoderm (eed; Sharan et al., 1991); and Emv-23 (Rinchik et al.,
1989).
Since a relatively small number of mouse translocation stocks are available, there
have been fewer mouse genes localized and/or cloned through the use of these
rearrangements. But examples do exist, including translocations that permitted analysis
of the Ts65Dn trisomy in a Down Syndrome model (Akeson et al., 2001) and the
identification of imprinted domains in mice (Cattanach and Kirk, 1985). More recently,
the use of a t(2;10) translocation has aided in the localization and cloning of the bicc
gene for autosomal recessive polycystic kidney disease in the mouse models 67Gso,
jcpk, and bpk (Chittenden et al., 2002; Price et al., 2002; L. Flaherty, pers. comm.).
67Gso, like 12Gso, is a stock from a large collection of translocation mutant mice, the
previously mentioned Gso stocks generated in mutagenesis studies at Oak Ridge
(reviewed by Culiat et al., 1997; Stubbs et al., 1997). Even with these examples of
mouse models, documentation of the use of chromosomal rearrangements as tools for
cloning mouse genes is not as prevalent as publications reporting the role of cytogenetic
abnormalities in the genetic characterization of human disease.

Using translocations as a tool to map and clone mutant genes
When searching for candidate genes, one of the most common ways to examine
the probability of a gene as being responsible for the phenotypic expression of a
mutation is to localize it within a region to which the mutation has been mapped. The
converse may also be used: establish finely tuned mapping of the mutation to a region in
which there is a gene whose misexpression, underexpression, or overexpression could
prove to be responsible for the phenotypic variations. Using a translocation as a guide
and fluorescent in situ hybridization (FISH)-based strategies (Mercer et al., 1993; Culiat
et al., 1997; Stubbs et al., 1997) to narrow the region surrounding the estimated
breakpoint interval of the 12Gso translocation, the search for likely candidate genes is
considerably facilitated. This FISH-based approach has been in use in the Stubbs
laboratory to localize the Mmu2 breakpoint of the 1Gso mouse (Stubbs, 1997; Carver
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and Stubbs, pers. comm.), the Mmu7 breakpoint of the 14Gso mouse (Culiat et al.,
1997), and the Mmu10 breakpoint of the 67Gso mouse (Chittenden et al., 2002; Price et
al., 2002); FISH has also been used in the cloning of human disease genes as well (e.g.,
Menkes disease; Mercer et al., 1993).
Because translocations create a visible disturbance in chromosome structure, the
mutation can be mapped through cytogenetic techniques to a well-defined chromosomal
region (Rutledge et al., 1986; Cacheiro et al., 1994). Therefore, the chromosomal
position can be estimated very early in the study of these mutations without the need for
the requisite large crosses that are generally used to map mutations in mice. Further
delineation of the breakpoint regions can be accomplished through the use of fluorescent
in situ hybridization (FISH) methods (Mercer et al., 1993; Culiat et al., 1997; Stubbs et
al., 1997). Gene markers in the outermost borders of the chromosomal band containing
the breakpoint are first used to isolate a series of bacterial artificial chromosome (BAC)
clones to be labeled with fluorescence or a hapten, and hybridized to metaphase spreads
generated from mice either homozygous -- or preferably, heterozygous -- for the
translocation. Because the map order of these genes is known, we expect the breakpoint
to lie between these two markers because they frame the band containing the breakpoint.
If breakpoint-flanking markers are indeed selected, FISH signals generated by these two
BACs will be separated onto two distinct translocation chromosomes. By contrast, the
same two markers will be linked on a normal mouse chromosome. However, if the
markers both mapped either above or below the translocation breakpoint, the signals
produced by the labeled BACs would remain paired together on the mutant
chromosome, just as on the normal chromosome. For example, if the markers Shb and
Ambp are used to isolate BACs, which are then hybridized to heterozygote chromosome
spreads (Figure 4), we would expect one of two outcomes. In the first outcome, two
pairs of signals will appear on two chromosomes, indicating that the breakpoint does not
lie between the two markers (Figure 4). In the second possible outcome, a linked pair of
signals will be detected on the normal chromosome in heterozygous spreads, and one
pair of signals will be seen on each of the translocated chromosomes. This second
outcome indicates that the two markers flank the breakpoint site. Once the breakpoint
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Figure 4. FISH-based strategy for mapping the chromosomal breakpoint. Solid
cylinders represent normal chromatids at mitosis, multicolor cylinders represent
translocated chromatids at mitosis, and yellow circles represent fluorescent-labeled BAC
clones. When hybridizing a pair of BAC clones with known map position to a
heterozygote metaphase chromosome spread, two scenarios are possible. The two
clones could both map above or below the chromosomal breakpoint (chromosome pairs
on the left side show clones mapping above breakpoint), or the clones can be separated
by the chromosomal breakpoint (chromosome pairs to the right). Once a pair of markers
is separated by the translocation, a clone mapping internal to this pair is used in
combination with the proximal and distal markers individually to further subdivide the
region (see text for more details).
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has been “anchored” by two markers, a marker internal to these is chosen for BAC
isolation and co-hybridization with each of the anchoring probes to divide the breakpoint
region (Figure 4). This process is repeated sequentially to narrow the breakpoint region
from a distance of 10+ cM to that of a few hundred kilobases, spanned by a single BAC
clone. Within that region, the candidate gene search can begin in earnest.
Knowledge of gene marker location within a given genetic interval is crucial to
this project for several reasons. First, gene markers that have been localized within the
designated breakpoint interval are the starting points of BAC isolation. Once the gene
order has been determined, it is possible to use BACs that have screened positive for
these genes as accurately placed probes for FISH. Second, these gene markers can give
some indication as to the remaining distance surrounding the breakpoint. Third, these
gene markers are the sources for candidate genes causing the phenotypes in the mutant.
Any gene(s) localized within the breakpoint region are fair game for disruption, and any
of these with any indication that they could play a role in the mutant phenotype are
worth more scrutiny. For this reason, the 12Gso project began with the mapping of
numerous gene markers to chromosomes 4 and 9. Before mapping began, the sizes of
the breakpoint regions measured approximately 15 centimorgans (cM) on Mmu 4
(homologous to portions of human 9) and 10 cM on Mmu 9 (homologous to portions of
human 3q, 6q, 11q, and 15q). Once these breakpoint regions were determined, genetic
mapping of the breakpoint region markers was done using interspecific backcross (IB)
mapping panels (Bonhomme, 1979). Although the possibility of a disrupted gene was
equivalent for either chromosome, more probes for Mmu4 were available because of a
genetic mapping experiment (Chakrabarti et al., 1996) that was completed prior to the
beginning of this project.

Consequently, mapping experiments were begun on

chromosome 4.
After these probes were mapped, clones suitable for FISH analysis were isolated
as cosmids and bacterial artificial chromosomes (BACs), selected by screening libraries
with markers that mapped to the regions of interest, and then rescreened to verify
positive clones. These isolated clones were used as probes for FISH, initially on Mmu 4,
to pinpoint the exact location of the breakpoint.
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12Gso carries a cytologically obvious reciprocal translocation, and as the
breakpoints were mapped to specific chromosomal bands, the next step in the
characterization of this mutation was the most tedious: pinpointing the exact location of
the breakpoint within this specific region.

By determining the location of the

breakpoints, the gene or genes associated with the phenotype could be more easily found
and analyzed. Though this process is the most difficult in cloning any mutation, the
cytogenetic landmarks available in the 12Gso mutation provide two advantages to this
end: the aforementioned assignment to a specific chromosomal band by cytogenetic
analysis, and the ability to use FISH as a means to efficiently span that chromosomal
band and cross the physical breakpoint boundary in a manner that is visually evident.
This FISH-based approach was used to narrow the region containing the breakpoint to a
single BAC clone, with the ultimate goal of finding a candidate gene or genes implicated
in producing the mutant phenotype. These genes would then be analyzed for verification
of candidacy and to explore developmental, hematopoietic, and other expression patterns
relevant to the gene(s).

The search for candidate genes
When examining the breakpoint regions, all genes that are located near the sites
of translocation, regardless of whether or not those genes are physically disrupted, need
to be analyzed because the possible effects on gene expression caused by chromosomal
rearrangements could occur from some distance away. This is exemplified by a
translocation breakpoint analyzed in patients with autosome sex reversal/campomelic
dysplasia, where although not disrupted by the translocation, the nearby SOX9 was
determined to be responsible for the phenotype (Wagner et al., 1994). Other examples
also exist, such as TWIST for Saethre-Chotzen syndrome (Krebs et al., 1997), the HOXD
cluster for mesomelic dysplasia (Spitz et al., 2002), and TBX5 for Holt-Oram syndrome
(Li et al., 1997). For this reason, the experiments to examine the expression of a
neighboring gene with characteristics that might also be consistent with some aspects of
the 12Gso phenotype will also be described.
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Sequence analysis of the BAC spanning the Mmu 4 breakpoint region indicated
the presence of the gene Abca1, whose position was already known, two Nipsnap-related
transcripts, and a short transcript annotated as an olfactory gene. The Abca1 gene is of
particular interest as a possible candidate for the early lethality exhibited by 12Gso
homozygotes. The 1 megabase (Mb) region surrounding Mmu9 breakpoint appears to be
relatively gene-poor, but contains two potential gene candidates: Tbx18, which is
expressed in somatic tissue, and Rock1, a ras-related kinase. Other genes in this region
include Snap91, a neuronally expressed gene, a hemoflavin-related EST, and an
uncharacterized EST expressed in brain. All of these genes will be discussed further in
Chapter 3.

Methods of locating and testing candidate genes
There are several ways in which a particular gene can be tested for candidacy.
Obviously, since we are working under the hypothesis that translocation-associated gene
disruption is the root cause of the phenotypes expressed by 12Gso mice, map position is
the first criterion. Although, as previously mentioned, the translocation may not
physically disrupt the gene, one would still expect the responsible gene to be located
near the break. Secondly, analysis of the gene product could aid in determining the
likelihood of candidacy by the kind of protein encoded by this gene, and if unknown, the
relationship of the protein encoded by the putative candidate gene to other proteins
whose functions might be applicable to the phenotype. Thirdly, relative levels and
locations of gene expression would also indicate candidacy.

Even without the

comparison of mutant and wild type tissues, expression pattern could be a strong
indicator; however, it is a much stronger positive indicator than a negative one.
Although expression information can be used to encourage further analysis of genes that
exhibit the expected patterns of tissue expression, it can be used to rule out candidate
genes only when fully documented and the phenotype in question is very well
understood. One method of testing expression, useful in the case of small samples from
which little RNA can be isolated, is that of reverse transcriptase polymerase chain
reaction (RT-PCR). Using available sequencing data, primers specific for various exons
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can be used to amplify specific regions of mutant RNA. RT-PCR screening could detect
secondary alterations that could affect gene regulatory regions, and could also determine
which portion of the gene was truncated in the generation of the breakpoint (Dirks et al.,
1996; Pai et al., 1994; Sato et al., 1996). It is more common, however, to test the gene
on a comparative Northern containing RNA from wild type and mutant tissues.
Northern blots are useful not only for determining differences in gene expression/
expression levels, as in RT-PCR, but can also determine if an aberrant transcript is
produced in mutant RNA. Finally, microarrays, which allow the quantitative and
qualitative measurement of gene expression through hybridization to an array of ESTs,
can be used as a means to determine which genes out of a large subset are expressed in a
particular tissue, and also to compare expression levels between various tissue samples
(e.g. McNeish et al., 2000).
In order to elucidate possible candidacy of the various genes within the 12Gso
breakpoint regions, analysis of the gene expression was carried out using a variety of
these methods.

The aims of the 12Gso project
The discovery of the 12Gso mutation provides a unique opportunity to map and
identify genes associated with skeletal development and leukemia, and to study their
molecular mechanisms in an animal model. Because the 12Gso translocation breakpoints
do not contain genes known to be involved in the Notch-Delta, Shh, or classic leukemia
gene pathways, the mutant phenotypes exhibited by 12Gso homozygous mice are very
likely to be associated with novel genes, or known genes interacting in previously
unknown pathways involved in somitogenesis, segmentation, or hematopoietic
development. This dissertation work has been devoted to the characterization and
development of this unique mouse model, including both phenotypic and genetic studies
as well as physical mapping and molecular analysis of the translocation breakpoint sites.
The long-range goals of this work are to identify the genes that are disrupted in 12Gso
mice, and to use these genes as the foundations for understanding the molecular bases of
inherited skeletal defects, reduced fitness, and leukemia in mammals.
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CHAPTER 2: MATERIALS AND METHODS

Alizarin red staining of the skeleton
To study skeletal structure, animals were euthanized with an approved inhalant
(chloroform or isofluorane) in order to not damage bone structure. Mice were skinned
and all internal organs, including the palate and tongue, were removed. Using a 20gauge needle, the brain was removed through the small hole at the base of the skull. For
mice with a higher fat content, the entire skeleton was placed in acetone overnight,
rinsed with distilled water, and placed in 2% potassium hydroxide (KOH) for the second
night. If skeletons were not fat-laden, they were placed immediately into 2% KOH the
first night; skeletons of young mice were treated in 1% KOH. The following day, the
skeleton was removed from the KOH and incubated 16-48 hours in 1:100 dilution of
0.4% Alizarin Red in 2% KOH (or 1% for younger skeletons). After incubation, the
skeleton was removed from the staining solution, rinsed with ethanol, and placed in a
clearing solution of 20% benzyl alcohol, 40% glycerol, and 40% ethanol for two days or
until sufficiently clear. Stained skeletons were stored indefinitely in 100% glycerol.

Combined staining of the skeleton and cartilage
After euthanasia, all skin and soft tissues were removed from the animal and the
carcass was soaked overnight in 95% ethanol. The following day, the skeleton was
incubated in a mixture of one volume glacial acetic acid, four volumes 95% ethanol, and
15 mg Alcian Blue (Sigma) per 50 mL final volume. The skeleton was left in this
solution for 16 to 48 hours for cartilage staining. Once the cartilage staining solution
was removed, the skeleton was rinsed in 95% ethanol for one hour, and then placed in
2% KOH for 6 to 24 hours. After incubation in 2% KOH, the skeleton was placed in 1%
KOH supplemented with 75 µg/mL Alizarin Red S (Sigma) for 12 to 24 hours to stain
the skeleton. Once the skeleton was sufficiently stained, it was cleared in a solution of
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20% glycerol/1% KOH for one week, with the solution changed daily. After clearing,
the stained skeleton was stored in a solution of 50% glycerol/ 50% ethanol for analysis.

Perfusion of the mouse for sectioning
Mice were euthanized as described for embryo isolation. The carcass was
sterilized with 70% and was dissected to expose the heart. A small cut was made in the
right atrium to vent the heart. A syringe attached to a 22 gauge needle was injected into
the left ventricle to flush the animal with 1x PBS containing 0.5% sodium nitrate and 10
units/mL heparin, followed by fixation with 4% paraformaldehyde (freshly made, in
1xPBS). Complete fixation was indicated by stiffness in the extremities of the carcass.
Tissues were examined for gross morphological abnormalities, then placed in 4%
paraformaldehyde solution overnight for the final fixation step, followed by storage in a
diethylpyrocarbonate (depc)-treated 70% ethanol solution.

Immunohistochemistry
All immunohistochemistry for this project was performed by Dr. Xiaochen Lu
and Edward Wehri. Slides for immunohistochemistry (IHC) were dewaxed by first
warming to approximately 60°C for 30 minutes, followed by three 5-minute xylene
washes. The slides were then rehydrated with a series of ethanol washes to prepare for
IHC. IHC was performed with the Histomouse-Plus kit (Zymed; South San Francisco,
CA). Manufacturer instructions were followed, with two exceptions. Prior to blocking,
the slides were incubated for 20 minutes in Target Retrieval Solution (DAKO;
Carpenteria, CA) at 96°C. The slides were then removed from the heat and cooled to
room temperature for 20 minutes. Following this step, the protocol proceeded with
blocking reagents as indicated until the hybridization step, which was carried out at 4°C
overnight.
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Determination of carrier status by breeding tests
The genotype of translocation carriers was first determined by semi-sterility
testing. According to the traditional method, males were bred to two females with a
normal karyotype that were dissected late in gestation and the number of dead implants
relative to normal, live fetuses was recorded. Carriers exhibited semi-sterility, or sired
litters with +/+ females that resulted in at least 50% dead implants and/or resorption
moles. Female carriers were tested by tabulation of resulting litter size when mated to
+/+ males. Females from the translocation stock consistently producing litters of less
than 5 offspring (compared to a normal average litter size of 10) were considered
carriers. Males in LLNL were tested in a manner similar to that of females. Karyotypic
analysis or FISH was used to confirm mouse genotypes.
Determination of heterozygosity by whole chromosome paints
Chromosomal painting was performed using FITC-conjugated mouse whole
chromosome paints (Cambio, Cambridge, UK). Manufacturer protocol was followed
through hybridization of the paints to the chromosomes. After incubation overnight at
42°C, the slides are washed twice for 5 minutes each in 50% formamide/2xSSC at 45°C,
followed by two washes of 5 minutes each in 0.1xSSC at 45°C. Biotinylated antifluorescein (Vector) was diluted 1:200 and FITC-conjugated Avidin (Vector) was
diluted at 1:100 in 4xSSC/1% Tween-20/1%BSA. Slides were incubated with the diluted
anti-fluorescein for 15 – 20 minutes at 42°C. After incubation, slides were washed three
times in 4xSSC/1% Tween-20 at 42°C for 5 minutes per wash. The slides were then
incubated with diluted Avidin for 15 – 20 minutes at 42°C, and washed in 4xSSC/1%
Tween-20 as previously described. Chromosomes were counterstained with 0.2 ng/mL
DAPI and examined using DAPI/FITC excitation filters (Applied Imaging, Santa Clara,
CA) on a Zeiss Axiophot microscope.

Isolation of embryos for expression studies and prenatal analysis
To generate embryos for usage in the expression studies, mating pairs of either
C57BL/6J x C3H/HeJ (B6C3) hybrid mice (Jackson Laboratory) or pairs consisting of
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12Gso heterozygous males and females (abbreviated 12Gso/+ X 12Gso/+) were caged
together and examined daily for vaginal plugs. The genetic background of the 12Gso/+
mice was B6C3, C57BL/10J, or 129x1/SvJ. When a vaginal plug was found, the female
was separated from the male. The developmental time was designated at 0.5 days post
coitum (dpc) on this date. Embryos were isolated at 9.5, 10.5, 11.5, 12.5, 15.5, and 18.5
dpc. On the date designated for isolation, the pregnant female was euthanized and her
abdominal cavity was opened for uterine access. The uterus was removed and placed in
cold phosphate buffered saline (PBS), where individual embryos were separated. For
extraction of the embryo from the embryo sac, the sacs were transferred individually to a
fresh petri dish containing cold PBS. All embryos were dissected from the deciduum
and yolk sac and transferred into freshly prepared cold 4% paraformaldehyde in PBS;
each 12Gso/+ X 12Gso/+ offspring was housed separately until genotyped. The yolk
sacs of 12Gso/+ X 12Gso/+ embryos were placed into a cell lysis solution [100 mM
Tris, pH 8.5, 5 mM EDTA, 200 mM sodium chloride (NaCl), 0.2% sodium dodecyl
sulfate (SDS), 100 mg/mL Proteinase K] overnight at 37°C in preparation for genotypic
analysis. Tail biopsies of older embryos were taken for karyotype analysis (see below),
and the musculature of the back was opened for complete fixation. Fixation occurred by
rocking at 4°C; length of fixation was dependent on embryo age: 1-2 hours for E9.5, 2-4
hours for E10.5, 4-6 hours for E11.5, 6-8 hours for E12.5, and overnight for the
remaining embryos. After fixation, embryos were dehydrated through a series of PBS
and methanol washes at 4°C: PBS, PBS, 25% methanol, 50% methanol, 75% methanol,
100% methanol, 100% methanol, and then stored at –20°C in a fresh change of 100%
methanol. Genomic DNA was isolated from the yolk sacs by isopropanol precipitation.
The supernatant was removed, and the pellets were air-dried and resuspended in dH2O.
Embryos for sectioning were embedded in paraffin, sectioned to a thickness of 5 - 10
microns using a Leica motorized microtome and attached to slides (embedding and
sectioning done by Dr. Xiaochen Lu).
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Outcrosses to test effects of genetic background
To test the effects of different genetic backgrounds on expression of the skeletal
phenotype in liveborn pups, 12Gso was crossed onto the mouse strains 129x1/SvJ and
C57BL/10J (The Jackson Laboratory). These two strains were chosen because of
documented evidence of higher penetrance of similar skeletal mutations, like Dll3pu
(Dunwoodie et al., 1997), when maintained on these two backgrounds. The 12Gso
translocation was transferred from B6C3 onto genetic backgrounds containing
129x1/SvJ and C57BL/10J alleles by mating females from these strains with male 12Gso
heterozygotes, followed by backcrossing of the male offspring to the inbred mother for 4
generations. The new lines were then maintained by heterozygote intercrosses.

Complementation testing
To determine whether or not 12Gso was allelic to the known recessive mutation,
tk, complementation crosses were carried out between 12Gso male heterozygotes and
female tk homozygotes (TKDU/Dn; Jackson Laboratories). Litters were observed and
recorded. Offspring were examined and genotyped for 12Gso carrier status by whole
chromosome paints. Male offspring heterozygous for 12Gso were backcrossed to tk/tk
females for two more generations, and litters were observed and recorded.
Amplification of microsatellite markers
Polymerase chain reaction (PCR) amplification of microsatellite markers was
carried out in an MJ Research thermocycler using a 55ºC annealing temperature.
Standard PCR conditions were used (1x Taq polymerase buffer, 1 mM dNTP mix, 2.5
mM MgCl2, 200 ng each forward and reverse primers, and 2 units Taq polymerase).
Sequences for the microsatellite markers were found on the Whitehead
Institute/Massachusetts Institute of Technology website (WI/MIT; http://wwwgenome.wi.mit.edu/).
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Acrylamide gel electrophoresis to resolve amplified products
Precast 15% TBE acrylamide gels (Biorad, Hercules, CA) were used in a small
vertical electrophoresis chamber (Biorad). Running buffer was 1xTBE. Samples were
mixed with TAE dye to monitor the run. After the dye had migrated past the end of the
gel, the gel was removed from its cast and stained for 45 minutes in 100 mg/mL
ethidium bromide and photographed.

Estimation of the maximum map distance between the translocation and the mutation
in 12Gso
To determine the expected frequency of a distribution of karyotypes at a given
recombination fraction, r, the class of 12Gso/12Gso was calculated with [(1-r)2] M,
where M equals the number of observed 12Gso/12Gso. The class of 12Gso/+ was
calculated with 2r(1-r) M, and +/+ was calculated with [(r)2] M. Because the values in
the +/+ class were very small, an approximation is made and the two non-mutant classes
(12Gso/+ and +/+) were combined to a single class (reducing degree of freedom to one).
The data from each class was then subjected to chi-squared analysis using the
formula (observed – expected)2/expected, and the corresponding values for each
recombination fraction were combined and either rejected or not at the .01 and .05
significance levels (6.3 and 3.84, respectively).
Because of the small numbers of generated 12Gso/12Gso animals, estimations
were made from all homozygotes produced, and not by individual background strains.
Probes used for genetic mapping
The probes selected for mapping were initially selected based on research
publications and marker mapping data publicly available on the Mouse Genome
Database (MGD; http://www.informatics.jax.org/) or the Human Genome Database
(GDB; http://www.gdb.org). Clones for these markers were acquired as gifts or ordered
from either American Type Culture Collection or the IMAGE Consortium. Plasmid
inserts were generated either by restriction digest or by PCR from the vector promoter
sequences. Later probes were generated by PCR from either genomic or cDNA
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templates, and primer sequence was determined from publicly available sequences in the
above-mentioned databases or in Genbank (www.ncbi.nlm.nih.org/). Besides the initial
locations, the various publicly available radiation hybrid (RH) maps at The Jackson
Laboratory (http://www.informatics.jax.org/) and the Whitehead Institute
(http://www.wi.mit.edu/), Ensembl database (http://www.ensembl.org/), and Unigene
and BLAST searches (http://www.ncbi.nlm.nih.gov/) were also used to find gene or
microsatellite markers for placing on the genetic map. Probes were originally chosen to
be spaced one to four centimorgans (cM) apart in the breakpoint region. Probes mapping
within smaller intervals were later obtained as the breakpoint region narrowed and as the
publicly available maps included more markers positioned within the determined
breakpoint intervals.

Interspecific backcross mapping
The interspecific backcross (IB) mapping panel used for genetic mapping was
generated by E.M. Rinchik and colleagues at ORNL [(C3Hf/Rl-MgfSl-ENURg / + X Mus
spretus) X C3Hf/Rl], and was typed for markers specific to related projects (Doyle et al.,
1996; Stubbs et al., 1996). The IB map currently contains more than 500 mapped
markers, extending over all autosomes and the X chromosome. The initial interspecific
cross used as a basis for these panels is a Mus musculus female and a Mus spretus male.
Since F1 males are sterile, the F1 females of this outcross are backcrossed to a male of
either of the parental genotypes. The panel in use in our laboratory uses the DNA from
160 of the F2 progeny from the crossing of the F1 female to a Mus musculus male; thus,
all F2 would carry at least one Mus musculus allele and either Mus musculus or Mus
spretus for the other allele at each locus. Genomic DNA was isolated from each of these
F2 progeny, and aliquots from each sample were subjected to a series of enzymatic
digests, one enzyme at a time, electrophoresed, and transferred to Southern blots to
generate a series of panels specific to each enzyme (Silver, 1985; Avner et al., 1988;
Copeland and Jenkins, 1991). Probes were hybridized to Southern blots (Sambrook et
al., 1989) containing the F2 digests, and the spretus restriction fragment length variants
(RFLVs) were recorded, as previously described (Avner et al., 1988; Stubbs et al.,
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1990). Gene linkage, order, and intergenic distances with associated standard errors were
calculated according to standard methods (Silver, 1985) using Map Manager data
analysis software (Manley, 1993).

Isolation of plasmid DNA
Plasmid DNA was isolated using either a standard alkaline lysis preparation
(Sambrook et al., 1989), or by using commercial kits and following the manufacturer’s
protocol. Commercial kits used for plasmid isolation were Wizard kits (Promega,
Madison, WI), Mini-prep Spin kits (Qiagen, Valencia, CA), or Midi Prep kit (Qiagen).

Isolation of DNA inserts
Inserts were generated in one of four ways: enzymatic digestion of the plasmid,
PCR of the plasmid, PCR with gene-specific primers from genomic DNA template, or
PCR with gene-specific primers from a cDNA template.
Enzymatic digestion was dependent on the vector into which the insert had been
ligated. Inserts were isolated from the vector using 1-2 units enzyme/µg DNA and the
associated buffers and conditions as indicated by the enzyme manufacturer.
Most PCRs were carried out using DNA template (100 ng plasmid, 50 ng cDNA,
500 ng genomic DNA), manufacturer-recommended buffer dilution, 2 mM MgCl2, 1
mM dNTPs, 200 ng primers, and 0.2 units Taq polymerase. PCRs were carried out on
either a Perkin-Elmer 9600 thermocycler or an MJ Research thermocycler. Cycling
times were usually 5 minutes at 94°C, 25-30 cycles of 1 minute at 94°C, 1 minute at
55°C, and 1.5 minutes at 72°C, 5 minutes at 72°C, then maintained at 4°C. Adjustments
were made to component concentrations and cycling conditions as necessary.
Once the digestion or PCR was completed, the sample was electrophoresed on a
standard 1% agarose TPE gel, and the band containing the insert DNA was excised.
Purification of the DNA from the agarose was performed using either overnight βagarose digestion followed by phenol/chloroform extraction and ethanol precipitation, or
by using commercially available kits (QiaQuick Gel Extraction Kit, Qiagen; Spin-X
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columns). Concentration of the isolated insert was determined by electrophoresis with
standard markers or by spectrophotometric analysis.

Isolation of bacterial artificial chromosome (BAC) clones
Initial BAC clones were isolated from the mBAC-6x library, generated from
females of a 129 strain. Later clones were isolated from the RPCI-23 library, derived
from C57BL/6 females.
Library screening was performed using EST clones or overgo oligonucleotides.
Labeling and hybridization conditions for EST probes were carried out as previously
described (Stubbs et al., 1990). Stringency of the filter washes progressed to 0.5xSSC,
0.1% SDS, at 65°C for 30 minutes. Filters were then wrapped in plastic wrap for
exposure on phosphoimager screens or X-OMAT autoradiographic film (Kodak).
Pairs of 24-mer oligonucleotides overlapping by 8 base pairs (overgos) were
generated

using

a

web-based

program

(OvergoMaker,

http://genome.wustl.edu/gsc/overgo/). Prior to 32P incorporation, 0.5 – 2.0 pmol of each
overgo in the pair were denatured at 80°C and annealed at 37°C. Labeling of the
denatured overgos was performed in 2% bovine serum albumin (BSA), 2 µL of buffer,
10 µCi 32P-dATP, 10 µCi 32P-dCTP, and 2 units Klenow polymerase. The BAC library
filters were prehybridized at 60°C in hybridization solution (1 mM EDTA, 7% SDS, 0.5
M NaPi, pH 7.2, 1% BSA) for 1 – 4 hours. One-half volume of each TE–3 and sodium
phosphate buffer was added to the labeled probe and the entire mixture was denatured at
80°C. Two-thirds of this mixture was added to the hybridization solution and applied to
the BAC library filters for 1-3 days at 60°C. After hybridization, the filters were first
washed in a solution of 1% sodium dodecyl sulfate (SDS) and 40 mM sodium phosphate
buffer, followed by two washes in a solution of 2xSSC buffer and 1% SDS. Each wash
proceeded for 20 minutes at 60°C. If necessary, the filters were washed in a fourth wash
solution (0.5xSSC, 0.1% SDS) for 5 minutes at 60°C. After washing, the filters were
rinsed quickly in hybridization solution and wrapped in plastic wrap. The BAC library
filters were exposed to phosphoimager screens and scanned using a STORM 860
phosphoimager and associated software. Images were analyzed for positive clones using
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a program (SCIL) developed by Laura Mascio-Kegelmeyer (LLNL) to run on a UNIX
platform.
Secondary screening of the positive clones isolated from the BAC library was
done mostly by robotics (LLNL mapping group) for large sample sets and by manual
methods for small sample sets. Samples were rearrayed for robotics by inoculation of
positive clones into individual wells of a 96-well plate containing L-Broth supplemented
with chloramphenicol and 10% glycerol (rearrays done by M. Groza, LLNL). The 96well plates were incubated at 37°C overnight, then stamped onto an equivalent-sized LBroth agar plate supplemented with chloramphenicol. The agar plates were grown at
37°C overnight and then transferred onto nitrocellulose. The nitrocellulose was
incubated overnight at 37°C and nicked with ultraviolet light (stamping done by H.
Badri, LLNL). Manual rescreening involved the restreaking of the positive BAC clones
onto L-Broth agar plates and overnight incubation at 37°C. Single colonies from these
plates were inoculated and grown in small-scale plasmid preparations. These plasmids
were digested with EcoRI or BamHI, electrophoresed, and subjected to Southern
blotting. The filters generated by either protocol were subjected to hybridization under
conditions equivalent to that of the initial library screening.

Culture of mouse splenocytes and generation metaphase chromosome spreads
After isolation of a portion of the spleen from the selected mice, splenocytes
were cultured in RPMI 1640 media supplemented with 20% heat-inactivated fetal bovine
serum (JHR Biosciences, Woodland, CA), 730 mg/mL L-glutamine (Gibco BRL,
Rockville, MD; 200mM/100x), 125 units/mL penicillin-G (Gibco BRL; 5000 iu/mL),
125 units/mL streptomycin sulfate (Gibco BRL; 5mg/mL), 90 mg/mL Concavalin-A
(Sigma, 1mg/mL), and 10 mg/mL β-mercaptoethanol (Sigma, St. Louis, MO; 5 mg/mL).
Cells were harvested after 48 hours and metaphase spreads were prepared. One hour
before the harvest, cultures were treated with ethidium bromide (Sigma; 10 mg/mL).
Thirty minutes later, 0.25 mg/mL colcemid (CIBA Pharmaceuticals, Suffern, NY) was
added. Cultures were centrifuged at 900 rpm for 5 minutes, and the pellet was
resuspended in a hypotonic solution of 75mM potassium chloride and incubated at 37ºC
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for 8 minutes. The cell pellet was again collected by centrifugation and fixed in
Carnoy's (1 part glacial acetic acid to 3 parts methanol). Following four washes with the
fixative, one to two drops of the cell suspension were dispensed on moist slides. The
slides were air-dried and subsequently baked overnight at 62ºC - 65ºC, and stored under
nitrogen at -20ºC.

Direct fluorescent labeling of probes by enzymatic methods
Enzymatic labeling of probes for FISH was done using the Prime-It Fluor kit
(Stratagene, La Jolla, CA), with slight modifications to manufacturer protocol.
Approximately 50 – 200 ng of each DNA probe to be analyzed was labeled. After
incorporation of fluorescein-conjugated dUTP, probes were precipitated with the
addition of 10 µg sonicated salmon sperm DNA, 5 µg Mouse Cot-1 DNA, 5 µL 3 M
Sodium Acetate pH 5.2 and 150 µL absolute ethanol. Slide denaturation, probe
hybridization, and slide washing steps proceded as per manufacturer protocol. Slides
were counterstained with the propidium iodide supplied with the kit, or with Vectasheid
plus propidium iodide (Vector Laboratories) and protected with cover glass. Slides were
examined using a Zeiss Axiophot microscope equipped with a Cohu CCD camera.
Image capturing and analysis was done with hardware/software from Perceptive
Scientific Instruments (now Applied Imaging, Santa Clara, CA).

FISH using biotinylated probes generated by degenerate oligonucleotide-primed PCR
Probes were generated by degenerate oligonucleotide-primed PCR (DOP-PCR;
Telenius et al., 1992a, 1992b), using biotin-16-dUTP for the labeled nucleotide. The
procedure includes two rounds of PCR, the first of which uses the degenerate primers to
reduce the size of the DNA to be labeled to between 300 and 600 base pairs. The second
PCR incorporates the labeled dUTP into these small fragments. Mouse Cot-1 and a
hybridization solution of 50% formamide, 10% dextran sulfate, and 2xSSC were added
to the probes, which were subsequently denatured for 10 minutes at 84ºC and
preannealed for 60 - 90 minutes at 37ºC. Slides were treated with RNase, dehydrated in
a series of ethanol washes, denatured at 71ºC in 70% formamide, 2xSSC buffer, and
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dehydrated again. Hybridizations were carried out overnight at 42ºC. Following
hybridization, stringent washes were performed at 45ºC: two washes for 10 minutes each
containing 50% formamide and 2xSSC buffer, one wash for 5 minutes in 2xSSC buffer,
and one wash for 5 minutes in PN buffer (0.1 M Na2 HPO4, 0.05% NP40, pH 8.0).
Slides were then preblocked with PNM for 5 minutes. All secondary detection reagents
(avidin-fluorescein, biotinylated anti-avidin) were diluted in PNM (PN, 5% dry milk, 1
mg/mL sodium azide). Diluted avidin-fluorescein (Vector, Burlingame, CA) was
applied for 30 minutes at room temperature. Slides were then washed three times for 3
minutes each in PN buffer, then again preblocked with PNM for 5 minutes. Biotinylated
anti-avidin (Vector) was then applied for 30 minutes at room temperature. Slides were
again washed and preblocked, and the avidin-fluorescein step was repeated. After the
final PN wash, slides were counterstained with DAPI and examined using a Zeiss
Axiophot microscope. Imaging was done with hardware/software from Perceptive
Scientific Instruments (now Applied Imaging, Santa Clara, CA).

PCR analysis of the 12Gso breakpoint region
The sequence of the Abca1 BAC contig and the ordered and oriented sequence
for

RPCI-23-353G1

were

submitted

to

the

Repeat

Masker

database

(http://repeatmasker.genome.washington.edu/cgi-bin/RepeatMasker) to block repetitive
sections in the sequence. Primer sets of 28-mer to 30-mer oligonucleotides specific to
each the interspersed non-repetitive regions were generated and used to amplify the nonrepetitive regions, followed by a second round of PCR to span repetitive regions (see
Appendix). Presence, absence, or size alteration of a 12Gso fragment was noted for each
PCR. Touchdown PCRs were carried out at a 60°C annealing temperature, with an
extended 5 min extension at 68ºC for 30 cycles. Samples were electrophoresed on a
1.5% agarose TAE gel by standard protocol.

Generation and screening of comparative genomic Southern hybridizations
The amplified regions of non-repetitive DNA generated in the PCR analysis were
pooled according to 10 kb spans, either directly from the PCR or after gel-isolation. The
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pools were

32

P-labeled by standard protocol for hybridization onto genomic Southern

blots. Genomic Southern blots were generated by the digestion of 12Gso homozygote
genomic DNA and the genomic DNA of various background strains (C3Hf/Rl, 101/Rl,
C57BL/10Ei, SEC/Rl) with a variety of enzymes. The digests were electrophoresed on a
0.8% agarose TPE gel, and subjected to Southern blotting under standard conditions.

Reverse transcriptase PCR (RT-PCR)
The cDNA for use in RT-PCR was generated from total RNA isolated from
mouse liver. All reagents used to generate the cDNA were from the Amersham cDNA
Synthesis kit (Amersham), according to manufacturer instructions for first-strand cDNA
synthesis. All PCR was carried out under standard conditions, using exon-crossing
gene-specific primer sets. RT-PCRs of +/+ and 12Gso/12Gso tissues were done in
parallel.

Isolation of mouse tissues and extraction of total RNA from mouse tissues
Mice were euthanized by cervical dislocation and sterilized with ethanol. The
tissues were removed and snap frozen in liquid nitrogen for storage. For extraction of
total RNA, the Trizol (Invitrogen) method was used. Manufacturer protocol was
followed, including the spin to remove excess cellular debris and fat.

Prior to

precipitation, however, a second phenol extraction was performed to further purify.
After the precipitation, the RNA was treated with DNaseI for 15 minutes at 37°C. The
reaction was stopped with 0.5 M EDTA, and a final phenol extraction and precipitation
were used to isolate the purified RNA species.

Preparation of Poly-A enriched mRNA
Poly-A enriched mRNA was generated using the Message Maker Kit
(Invitrogen). Manufacturer protocol was followed.

52

Expression analysis using Northern blotting methods
RNA samples to be analyzed were denatured in a solution of 0.5x MOPS buffer
(0.2M MOPS, 50 mM sodium acetate, 5 mM EDTA), 17.5% formaldehyde, and 50%
formamide and labeled with ethidium bromide. Samples were electrophoresed on a
denaturing 1% agarose gel (1xMOPS buffer, 20% formaldehyde) in 1xMOPS buffer.
After electrophoresis, the gel was subjected to standard Northern blotting methods
(Sambrook et al., 1989).

Microarray analysis
Bone total RNA samples from a 12Gso/12Gso female and an age-matched B6C3
female were submitted to Gene Expression Resource (Department of Medical Pathology,
University of California, Davis) for comparative microarray analysis on Affymetrix gene
chip MG-U74Av2. The 12Gso mouse was the offspring of a 12Gso/+ male on a B6C3
background and a F4 C57BL/10J 12Gso/+ female.

Culture of mouse fibroblasts and corresponding metaphase chromosome spreads
Biopsies of the mouse tails were dissected and digested overnight in 2000
units/mL collagenase II diluted in prepared fibroblast culture medium (DMEM/F-12
(Gibco BRL, Rockville, MD) supplemented with 25% heat-inactivated fetal bovine
serum (JHR Biosciences, Woodland, CA), 730 mg/mL L-glutamine (Gibco BRL;
200mM/100x), 125 units/mL penicillin-G (Gibco BRL; 5000 iu/mL), 125 units/mL
streptomycin sulfate (Gibco BRL; 5mg/mL) in a 37ºC humidified CO2 incubator. The
remaining fibroblasts were pelleted by centrifugation and resuspended in prepared
fibroblast culture medium. The resuspended fibroblasts were transferred into to a 75
cm2 flask that was coated with gelatin (Sigma). Cells were grown in a 37ºC humidified
CO2 incubator, and media was replenished every 48 hours. When the cells grew to
approximately 70% confluency, 0.5 mg/mL colcemid was added and the flask was
incubated an additional 4 – 6 hours. The cellular layer was then washed twice with
sterile PBS (Gibco BRL) and attached cells were released with trypsin/EDTA solution
(Gibco BRL). The cells were centrifuged at 1100 rpm for 5 minutes, and the pellet was
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resuspended in a hypotonic solution of 75mM potassium chloride and incubated at 37ºC
for 20 minutes. The cell pellet was again collected by centrifugation, then fixed in
Carnoy's (1 part glacial acetic acid to 3 parts methanol). After 4 washes of fixative, 2 – 3
drops of the final cell suspension were dispensed onto moist slides. Slides were allowed
to air-dry overnight and were stored at -20ºC in vacuum-sealed bags.

Breakpoint fragment isolation and sequencing
Generation of breakpoint-containing fragments was done using the Universal
Genome Walker kit (Clontech); reactions of 12Gso/12Gso and C3Hf/Rl were run in
parallel according to manufacturer instructions. Final products were PCR-amplified
under standard conditions using the primer set generating the fragments [Abca1d-R (see
Appendix) and the AP1 primer from the kit]. Fragments were prepared for sequencing
by Dye Terminator reaction (Applied Biosystems) with 30 ng of each sequencing primer
[Abca1dnested-R (see Appendix) and the AP2 primer from the Universal Genome
Walker kit]. Sequencing reactions were run on an ABI 377 (Applied Biosystems) and
analyzed by BLAST analysis (NCBI; http://www.ncbi.nlm.nih.gov/).
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CHAPTER 3: RESULTS

Characterization of defects in the skeleton and cartilage of 12Gso mutant mice
The homozygous 12Gso mutant mice can be visually identified at one day of
postnatal life by their shortened body length, kyphoscoliosis, hip dysplasia, and often, a
reduced or kinked tail (Figure 2). Examinations of skeletal preparations of surviving
adult mutants indicate the presence of bifid ribs, fused, jumbled, and hemivertebrae, as
well as block vertebrae in the tail (Figure 5). Malformations in the tarsals, cranium, and
sternum were also present in those mice on a BLH background, but these types of bone
malformations were not seen after the mutation was transferred onto different genetic
backgrounds in the move to a clean facility at LLNL (e.g., B6C3, C57BL/10J,
129x1/SvJ; The Jackson Laboratory). Despite these skeletal malformations, no apparent
effect is seen in the majority of the appendicular skeleton, for the remainder of the limbs
appear normal.
Skeletal staining was later done using a combination of Alizarin red and Alcian
blue to determine if cartilage irregularities were also present. The skeleton of an
affected 12Gso homozygote was stained at one-day postnatal, showing not only the bifid
ribs and bone fusions, but also an altered morphology along the vertebral column. The
vertebrae appeared to have developed in a slightly more regular fashion than those of the
skeletons stained by Alizarin red alone, but there was also incomplete closure along the
backbone, indicating multiple ossification centers, and improper attachment of the ribs in
the thoracic vertebral region (Figure 6).

Histopathology
As part of the phenotypic characterization, pathologic examinations of all major
organ systems were conducted for adult and weanling animals. All organs examined
from the homozygous mutant animals, including heart, lungs, liver, kidney, stomach and
intestines, appeared normal on gross examination (X. Lu, pers. comm.). Sections taken
of E17.5 homozygous mice and normal littermates were examined by standard
hematoxylin and eosin (H&E) stains. Although staining revealed the relative persistence
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Figure 5. Skeletal anomalies of the adult 12Gso homozygous mouse. Panels A., C.,
E., and G. are 12Gso/12Gso; panels B., D., F., and H. are +/+. Aberrations are seen in
the axial skeleton, but the appendicular skeleton (e.g., the tarsals) appears normal. A.
12Gso/12Gso ribs. Note the presence of a bifid rib (arrow) and the crowded attachment
of the ribs to the vertebral column (top of image). B. +/+ mouse ribs. C. 12Gso/12Gso
thoracic vertebrae. The vertebrae are crowded and block-like, and incomplete closure of
the vertebral column is evident (demarcated by open arrows). D. +/+ thoracic vertebrae.
E. 12Gso/12Gso lumbar and sacral vertebrae. Arrows indicate the extreme fusion of the
vertebrae in this region, also evident by the lack of space between the vertebral
structures. F. +/+ lumbar and sacral vertebrae. G. 12Gso/12Gso tarsals. No apparent
defect is evident. H. Normal tarsals. I. 12Gso/12Gso (top) and +/+ (bottom)
skeletons.

The 12Gso/12Gso skeleton is shorter than the +/+ skeleton, and the

12Gso/12Gso tail is extended at an odd angle.
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Figure 6.

Skeletal anomalies are present in E18.5 12Gso/12Gso mice.

5x

magnification. (A.) The 12Gso/12Gso embryo has bifid ribs (arrow), and the remaining
ribs are flimsy, crowded, and malformed, as compared to the straight and evenly spaced
ribs of the +/+ sibling (B.). The vertebral column of the 12Gso/12Gso embryo (C.) has
delayed closure in the cervical and lumbar regions (open arrows). Rib fusions are
evident near the sites of attachment (e.g., white arrows) and as bifid fusions (closed
arrows). (D.) The +/+ sibling maintains an even closure of the vertebral column (open
arrow) and consistent amounts of ossification at the sites of rib attachment (white
arrows). (E.) Again, highlighting the improper closure of the vertebral column in the
12Gso/12Gso lumbar region (solid arrow), and the presence of thickened prevertebrae in
the narrowed sacral region (open arrow). (F.) The +/+ embryo, however, maintains an
even closure along the vertebral column (closed arrow) and consistent thickness in the
prevertebrae (open arrow).
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of a metameric pattern in the prevertebrae of 12Gso homozygotes, this tissue was
developmentally delayed and presented as abnormally shaped and poorly spaced
segments. These segments were adjacent to the spinal cord, which not only appeared
thickened in the 12Gso homozygote, but also lacked the characteristic arch presented in
the normal embryo. The chest cavity in the 12Gso/12Gso embryo was also slightly
larger in comparison to the normal mouse, possibly because of the decreased thickness
of the sternum in the mutant (Figure 7). Magnified regions of the cervical and thoracic
vertebrae verified the fusion of prevertebral segments and the misalignment of the
vertebrae (Figure 7). Bone sections from a 6-week old 12Gso/12Gso mouse also
exhibited a dramatic decrease in the intervertebral space, resulting in a compression of
the nucleus pulposus (Figure 8). The bone is also being eroded internally by excessive
osteoclast activity in various parts of the skeleton, possibly through the same mechanism
causing unusual proliferations of nucleated cells within the marrow (Figure 8).
Examination of bone sections from several 12Gso/12Gso mice on BLH, B6C3,
and C57BL/10J background strains revealed a proliferation of nucleated cells in the bone
marrow of homozygotes, indicative of the type of hyperplasia that occurs in leukemia
(Figure 9). The magnitude of this affected growth and the clustering of the cells into
diffuse patches within the marrow suggested that this disorder may contribute to the
early death of 12Gso homozygous mice (X. Lu, pers. comm.). The +/+ bone sections
show many other cell types, such as granulocytes, neutrophils, and megakaryocytes,
whereas the 12Gso/12Gso sections do not present these cell types. It may be, however,
that the massive expansion of the lymphocytic cell type is preventing visual observation
of the other cell types. Immunophenotyping of the bone marrow was attempted as a
means to determine the form of leukemia present. Antigens against B-cells and T cells
bound to cell populations in both the 12Gso/12Gso and +/+ bone marrow sections (X.
Lu, pers. comm.; data not shown), but accurate quantitative analysis from these slides is
not possible without flow sorting the cell types. For this reason, all that can be
conclusively said about the leukemia present in 12Gso homozygotes is that it is
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Figure 7. Aberrations are present in the skeleton of E17.5 12Gso/12Gso embryos.
Panels A. and C. are 12Gso/12Gso, and panels B. and D. are +/+. All sectioned
embryos pictured are stained with hematoxylin and eosin. A. and B. 10x magnification.
The 12Gso/12Gso embryo (A.) does not have the characteristic arch in either the spinal
cord (open arrow) or the prevertebrae (closed arrow) that is present in the normal
embryo (B.). C. and D. 40x magnification, second cervical vertebra to the fourth
thoracic vertebra.

The 12Gso/12Gso embryo (C.) has fusions in the prevertebrae

(closed arrows) that contribute to the misalignment of the vertebrae (indicated by a
dashed line, connecting the dorsal portion of the vertebrae to the ventral portion). The
vertebrae retain a metameric pattern, but the size and shape of the structures are not
consistent (e.g., c4 and c5) as in the wild type mouse (D.). These alterations in
alignment, size, and shape in the 12Gso/12Gso embryo have also constricted the spinal
column in the thoracic region (open arrow). Abbreviations: sc, spinal column; c2,
second cervical vertebra; c4, fourth cervical vertebra, c5, fifth cervical vertebra; t4,
fourth thoracic vertebra.
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Figure 8. Sections of 6-week old 12Gso/12Gso mice indicate abnormal bone and
marrow structure. Abbreviations: L4, 4th lumbar vertebra; L5, 5th lumbar vertebra, ivs,
intervertebral space. 40x magnification of sections stained with hematoxylin and eosin.
(A.) Sections through the 4th and 5t h lumbar vertebrae of the 12Gso/12Gso mouse
indicate a drastic decrease in the intervertebral space, causing a constriction of the
nucleus pulposus (closed arrow). The cellular distribution of the bone marrow is also
abnormal (open arrow); nucleated cells (purple) are proliferating in dense dispersed
patches, with reduced interspersed levels of blood cells (pink). In the +/+ mouse (B.),
however, the intervertebral space and nucleus pulposus are much larger than in the
12Gso/12Gso (closed arrow), and a normal distribution of cells is seen in the bone
marrow (open arrow). A section through the end of the tibia in 12Gso/12Gso (C.)
shows the thinned walls of the bone (closed arrows), being eroded by the marrow
components (arrowheads). The soft bone at the knee joint is extensively eroded (tissue
flap; teal arrow), and an increase in proliferating cells from the marrow at the joint can
be seen (green arrow). Again, the marrow is proliferating in dense patches, leaving large
empty areas in the marrow (open arrow). The +/+ mouse (D.) has much thicker bone
walls (closed arrows), and no erosion of the inner surfaces (arrowheads). The marrow is
distributed normally (open arrow), and only a small concentration of marrow is present
at the knee joint (teal arrow, green arrow).
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Figure 9. The bone marrow of 12Gso homozygous mice shows a diffuse pattern of
lymphocyte proliferation. 400x magnification of bone marrow sections stained with
hematoxylin and eosin. The bone marrow in the 12Gso/12Gso adult mouse (A.) shows
dense, patchy proliferation of nucleated cells (purple, indicated by green arrow) of
lymphocytic origin, and a decrease in the blood cell population (pink cells, indicated by
rd arrow), leading to large open spaces in the bone marrow. The +/+ adult mouse (B.)
shows a normal distribution of lymphocytes (purple cells, green arrow), other
hematopoietic cell types (orange arrows), and an adequate supply of blood cells (pink
cells, red arrow). (C) The bone marrow in the 12Gso/12Gso 6 week old mouse also
shows hyperproliferation of lymphocytes (green arrow), and the bone marrow of the +/+
6 week old mouse (D) displays a wide range of hematopoietic cell types (light purple
and pink stains; orange arrows).
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lymphocytic, and the proliferation patterns of these lymphocytes in the bone marrow
imply a chronic form of B-cell leukemia.

Preliminary studies of the effects of genetic background on survival and expression of
the skeletal phenotype
To determine whether or not homozygous mutants were being born live but
without discernable phenotype, the karyotypes of liveborn pups from heterozygote
matings on several backgrounds were tracked. The results of the genotyping experiments
contradicted the hypothesis that homozygous mice were being born live without skeletal
malformations. 177 liveborn animals from 12Gso heterozygote crosses on various
genetic backgrounds were karyotyped; of these, 14 were 12Gso/12Gso (Table 2; 36
animals from ORNL not included). The first background strains to be tested were BLH,
C3Hf/Rl, and B6C3, on which 12Gso/12Gso production was suppressed (Table 2).
Crosses between translocation carriers produce many embryos with an unbalanced
complement. The number of either mutants or wild types from these crosses should
equal 1/6 of liveborn progeny, much more than the observed numbers for 12Gso on
BLH, C3Hf/Rl, or B6C3.
To further study the reasons for the lack of surviving mutants on the B6C3
genetic background, a series of embryos in developmental stages from E9.5 to E18.5
(inclusive) were isolated from heterozygote crosses. Though none of the embryos could
be conclusively identified by gross observation as a mutant, a few appeared
developmentally delayed in the earlier stages or runted at later stages (8 embryos of of
46 embryos isolated). Preliminary karyotyping of embryos at later stages of E17.5 and
E18.5 indicated that an expected number of mutants were developing to this stage (4
embryos karyotyped as 12Gso/12Gso out of 14 total karyotyped offspring), suggesting
that the homozygous animals die during the final stages of development or perhaps just
after birth.
To test the possibility of genetic background effects, and for use in possibly
increasing the number of liveborn pups expressing the mutant phenotype, 12Gso was
crossed onto two very different inbred strains, C57BL/10J and 129x1/SvJ (The Jackson
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Table 2. Karyotype analysis of liveborn offspring from 12Gso/+ X 12Gso/+ crosses

12Gso/12Gso

12Gso/+

+/+

Total

C3Hf/Rl

0

2

3

5

B6C3

4

60

14

78

129x1/SvJ

1

11

2

14

C57BL/10J

5

27

12

44

Totals

10

100

31

141
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Laboratory). After only a few generations, the number of liveborn animals with skeletal
malformations (and a 12Gso/12Gso karyotype) increased, most notably on
the C57BL/10J background, on which the production of homozygotes is approximate to
expected rations (Table 2). These data are very preliminary, but suggest that alleles
shared by C3Hf/Rl and [C3H/HeJ X C57BL/6J] hybrids are associated with increased
perinatal mortality of 12Gso mutant mice, whereas alleles carried by C57BL/10J inbred
line increase viability of the mutant animals.

Concordance between skeletal phenotype and inheritance of the 12Gso translocation
While collecting data for large breeding experiments at ORNL, all offspring from
12Gso translocation carrier crosses that displayed aberrant phenotypes were subjected to
cytological analysis. All 4 liveborn animals (from 36 liveborn offspring) clearly
displaying skeletal defects, ranging from obviously shortened spine to kinky tails, were
genotyped as homozygotes, while littermates or the animals expressing other potential
phenotypes were genotyped as heterozygotes or wild types (K.T. Cain, W.M. Generoso,
N.L.A. Cachiero, pers. comm.). Additional breeding studies conducted at LLNL have
also identified 10 liveborn 12Gso mice with the skeletal phenotype (10 mutants/141 total
karyotyped from carrier crosses), and all of these were found to be homozygous in FISH
or chromosome painting experiments. Analysis of breeding records from 12Gso/+ X
12Gso/+ matings indicated that the birth rate of live homozygotes on the C3H, B6C3,
and 129x1/SvJ genetic backgrounds was lower than predicted, though production of
heterozygote and wild type offspring was normal (Table 2).

Estimation of the maximum map distance between the translocation and the mutation
in 12Gso
To estimate maximum map distance, an iterative chi-squared analysis was done
on data from records of karyotyped offspring from 12Gso heterozygote crosses. 14
karyotyped 12Gso/12Gso mice have been generated (M). Because of the small number
of homozygotes produced, relatively large regions of map distance were expected. Data
indicated that the hypothesis of the maximum distance between the mutation and the
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translocation could be rejected for distances of 11 cM and 17 cM, but not rejected at 10
cM and 16 cM, at the .05 and .01 levels, respectively. It can then be said with 95%
certainty that the maximum possible distance between the translocation and the mutation
is less than 11 cM, and with 99% certainty that the distance is less than 17 cM.

Testing genetic background of the Mmu4 breakpoint region and surrounding DNA.
As suspected by analysis of results generated from genomic Southern blots
hybridized with probes within the 12Gso critical region (data not shown), microsatellite
markers mapping closest to the chromosome 4 breakpoint in 12Gso indicated that the
DNA surrounding the translocation breakpoint was of the C3Hf/Rl origin. This would
indicate that the mutagenic lesion initially occurred on a C3Hf/Rl chromosome 4 (Table
3). Because most of the generations of 12Gso were maintained on stocks that contained
C3Hf/Rl genetic material, it was necessary to extend the microsatellite analysis further
from the breakpoint to determine if there was any 101/Rl DNA present at more distant
loci (Table 3). Because DNA contributed by the mutated founder male and animals
from subsequent crosses could not be distinguished, the size of the interval remaining
from the originally mutagenized chromosome could not be measured in recent
representatives of the 12Gso stock. Loci surrounding the chromosome 9 breakpoint
were not analyzed because of the lack of specific breakpoint location on that
chromosome at the time of these studies.

Genetic mapping: locating genes on Mmu4 and Mmu9
The original sizes of the breakpoint regions, based on chromosomal band size,
were approximately 10 cM for either chromosome. The original Mmu 4 region was
homologous to portions of human 9 and the original Mmu 9 region was homologous to
portions of human 3q, 6q, 11q, and 15q.

Once these breakpoint regions were

determined, genetic mapping of the breakpoint region markers was done using IB
mapping panels. Mapping was begun on chromosome 4, establishing the placement of
genetic markers at a depth of approximately 1 marker every 1-2 cM within the region of
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Table 3. Microsatellite and gene markers used to characterize the 12Gso Mmu4
breakpoint region.

Marker

JAX position
(cM from
centromere)

MIT position
(cM from
centromere)

D4Mit99
D4Mit18
D4Mit107
D4Mit238
D4Mit229
D4Mit112
D4Mit271
D4Mit88
D4Mit110
Nipsnap4
Nipsnap3
Abca1
D4Mit272
*D4Mit184
*D4Mit163
*D4Mit240
D4Mit151
D4Mit82
D4Mit178
D4Mit348
D4Mit116

5.0
5.2
12.1
17.9
20.8
20.8
20.8
20.8
21.9
23.1
23.1
23.1
21.9
21.9
21.9
21.9
28.6
32.5
35.5
40.0
40.0

8.7
8.7
16.4
21.9
23.0
24.0
24.0
24.0
24.0
25.1
25.1
25.1
25.1
29.5
31.7
30.6
33.9
36.1

Ensemble
position
(Mb from
centromere)
11.408
41.680
55.309
58.671
59.545
59.686-59.697
59.709-59.719
59.731-59.901
60.091
60.533
66.983
72.150
75.527
95.928

12Gso DNA
at this locus?

i
C3H
C3H
C3H
C3H
C3H
C3H
C3H
C3H
C3H
C3H
C3H
i
C3H
C3H
C3H
C3H
i
C3H
C3H
C3H

i = impossible to determine; C3Hf/Rl and 101/Rl alleles are the same size
- = marker not in database
* = map order unclear
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interest (Figure 10). Additional mapping on Mmu 9 also verified the genetic interval of
various markers within the breakpoint region on this chromosome as well (Figure 11).

Mapping the Mmu 4 translocation breakpoint using FISH and the available public
databases
Early rounds of FISH isolated the breakpoint between the markers Shb and
Ambp (Figure 12). FISH experiments with genetic markers gradually narrowed the
breakpoint region to one in which we had no probes available at the time, between
flanking markers Baat and Lv. Further FISH experiments were greatly facilitated by the
plethora of information that has recently become publicly available. Not only have
sequences been submitted, but also maps that contain probe contigs and sequence
annotation. These rapidly developing tools can only accelerate the discovery of new
mutations within our colony. Prescreened BACs from the BAC/PAC database
(http://www.chori.org/bacpac/home.htm) were then used to narrow the breakpoint
interval to a region flanked by Baat and the microsatellite marker D4Mit272.
With the advent of databases such as the FPC database and the Jackson
Laboratory and the Whitehead Institute/Massachusetts Institute for Technology radiation
RH maps, estimation of probes lying between the markers of Baat and D4Mit272 was
facilitated. The size of this region, as estimated from these markers' positions on the
publicly available RH maps, and the approximated kilobase (kb) to centiray (cR)
distance on Mmu 4 (MIT database), was approximately 4 Mb. Database searches
indicated that two of the BACs contained within the FPC contig incorporating the Baat
marker were positive for D4Mit215, and some distance proximal to this BAC in the
same contig, other BACs were positive for D4Mit88. This microsatellite marker was
shown by both RH maps to lie between D4Mit215 and D4Mit272, a good indication that
the breakpoint could be near (Figure 13). FISH experiments with numerous BACs
within this interval narrowed the estimated region to approximately 1 Mb, within the
region that lay between two FPC contigs: the proximal contig containing Baat,
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Figure 10. Genetic map of mouse chromosome 4. Numbers to the left are the
distances between the markers in centimorgans; marker placement is not to scale. The
chromosomal band that contains the 12Gso breakpoint (Mmu 4B3) is denoted, and
extends from Col15a1 to Txn. Markers listed in green were used to isolate BAC clones.
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Figure 11. Genetic map of mouse chromosome 9.

Numbers to the left are the

distances between the markers in centimorgans; marker placement is not to scale. The
chromosomal band that contains the 12Gso breakpoint (Mmu 9E3.2) is denoted, and
extends from Htr1b to Rbp1.
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Figure 12. Initial Mmu 4 FISH results. Hybridization of mBAC6x-496F24 (Shb) and
mBAC6x-202I7 (Ambp) to 12Gso homozygote (A.) and wild type (B.) metaphase
chromosome spreads. The pairs of signals on each of the translocated chromosomes in
the homozygote indicate the markers are separated by the translocation. C. Map of the
Mmu 4 breakpoint region, from band B1 to band B3. The current breakpoint region, as
determined by FISH, is denoted in red. D. Ideotype of the 12Gso translocation, for
reference.
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Figure 13. Using the mouse radiation hybrid maps and fingerprinted contigs to
narrow the breakpoint region. (A.) Comparison of publicly available radiation hybrid
maps. Markers appear to be in accordance, and two genes near the breakpoint region
were recognized (blue). (B.) A database of fingerprinted BAC contigs was useful in
locating BAC clones within the breakpoint region. All BACs listed for the FPC contigs
were subject to FISH analysis.
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D4Mit215, and D4Mit88, and the distal contig containing D4Mit272 and D4Mit184
(Figure 13).
To resolve this gap, the corresponding human region, 9q31, was screened for
genetic markers that might be used for obtaining BAC clones. Although earlier
examination of the region just proximal to Baat in human proved to have inconsistent
homology, one marker distal to Baat on the Ensembl database (Fin16) hit not only a
BAC sequence in National Center for Biotechnology Information (NCBI;
http://www.ncbi.nlm.nih.gov/) genomic survey sequence database, but also a new
fingerprinted contig in the FPC database. Using the mouse trace sequences indentified
from the human contig, more positive clones in the fingerprinted contig containing the
Fin16 positive BAC were found, thus solidifying the indication that this contig might
close the gap (Figure 14).
Upon searching the Celera and Ensembl mouse databases, it was determined that
these BACs did indeed map into the region between D4Mit88 and D4Mit272, and
confirmed the distance between those two markers to be 1 Mb (Figure 15). Using these
databases as a guide, BACs were chosen at intervals across this distance for FISH
analysis, and the breakpoint region was eventually narrowed to a single BAC clone,
RPCI-23-353G1 (Figure 16). To determine more precisely the position of the breakpoint
region within this BAC, FISH experiments were continued with BAC clones RPCI-23302N5 and RPCI-23-426F5, which overlapped RPCI-23-353G1 on the proximal and
distal ends, respectively. The estimated interval of overlap of these BACs was
determined by NCBI BLAST analysis. The experiments with these BACs narrowed the
breakpoint interval to an estimated 7.5 kb (Figure 16).

Examination of the sequence of the breakpoint-spanning BAC, RPCI-23-353G1
The sequence of BAC RPCI-23-353G1 (Genbank accession #AC091466),
although in unordered pieces, was submitted to the NCBI Entrez database. Using the
automated MyGodzilla comparative sequence analysis display from the VISTA suite of
sequence analysis tools (http://www.vista.lbl.gov/), it was possible to assemble this
mouse sequence based on its best sequence match in the human genome, as well as
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Figure 14. Analyzing the human BAC clone contigs for homologous mouse BAC
clones. The human region homologous to the 12Gso Mmu4 breakpoint region was
searched for links to possible clones that could be used by FISH to close the sequence
gap in the breakpoint interval. The BAC clones listed on the top tier are human BAC
clones listed on the Ensemble database. The presence of known genes is then indicated,
as well as mouse trace sequences that showed some homology to a relevant sequence in
the NCBI gss database. Any EST markers within the region present on the RH/FPC
databases are indicated. The bottom tier indicates BAC clones for which BLAST hits
were generated with the aforementioned sequences, and the subsequent new FPC contigs
determined by alignment of these BLAST hits.
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Figure 15. Framing the 1 Mb critical region at the 12Gso chromosomal breakpoint.
(A.) Hybridization of RPCI-23-111F13 (

Baat) and RPCI-23-32D21 ( D4Mit272) to

12Gso heterozygote metaphase spread. The three pairs of signals indicate that the
markers are separated by the translocation. (B.) Hybridization of RPCI-23-114O15
(D4Mit88) and RPCI-23-3D21 (D4Mit272) to 12Gso heterozygote metaphase spread.
Again, these markers are separated by the translocation. Because of the close distance
between the markers, multiple signals on the same chromosome appear as a single bright
pair. (C.) Map of the Mmu 4 breakpoint region, with BAC clones and genetic markers
included. The 4 Mb region is the distance represented by the FISH results in panel A.,
and the 1 Mb critical region (red) is the estimated breakpoint region represented by the
FISH results in panel B.
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Figure 16. The 12Gso chromosome 4 breakpoint lies in the region spanned by BAC
RPCI-23-353G1. FISH analysis of BAC RPCI-23-353G1 with a proximal marker (A.),
distal marker (B.), and alone (C.) all present evidence that this BAC clone spans the
Mmu 4 breakpoint. (D.) BAC clones RPCI-23-302N5 and RPCI-23-416F5 overlap
BAC RPCI-23-353G1, and are separated by the breakpoint. The distance between
RPCI-23-302N5 and RPCI-23-416F5 endclones is only 7.5 kb. As neither clone
presents evidence of spanning the breakpoint when hybridized alone (data not shown),
the breakpoint region should lie either between, or near the ends of, these two BACs.
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to generate a comparative plot to estimate the positions of possible exons. The plot
confirmed the data from the annotation on the Ensembl website: the presence of the gene
Abca1, whose position was already known, and possibly two other unknown genes.
According to our original genetic maps, Abca1 was outside the breakpoint interval, and
thus had not been used to screen the libraries once the region had been narrowed to Baat
and Lv.
In the search for sequences of BAC RPCI-23-353G1, a publication that reported
the sequence of the 280 kb surrounding Abca1 (Qiu et al., 2001) was found. The
sequences listed for the contig encompassed all but 20 kb of BAC RPCI-23-353G1.
Abca1 is expressed almost ubiquitously, although highest levels are present in liver.
Defects in human ABCA1 result in Tangier disease, a metabolic disorder characterized
by a defect in cellular cholesterol removal. Thus, the most studied role of Abca1 is with
regard to lipid transport, but Abca1 also has roles in inflammation and macrophage
function and recruitment (Schmitz et al., 1999; Harmon et al., 2000). The two Nipsnaprelated sequences, Nipsnap3 and Nipsnap4, are immediately downstream of Abca1.
Each gene spans about 10kb in genomic length, they have 6 and 7 exons, respectively,
and they produce ~1.5 kb transcripts that are closely related in sequence. Nipsnaps are
related to the C. elegans nonneuronal SNAP25 protein (Qui et al., 2001). The functions
of these two gene products are unknown. The proteins encoded by these candidate genes
have strong identity (70-80%) to the human protein HSPC299, the cDNAs for which are
isolated from CD34+ stem cells in blood and from the bone marrow of a patient with
chronic myelogenous leukemia (GenBank, NCBI Entrez). CD34 is expressed during the
induction of primitive hematopoiesis and vasculogenesis, and although the early
molecular and cellular events involved in these processes are not well understood, it is
known that transplantation of CD34+ stem cells leads to the production of cells from the
lymphoid, myeloid, and erythroid lineages (Sutherland and Keating, 1992). These
characteristics implicated the Nipsnap genes as potential candidates for the 12Gso bone
marrow/lymphoproliferative phenotype. The olfactory receptor sequence located
downstream of the Nipsnap genes represents an unlikely candidate, as this family of
genes encodes receptors expressed exclusively in the olfactory neuroepithelium that
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respond to odorants through the regulation of secondary messengers (Restrepo et al.,
1996). This sequence, and the ordered and oriented RPCI-23-353G1 BAC sequence,
allowed the search for the breakpoint region by PCR analysis.

Strategy using PCR and genomic Southern hybridization to analyze the breakpoint
region outside of the Abca1 gene
To identify the Mmu4 breakpoint, PCR primers were generated to span segments
of 0.5-5 kb across the entire sequence of RPCI-23-353G1 outside of the Abca1 gene
(Figure 17). PCR was carried out with C3Hf/Rl and 12Gso/12Gso DNA samples as
templates to identify fragments that were generated in the normal but not the 12Gso
DNA sample, indicating the presence of a rearrangement. No PCRs indicated deletion
or chromosomal breakage, as all produced an equivalent product from both C3Hf/Rl and
12Gso/12Gso DNA samples (data not shown).
In addition, pools of normal PCR products from the region of RPCI-23-353G1
outside Abca1 were hybridized to Southern blots of C3Hf/Rl and 12Gso/12Gso DNA
samples, and no alternatively sized or missing fragments detected (data not shown).

Results of RT-PCR with Abca1
Not until the PCRs and their subsequent hybridization to genomic Southern blots
exhausted the region did the search for the breakpoint within the Abca1 gene proceed.
Because of the daunting size of this gene (almost 200 kb of genomic DNA and 8 kb
cDNA), RT-PCR was used to cross the region more rapidly.
To traverse the large Abca1 gene during breakpoint localization, RT-PCR of liver
cDNA was performed, using primers sets generated from either end of the gene and
gradually walking inward. The rationale for these experiments was that if the breakpoint
occurred within the gene, a stable, full-length transcript could not be produced from the
gene in mutant tissues, and that either all or part of the transcript would be missing in
tissues of 12Gso/12Gso mice.
To span the large Abca1 gene, we tested the presence of 5’- and 3’-end sequences
of the gene in transcripts produced in liver using RT-PCR.
89

RT-PCR on liver

Figure 17. Schematic of the Mmu 4 breakpoint region encompassed by the
published Abca1 contig (Qui et al., 2001) and the methodology used to find the
12Gso breakpoint. The published contig is 278 kb in length, and RPCI-23-353G1 maps
from approximately 92 kb from the beginning of the contig sequence, and extends
approximately 40 kb past the end of the contig. Arrows above gene names represent the
direction of transcription relative to the contig; Abca1 = ATP binding cassette 1; N3,
Nipsnap3; N4, Nipsnap4; Olf37, gene from the olfactory-37 gene cluster. Initially,
comparative genomic PCR was performed in the region outside the Abca1 gene, using
primer sets generated from all non-repetitive sequence to span the entire region, and
results verified by hybridization to genomic Southern blots. As Abca1 spans a large
portion of both this published contig and the BAC RPCI-23-353G1, RT-PCR analysis
was used to traverse the gene.
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samples was conducted first with primer sets crossing exons 2 and 3 and crossing exons
49 and 50. Initial results indicated the presence of a stable 5’ Abca1 transcript in
12Gso/12Gso liver, but 3’ Abca1 sequences could not be detected in liver cDNA
samples produced from 12Gso homozygotes (Figure 18). Additional primer sets were
used to walk inward from the 3’ end of the gene; Abca1 sequences located 3’- of exon 30
were consistently undetected in 12Gso/12Gso cDNA samples whereas primer sets
encompassing exons 1 to 30 were consistently detected Abca1 cDNA in approximately
normal abundance in the mutant liver (Figure 18). This indicates the gene must be
broken somewhere in the interval contained by the next downstream primer set, between
exons 30 and 35. Later RT-PCR experiments established the breakpoint to lie in an
approximately 600 bp segment between exons 34 and 35 (Figure 19).

Results of comparative microarray analysis
To identify possible clues to the bone marrow defect exhibited by 12Gso/12Gso
mice, bone total RNA samples from a 12Gso homozygote female from a B6C3
background and an age-matched B6C3 female were isolated and sent to the UC Davis
Cancer Center microarray facility for analysis on Affymetrix gene-chip arrays.

The

preliminary data presented from the microarray analysis indicated effects on expression
level in numerous genes (Table 4), the vast majority of which were downregulated. The
genes have been arranged into the following categories: lipid trafficking and metabolism
(n=11), inflammation (n=6), thrombosis and hemorrhage (n=10), steroid metabolism
(n=5), hematopoiesis (n=10), liver enzymes (n=8), neurological (n=18), and
miscellaneous (n=11).

Wild type mouse Northern blot analysis
Because tissue expression of many of the candidate genes from the breakpoint
regions was unknown, probes from these transcripts were hybridized to a series of
Northern blots from Clontech (CA). The blots used for this analysis included their
mouse RNA Master Blot, which contains a spotted array of normalized mRNA from
numerous mouse tissues, the mouse MTN blot, which was an mRNA Northern blot
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Figure 18. RT-PCR analysis of the Abca1 gene.

(A.) Initial RT-PCR using

12Gso/12Gso and +/+ liver cDNA generated a product from the 5’ end of Abca1 (exons
2-3; yellow arrow), but no product from the 3’ end (exons 48-49; white arrow),
indicating the gene produces a stable 5’ transcript, but is likely to be truncated. (B.)
Primer sets that spanned multiple exons were then used to move upstream from the
truncated 3’ end of Abca1 to determine where the gene is truncated. Primer sets A, B, C,
and D, which are listed in 3’ to 5’ order, did not produce a product with RT-PCR (white
arrows), but primer sets E, F, and further 5’ did produce an RT-PCR product. (C.)
Schematic of the Abca1 gene including localization of the expected products from +/+
RT-PCR relative to exon number. Primer set E, the most 3’ primer set to generate an
RT-PCR product, spans exons 27-30 of the Abca1 gene, and primer set D, the most 5’
primer set to lack an Abca1 RT-PCR product, spans exons 30-35. From this data, it can
be interpreted that the 12Gso transcript of Abca1 is stable at the 5’ end, but the 3’ end is
truncated after exon 30.
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Figure 19. RT-PCR analysis of the Abca1 region narrows the breakpoint interval to
approximately 600 base pairs. The number from the name of each primer represents
the exon from which it originated; F, forward primer; R, reverse primer. RT-PCR with
liver cDNA in both C3Hf/Rl and 12Gso/12Gso tissues indicated the presence of a
transcript in exons 30, 31, 32, and 33, but no product was observed in the amplification
of exons 34-35 (arrow), implicating this 600 bp region as the location of the
chromosomal breakpoint.
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Table 4. Results from the preliminary comparative microarray experiment, using
12Gso/12Gso and B6C3 bone total RNA: genes with 10-fold or greater change in
expression between the RNA samples. -denotes a decrease in expression; + denotes an
increase in expression.
Functional
Category

Gene

Lipid pathways

ApoA5
ApoA2
ApoA1
L-FABP
ApoH
Adipsin
Tap1
Ambp
Urate oxidase
α-1 protease inhibitor 5
ApoH
Hemopexin
At3
Vitronectin
α-2 macroglobulin
Cyp3a11
Cyp3a16
Acid nuclear phosphatase 32
Erythroid differentiation factor
RGS5
SCL/Tal1
ST2L/IL1RL1/ Lymphocyte
antigen 84
Glycine-N-methyltransferase
Prohepicidin
Regucalcin
Phneylalanine hydroxylase
G substrate mRNA
Gas5
Gria1
Calbindin
Snap25
Nsp

Inflammation

Thrombosis and
hemorrhage
Steroidogenesis
Hematopoietic

Liver enzymes

Miscellaneous
Neurological
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Fold Change
in Gene
Expression
-26
-23
-23
-23
-18
+10
+11
-52
-32
-26
-18
-15
-24
-13
-10
-26
-21
+15
+13
+13
+10
+10

Genbank
Accession
Number
AI785422
AV038316
U79573
Y14660
Y11356
X04673
U60020
X68680
M27695
M75717
Y11356
U89889
AI226846
M77123
M93264
X60452
D26137
U73478
AJ007909
U67188
U01530
D13695

-32
-26
-16
-13
-26
+32
-35
-28
-16
-16

D89664
AI845514
U32170
X51942
AF071562
AI8949615
X57497
D26352
M22012
AW123115

containing common mouse tissues, and the Immune MTN blot, which contained mRNA
from various human immune system sources. Nipsnap3 was expressed in almost all
tissues on the Master Blot, with strongest expression in liver, smooth muscle,
epididymus, uterus, submaxillary gland, kidney, and 7-day embryo. Expression on a
total RNA multiple tissue Northern blot was limited to liver, stomach, thymus, and weak
expression in spleen (Figure 20). The expression level of Nipsnap4 was weak in all
tissues. Nipsnap4 was expressed only in testes on the Clontech Mouse MTN blot, in the
submaxillary gland and epididymus of the Master Blot (weak expression in thymus,
ovary, uterus, prostate, skeletal muscle, and 11- and 17-day embryo). Expression was
seen in thymus and fetal liver, with weaker expression in the bone marrow and
peripheral blood leukocyte on the Clontech Human Immune Blot (Figure 21). Tbx18 was
not expressed in adult tissues, as expected (data not shown).

RT-PCR analysis of nearby Mmu 4 genes
Once the genomic PCR across the region outside the Abca1 gene was completed,
a physical disruption of the Nipsnap-related genes was excluded. However, as indicated
by the genes cloned in several translocation studies, these genes could not be excluded
from our analysis, especially in light of the tissue distribution of Nipsnap3 transcripts
indicated by representation in various EST libraries. RT-PCR of liver using primers
generated from the 3’ end of Nipsnap3 indicated that a stable transcript is expressed at
similar levels in 12Gso/12Gso and +/+ mice (Figure 22). These results imply that these
genes are expressed normally in mutant tissues and are unlikely to be involved in the
12Gso phenotype. The olfactory receptor gene was not tested, as not only is it an
unlikely candidate, but it maps further downstream and further from the breakpoint site
than even Nipsnap3 and Nipsnap4.

Testing potential allelism between 12Gso and the tk mutation
One of the ways to investigate the relationship between known genes or known
mutant alleles and different aspects of the 12Gso phenotype is to perform
complementation testing. Complementation testing is a classical genetic method used to
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Figure 20. Wild type Nipsnap3 expression. Hybridization of Nipsnap3 to a Clontech
mRNA Master Blot indicated expression of Nipsnap3 in most tissues (red boxes), with
highest expression in liver and smooth muscle (A.). (B.) Key for interpretation of
expression data from the mRNA Master Blot.
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Figure 21. Wild Type expression of Nipsnap4. (A.) Results from hybridization of
Nipsnap4 to an mRNA Master Blot (Clontech), 1 week exposure. Major sites of
expression were the submaxillary gland and the epididymus (red boxes). (B.) Key for
interpretation of expression data from the mRNA Master Blot. (C.) Highest levels of
expression of Nipsnap4 in the tissues tested was only seen in mouse testis, but weak
expression was also indicated in human lymph node, fetal liver, bone marrow, and
peripheral blood leukocyte (D.).
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Figure 22.

RT-PCR analysis of 3’ Nipsnap3. Primers spanning exons 6-7 of

Nipsnap3 were used for RT-PCR with 12Gso/12Gso and C3Hf/Rl liver cDNA. Both
12Gso/12Gso and C3Hf/Rl generate an intact transcript for Nipsnap3.
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determine the relationship between a recessive mutant locus and a previously
characterized recessive mutant locus. This method can be used to determine whether the
two mutations are allelic (representative of mutations within the same gene) or if they
are not related (and therefore complement each other to yield animals with normal
phenotypes). Complementation testing may also reveal that two genes are nonallelic but
noncomplementing, indicative of genetic interaction, for example when loci on different
chromosomes are members of the same genetic pathway. Phenotypic analysis of the
offspring from a cross between mice carrying both mutations will determine their
relationship.

For example, if the two mutations are allelic (or nonallelic

noncomplementing), a double mutant animal would express the aberrant phenotype. In
the case of allelism, this genotype could be represented as t1/t2 for the particular locus
affected in mice with the mutations t1 and t 2. However, if the mutations are not
complementary, the double heterozygote for these mutations would have a normal
phenotype because of the presence of a wild type allele at both loci (Silver, 1995).
One of the mouse skeletal mutants mapping to chromosome 9, tail-kinks (tk;
Table 1), mapped within the 12Gso breakpoint interval until later FISH mapping events
narrowed the region to 1 Mb. tk homozygotes have short, very kinked tails, and minor
aberrations in the vertebral column. The phenotype can be observed as early as E10,
when differentiation of the cervical sclerotome is absent. Penetrance in this mutant is
complete, but genetic background can influence viability (Gruneberg, 1955; Lilly, 1972).
Although the tk phenotype is much less severe than that of 12Gso, the two mutations do
share common traits: the presence of kinky tails and aberrations in the vertebral column.
For this reason, the two stocks were subjected to complementation testing. No other
classical mouse mutations map near either 12Gso breakpoint region.
Phenotypic and genotypic examination of 12Gso X tk offspring indicated that
although some of the pups did indeed exhibit a modest phenotypic effect related to that
of tk (although not so severe as 12Gso/12Gso), not all of the 12Gso heterozygotes were
phenotypically identifiable. Because of this, the allelism tests were inconclusive and
more breeding was done to determine allelism because the compound heterozygote
phenotype could be affected by background strain, as are both homozygote phenotypes.
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12Gso heterozygote male F1 offspring of these allelism crosses were then backcrossed
to their mothers, and offspring from these crosses were then examined. First generation
offspring from these crosses were karyotyped by the mouse whole chromosome paint
method (8 12Gso/+, only one with with a slightly kinked tail; 10 +/+). For the second
and third generations, genotype could partially be determined by phenotype, using coat
color and tail phenotype as a guide. As the tk phenotype in this stock is linked to dilute,
the tk mice have a dilute gray coat color as well as tails with kinks. 12Gso heterozygotes
have straight tails, and either a black or brown coat color. F2 production was ceased
when none of 25 F2 offspring exhibited evidence of allelism (13 12Gso/+ with brown or
black coat and straight tails; 12 tk/tk with dilute gray coat color and kinked tails). F3
production ceased after 19 offspring, with equivalent results to that of the F2 generation
(10 12Gso/+ with brown or black coat and straight tails; 9 tk/tk with dilute gray coats
and kinked tails).

Mapping the Mmu 9 chromosomal breakpoints
FISH experiments on Mmu9 narrowed the region to approximately 4 Mb,
between the markers between the markers of Mod1 and Rasgrf1 (Figure 23). BACs were
selected using the same databases employed for Mmu4. FISH experiments narrowed the
breakpoint interval to approximately 1 Mb, between the BAC clones RPCI-23-67P8 and
RPCI-23-94L9, which are estimated to map 87.8 and 88.8 Mb from the centromere of
Mmu9, respectively (Figure 24).
As previously mentioned, the Mmu9 region is relatively gene-poor (Figure 24).
The most proximal gene, Snap91, is mainly expressed in brain tissue with active
synaptogenesis or synapsis maturation, functioning in calcium-dependent proteolysis
(Zhou et al., 1992). However, there is elevated expression in two related cell lines:
HL60, a lymphoblast line derived from promyelocytic leukemia, and MOLT-4, a cell
line derived from T-cell acute lymphoblastic leukemia. Tbx18 is one of a large family of
T-box containing transcription factors, so named because they encode a DNA-binding
domain first characterized in the brachyury (T) gene product. Members of this gene
family are involved in developmental processes (Papaioannou and Silver, 1998; Smith,
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Figure 23. Initial 12Gso chromosome 9 FISH. The12Gso chromosomal breakpoint
lies between the markers of M o d 1 and R a s g r f 1 on Mmu9. A. Simultaneous
hybridization of RPCI-23-6D7 (Scg3) and RPCI-23-124J8 (Mod1) indicated that the
clones are not separated by the chromosomal break. B. Cohybridization of RPCI-23124J8 (Mod1) and RPCI-23-118J13 (Rasgrf1) indicated that the two markers have been
separated by the translocation. C. Cohybridization of the clones RPCI-23-118J13
(Rasgrf1) and RPCI-23-142P8 (Rbp1) indicated that these markers were not separated by
the translocation. D. Map of Mmu9, E3.1 – E3.2. Distances between markers are
indicated in both the numbers of centimorgans and Mb from the centromere. The Mmu
9 region now known through FISH results to contain the chromosomal breakpoint is
noted in red.
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Figure 24. Narrowing the 12Gso chromosome 9 breakpoint. The Mmu 9 breakpoint
of 12Gso is contained within a 1 Mb region, flanked by BACs RPCI-23-67P8 and RPCI23-94L9. A. Hybridization of the proximal BAC RPCI-23-124J8 (Mod1) and BAC
RPCI-23-145F6 produced three signals, thus indicating the region spanned the
chromosomal breakpoint. B. The overlapping region, flanked by the BAC markers
RPCI-23-67P8 and RPCI-23-118J13 (Rasgrf1), also indicates the presence of the
breakpoint between these two markers. Interpretation of the data from A. and B. would
presume the breakpoint maps between RPCI-23-67P8 and RPCI-23-145F6. C. FISH
with BAC RPCI-23-94L9 and RPCI-23-118J13 (Rasgrf1) allows for the further
reduction of the estimated breakpoint region to that flanked by BAC RPCI-23-67P8 and
RPCI-23-94L9, a distance of 1 Mb. D. Map of the Mmu 9 critical region, including the
map positions of BAC markers used in FISH analysis and nearby gene markers. The 1
Mb region to which the 12Gso breakpoint maps is indicated in red. This 1 Mb region is
relatively gene-poor; only 5 ESTs are evident in the region: Snap91, a hemoflavoproteinrelated EST, two uncharacterized ESTs, and Tbx18.
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1999). In the mouse, the Tbx18 gene is expressed from E7.75 to E13.5 in the anterior
portions of the somitomeres in the presomitic mesoderm, and in the sclerotome of the
epithelialized somites. Transcripts were also detected in the developing heart and limb,
the genital ridge, and the vibrissae (Kraus et al., 2001).
One of the uncharacterized ESTs from chromosome 9, Rock1, is thought to be
involved in transcription and encodes regions of M-repeats, protein motifs common in
many myosin heavy chains, and a rho domain, found in some members of the ras family
of oncogenes. Libraries from which this EST was isolated include osteoclast, bone,
cartilage, neonatal kidney, and 11-day embryo. Another of the ESTs from chromosome
9 encodes a transmembrane domain, and library tissues are mostly brain-related. The
final EST of the chromosome 9 region is related to flavohemoproteins and encodes an
oxidoreductase FAD-binding domain and cytochrome b5 domains. This EST has been
isolated from numerous libraries, some of which are bone, B-cell and tumor.

Analysis of a fragment containing the t(9;4) chromosomal breakpoint
To clone the Mmu9 breakpoint, primers derived from the Mmu4 junction
sequences were used to carry out a "Genome Walk" across the breakpoint in 12Gso
homozygote DNA. This method permits PCR generation of sequences extending from a
gene-specific primer to a linker sequence ligated to the end of a restriction enzyme site
located within 6 kb from the primer sequence. A primer designed from Abca1 exon 35
was used to walk "upstream" relatively to the gene into adjoining Mmu 9 sequences.
The results from the Genome Walker experiment provided two PCR products
representing restriction fragments in 12Gso/12/Gso DNA that were not present in
C3Hf/Rl DNA (Figure 25). The wild type fragments in this region, as predicted by
published DNA sequences, were large (~10 kb) and expected to exceed to limits posed
by the kit (Figure 25). No Genome-walking fragments from the use of Abca1-exon 35
primers were expected in wild-type DNA. The two resulting fragments in 12Gso/12Gso
DNA, therefore, could represent breakpoint-spanning fragments, and were thus isolated,
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Figure 25.

Results from the Genome Walker experiment.

Abbreviations: F,

forward primer from exon 34; R, primer set D reverse primer. A. Use of the Genome
Walker kit (Clontech) resulted in the production of two different fragments from
libraries of digested 12Gso/12Gso DNA (DraI and P v uII libraries; arrows). Band
intensities of the 300 and 600 bp fragments were amplified for greater visibility. B.
Schematic of the expected and resulting products from the Genome Walker experiment.
Arrows designate primers used for the genome walk. Black bars represent the various
fragments expected from +/+ DNA, and the resulting fragment generated in 12Gso is
labeled in red within the black bars.

112

113

subcloned, and sequenced. BLAST analysis of the sequence from the smaller fragment
indicated that this fragment did contain sequence both from Abca1 and Mmu9. The
Abca1 sequence ended 46 base pairs upstream of Abca1 exon 35, and the Mmu9
sequence matched public mouse DNA sequence roughly 85 kb from Tbx18 and roughly
300 kb from the Rock1 EST. There was a 2 base pair ambiguity in the sequence, which
could have originated from either chromosome, but no complex insertions or deletions
are apparent at the translocation breakpoint (Figure 26).

As the breakpoint junction

maps to the location predicted by FISH analysis, these large rearrangements were not
expected. Complete analysis of the breakpoint sequence for the possible presence of
small rearrangements awaits the cloning of the reciprocal breakpoint junction.
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Figure 26. Double-pass sequence of the t(9;4) PvuII fragment generated in the
Genome Walker experiment. Alignment of the t(9;4) breakpoint clone sequence (top
line) with homologous sequence from a region of Mmu 9 mapping approximately 88.5
Mb from the centromere (middle line, green). and Abca1 (bottom line, blue). The t(9;4)
sequence is color-coded to match alignments. There are two ambiguous base pairs at the
junction (red); these base pairs could have derived from either Mmu4 or Mmu9.
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CHAPTER 4: DISCUSSION

The goal of the 12Gso project
While the original purpose of the 12Gso project has not altered since its
inception, the focus of this project has expanded as new knowledge about the mutation
has come to light. When work on 12Gso began, only basic information was available:
the mouse carried a reciprocal translocation and exhibited profound skeletal deformities.
A few small but obscure clues to the reduced fitness were also available, such as the high
dead implant rate, decreased homozygous mutant survival, failure of liveborn mutants to
thrive, and the scruffy coat that accompanies many mouse immune disorders. As this
research progressed, however, this mutant undertook new roles as a model to support
research in hematopoietic development and lipid metabolism.
This thesis work has been devoted to the characterization and development of
12Gso, a unique mouse model exhibiting skeletal malformations, aberrant
hematopoiesis, and disruption in lipid transport. The focus of this work included
phenotypic and genetic studies, as well as physical mapping and molecular analysis of
the translocation breakpoint sites. The long-term goals of this work are to determine and
characterize the gene(s) disrupted by chromosomal breakage in 12Gso mice, and to
utilize those gene(s) as a basis for uncovering the mechanisms that underlie inherited
forms of lymphoproliferation, skeletal defects and development, and lipid transport in
mammalian systems.

Analysis of the skeletal phenotype of 12Gso homozygotes
These studies have linked outward morphology of homozygous 12Gso mice to
specific skeletal anomalies including rib and vertebral fusion and improper vertebral
formation and spacing. By contrast, the animals have a relatively normal appendicular
skeleton. These skeletal deformities are strikingly similar to those presented in members
of the Notch-Delta segmentation pathway, hinting that the likeness between these
mutants and 12Gso may not be superficial, but could reflect nearly identical types of
disruptions in basic skeletal development. These data strengthen the likelihood that the
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12Gso mutation disrupts a gene that represents another link within that developmental
cascade. Even if 12Gso does not prove to be a member of this developmental pathway,
the skeletal phenotype associated with this mutation is strongly indicative of
segmentation defects. More specifically, the two characterized mutations that most
resemble12Gso are Dll3pu and Lfng-/-, both of which exhibit a lack of segment borders
and random rostrocaudal polarity in the null state. This is in contrast to several other
members of the Notch-Delta pathway, which either present segment borders or
completely nonpolarized or polarized somites (Table 5). From this we can hypothesize
that the gene(s) affected in 12Gso may be closely related to either the Delta or fringe
genes or interacting partners of these loci.
The aberrant skeletogenesis presented in 12Gso homozygotes is phenotypically
similar to the NBCC and spondylocostal dysostosis disease phenotypes outlined
previously. However, as the genes responsible for these phenotypes are known (Ptch
and Dll3, respectively), and neither of these are candidates for 12Gso, the gene
responsible for the skeletal phenotype in 12Gso is likely to represent a novel disease
mechanism. The 12Gso homozygous phenotype may still represent the manifestation of
a gene within a pathway that is also disturbed by some of these known human and
mouse mutations, either as an upstream or downstream affector. Database searches
currently indicate no abnormal skeletal phenotype linked to 6q14, the homologous
region to which the 12Gso breakpoint has been narrowed on Mmu9. However,
Shwachman-Diamond syndrome, although mapped to HSA7, was documented in a
single patient with a t(6;12)(q16.2; 21.2) translocation (Masuno et al., 1995). This
syndrome carries not only the skeletal phenotype of chondroplasia, but also bone
marrow aberrations that frequently become leukemic (Pringle et al., 1968; Smith et al.,
1996). It is possible that while this patient may not have actually presented ShwachmanDiamond syndrome, the phenotype could be related to those documented for 12Gso
homozygotes.

118

Table 5. Targeted alleles of Notch-Delta pathway genes involved in mammalian
skeletogenesis.

Notch-Delta pathway gene
Notch1

Protein function

Knockout phenotype

Receptor

Embryonic lethal; irregular
somite border
Profound vertebral
aberrations; lack of somitic
segment borders; random
polarity
Profound vertebral
aberrations; lack of somitic
segment borders; lack of
polarity
Reduced viability before
birth and until weaning;
profound vertebral
aberrations; lack of somitic
segment borders; random
polarity
Early lethality; skeletal
anomalies; lack of somitic
segment border; caudalized
polarity

Dll3

Ligand

Dll1

Ligand

Lfng

Glucosyl transferase

Mesp2

Transcription factor
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The abnormal bone marrow phenotype in 12Gso/12Gso is leukemic
Most mouse models of B-cell hyperproliferation derive from genes specifically
targeted by transgenics or knockouts, so finding novel genes associated with this family
of diseases is rare, and is mostly limited to human case studies. Because 12Gso does not
develop the hepatosplenomegaly normally associated with human leukemias, the
leukemia may not have been identified had the mice not been sectioned to examine bone
structure. The marrow of a 12Gso homozygote was first examined using the acidic/basic
combination of an H & E stain to study the composition of the bone marrow and liver.
Upon examination, it was noted that a marked cellularity was present, and the cells bear
morphological similarity to B-cells. Further examination of this mouse and several other
12Gso homozygotes at various ages confirmed this, and the darkly staining nuclei and
diffuse congregations of these cells are associated with the histology of chronic
lymphocytic leukemia.
As the signals from hematopoietic antigens tested on the 12Gso/12Gso and +/+
samples were relatively equivalent, more sensitive methods would be needed to ascertain
any quantitative differences in expression. And although hepatosplenomegaly is
distinctly lacking in 12Gso homozygotes, the grossly normal organ pathology does not
rule out the possibility of 12Gso being a model for CLL, as 12Gso homozygotes do
present a clonal expansion of mature B-cells such as defined by the epidemiology of
CLL. If 12Gso truly represents a model of CLL, it would be one of the few mouse
models that exist for this common leukemia, and one with a previously uncharacterized
disease mechanism, as the 12Gso chromosomal breakpoints do not overlap with known
genes associated with classical pathways contributing to the manifestation of this
disease.
Numerous deletions mapping to the region between HSA 6q13-q21, which shares
homology with the 12Gso Mmu9 breakpoint region, have been documented with relation
to many different forms of leukemia, including ALL, AML, and CLL, and are often
associated with a poor prognosis. This information would lead to the assumption that
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the Mmu9 gene affected in 12Gso/12Gso mice is likely to be associated with the bone
marrow hypercellularity. However, a known gene that would indicate involvement in a
leukemic phenotype has not been specifically mapped to this region, so elucidation of
the gene responsible for this phenotype in 12Gso homozygotes would provide a valuable
resource for dissecting the mechanisms underlying these common human diseases.

Penetrance of the 12Gso homozygous phenotype
Preliminary data showed that the reduction in number of viable mutants in early
breeding studies at LLNL was related to background genetic effects, as mutant
production again increased after backcrossing the 12Gso translocation onto an inbred
C57BL/10J background for four generations. These data indicate that the penetrance of
the phenotype is variable, as different extremes are seen on different backgrounds. The
translocation homozygotes do not survive well on a B6C3 background, and though
generally less viable, survive past birth on BLH and C57BL/10J backgrounds. Studies
done on many other mouse mutations have also indicated the importance of background
when examining phenotype (e.g., Gruneberg, 1954; Green, 1955; Letts et al., 1995) and
these studies indicate that genetic modifiers of the 12Gso/12Gso lethality and skeletal
defects also differ between mouse strains.
It was for this reason that several generations of offspring were generated during
complementation testing with tk, even when it seemed apparent that the mutation was
not allelic by the first generation. However, after three generations, no real indication of
allelism was present, indicating the two mutations are complementary. Although
allelism with tk would have more readily given a greater amount of information
regarding the 12Gso phenotype, as well as to more quickly pinpoint the Mmu9
translocation breakpoint, it appears that these two mutations, though similar, are not
allelic. No other known skeletal mutations map near the 12Gso breakpoint; the closest
mutations other than tk are kyphoscoliosis and Bmp5se both of which map more than 6
cM outside the breakpoint interval, and neither of which are closely related to the 12Gso
phenotype. If Tbx18, or another undiscovered gene is the candidate for the 12Gso
skeletal phenotype, allelism testing for this gene would need to be done in an alternate
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manner. A mouse knockout of Tbx18 (or the gene suspected) could be generated, or the
presence of this affected gene in mutagen-treated (such as ENU or EMS treatment)
collections of either mice or ES cell lines (Chen et al., 2000; Munroe et al., 2000) would
be a useful resource for testing candidacy, thus providing possible evidence for the
association of this gene with the 12Gso phenotype.

The relationship between translocation breakpoints and gene(s) associated with the
mutant phenotypes
One of the questions frequently asked when examining a phenotype derived from
mutagenesis schemes is with regard to the possibility of a second, linked mutation that is
responsible, either in part or in whole, for the mutant phenotype. While this scenario
cannot be entirely ruled out at this point in the 12Gso project, the methodology used to
screen offspring has greatly reduced the probability of this occurrence. First, animals
were selected for further breeding experiments based on karyotype, rather than
phenotype. Because the karyotypic presence of the translocation is required for
establishment as a carrier, one-sixth of the progeny from carrier matings (reduced from
one-fourth because of unbalanced complement in a portion of the embryos) should
receive a copy of the translocation from each parent. If manifestation of the phenotype
is consistent with the inheritance of two copies of the translocation, these translocation
homozygotes should be phenotypic mutants. In keeping with this, all mice born with the
skeletal phenotype were genotyped as homozygous for the translocation, and prenatal
death was also clearly associated with inheritance of two copies of the translocation.
Conversely, none of the non-affected mice genotyped carried two copies of the
translocation. These results support the concordance of the phenotype with the
genotype, even if specific and solitary involvement of the translocation is not proven.
To deduce the actual possibility of a second, linked mutation being associated
with the phenotype, analysis of the genomic region surrounding the breakpoint was done
to determine the quantity of remaining founder DNA surrounding the breakpoint.
However, our data indicate that the initial mutagenic lesion occurred on the C3Hf/Rl
chromosome of the mutagenized founder male and not on the 101/Rl chromosome. No
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101/Rl-specific alleles were detected in the 20 cM region surrounding the breakpoint.
Because C3Hf/Rl and later, B6C3, were used to maintain the 12Gso stocks its is
impossible to determine where founder DNA ends and maintenance stock DNA begins,
at least on chromosome 4. Because direct measurement of the amount of founder DNA
is impossible to determine, we must use the rough estimate provided by Silver’s
equation. These calculations predict that only 10 cM of DNA from the originally
mutagenized chromosome remain in present stocks.

If 1 cM is equivalent to

approximately 2 Mb (Silver, 1987), this distance can be estimated as an averaged 20 Mb.
Chi-square analysis predicts that the maximum possible distance between the
translocation and the mutation can be estimated, with 95% certainty, to be less than 11
cM. While this distance may be large, the size of the sample to be analyzed certainly has
a large influence on these numbers. As numbers of liveborn mutants increase, and with
the assumption that the 12Gso/12Gso karyotype will accompany the phenotype, the
estimated interval should decrease. However, it must be noted that these data are
assuming no there is no recombination suppression deriving from the translocation
breakpoint.
At this time, the issue of recombination suppression must be addressed,
especially since the projected estimates of founder DNA are based on theoretical and not
observed data. Yeast is frequently looked to for models of translocations because of the
frequency of occurrence in the species, and recombination suppression almost invariably
accompanies translocations in yeast (Herman, 1978; Rosenbluth and Baille, 1981;
McKim, 1990). This reduction of crossover events is also seen in Drosophila
translocation heterozygotes, albeit not to the same extent (Roberts, 1970; Roberts, 1976;
Hawley, 1980). However, this generalization may not be made for mice. Studies with
regard to synaptonemal complexes and crossover events have indicated the arm ratios of
the synaptonemal complexes in Giemsa (G)-dark bands is much shorter than that of Glight bands (Solari et al., 1980), possibly due to differential packaging as evidenced by
synaptic participation differences between heterochromatin and euchromatin at
pachynema (Stack, et al., 1984). Indeed, differences in condensation, replication, and
GC content are known to exist within the G-dark and G-light bands (Bickmore and
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Sumner, 1989), so differential packaging of the different bands is not an unreasonable
assumption. The degree of synapsis is inversely related to the amount of crossing over:
crossover could preferentially occur in the G-light bands, where synapsis is limited to
homology (Ashley, 1988). These findings are especially relevant with regard to
chromosomal translocations, and represent the foundations of a theory put forth by
Ashley (1988). This theory states that when both chromosomal breakage events in a
translocation occur in G-light bands, there is no recombination suppression, but if one or
both of the chromosomal breakage events occur in a G-dark band, evidence of
recombination suppression does not exist. This theory was further tested by Ashley and
Cachiero (1990), and the definition was further refined to include the bands designated
as “hatched” (Nesbitt and Francke, 1973) to behave as G-light bands and those
designated as “stippled” to behave as G-dark bands when synaptic behavior is analyzed.
With all of this in mind, it must be noted that the translocation breakpoints of 12Gso,
4B3 and 9E3.2, both occur in G-light bands, and in accordance with theory, should not
be subject to significant levels of recombination suppression. This said, it must be noted
that recombination suppression cannot be completely ruled out, as certain mouse
regions, including that of the t region (Justice and Bode, 1988), are subject to repression.
Our data predict that if a second mutation is responsible for the 12Gso
phenotype, it must be closely linked (within 20 Mb) to the translocation breakpoint sites.
Given the low frequency of mutational events expected from the mutagenic regimen in
which the 12Gso mutation arose, the existence of a second mutation is highly unlikely,
although the possibility must be taken into account in further studies with this mutant
strain.

At least, these studies provide support for the notion that mapping the

translocation breakpoints will bring us near the site of the gene(s) that are disrupted by
mutation in this mouse strain. While disruption of the gene is supportive evidence with
respect to candidacy, the possibility of another affected gene cannot be ruled out, even if
this second locus is not disrupted directly by the translocation or a second mutation.
Instances of position effects have been reported in species ranging from Drosophila to
human, but the distance of the affected loci from the translocation (inversion, deletion,
etc.) is usually less than 300 kb (Bedell et al., 1996). While the exact mechanism by
124

which position effects occur is elusive, current theories propose that the effects are
usually caused by either position effect variegation, in which aberrant repression of a
translocated gene is caused by condensation of the proximal heterochromatin
(Eissenberg, 1989; Henikoff, 1990), by more subtle, long-range chromatin effects
(Townes and Behringer, 1990; Romao, 1991), methylation (Bartholomew and Ihle,
1991), or by long-range transcriptional elements (Feingold and Forget, 1989; Elder,
1990). However, this is unlikely (discussed below).

Localization of the 12Gso chromosomal breakpoints
The molecular analysis of the 12Gso translocation was initiated with the
placement of markers on Mmu 4. At that time, the maps and probes for Mmu 4 were
more complete and accessible than those available for Mmu 9. Many of the probes
required for this project were not at that time mapped in mouse; these probes were
obtained by the hybridization of clones from the homologous human regions to the
mouse IB panels. The mapped gene marker probes were then used to isolate BAC
clones for FISH mapping. Several probes corresponding to gene markers were initially
used in FISH mapping of Mmu4, scattered at variable distances along the length of the
chromosome. These FISH experiments gradually narrowed the breakpoint region to one
in which we had no probes available at the time, between flanking markers Baat and Lv.,
to BACs selected from the public databases, and finally, a single BAC clone that
spanned the breakpoint (RPCI-23-353G1). The sequence of this BAC was used to
generated primers for more accurate localization of the chromosomal breakpoint on
Mmu4. These primer sets eventually exhausted the region of the BAC sequence outside
of the Abca1, so RT-PCR was used to traverse the Abca1 gene. The breakpoint was
indeed found in the Abca1 gene, between exons 34 and35.
The possibility of position effects and the altered expression of genes
neighboring the breakpoint were discussed previously (see above). However, as the
chromosomal break occurred within Abca1, expression levels and patterns should be
indicative of the candidacy of this gene, and expression analysis of neighboring genes
would also determine if multiple genes are affected by the Mmu 4 chromosomal
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breakage events. If immediately neighboring genes are not affected, other genes further
upstream or downstream of Abca1 are unlikely to be affected without the existence of a
second mutation. What must also be considered is that the phenotypic effects seen in
12Gso may not be due to the disruption of only one gene. Because there are two
chromosomes broken, there still exists the possibility of two genes being affected by this
translocation. For this reason, FISH analysis on both sides of the chromosomal break
was necessary. The 1 Mb size of the Mmu9 region, established by FISH analysis,
represented a manageable distance for analysis of additional candidate genes.

Molecular analysis of breakpoint region
Because the breakpoint has been specifically localized, cloned, and its sequence
is in the process of being analyzed, access to the answers to several questions is now
possible. The first of these questions is asked with regard to why the translocation
occurred at that precise location, and what genomic features preclude breakage and
nonhomologous recombination between the two chromosomes.
The mechanisms that drive the formation of translocations remain elusive, and
vary slightly depending on whether the derived translocation is somatic or germline.
The possibilities presented in somatic cells are much less complicated than those in
germline cells, and include homologous recombination, such as an exchange between
repetitive elements, or nonhomologous recombination, which could either be a random
event (e.g., double-stranded breakage events from radiation damage that are
consequently repaired) or nonrandom (e.g., enzyme cleavage). Regarding germlinederived translocations, which can be compared to those produced in the mouse heritable
translocation test, the translocation could occur in either sex, in pre-meiotic, meiotic, or
post-meiotic stages, and could then either be homologous, random nonhomologous, or
nonrandom nonhomologous.

It has been generalized that most mammalian

translocations are a result of nonhomologous recombination. Studies have shown that, at
least in mouse and human, the distribution of chromosomal translocation breakpoints has
been relatively random, albeit slightly biased towards occurrence in G-light bands
(Warburton, 1991; Stubbs et al., 1997).
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However, analyses of many different translocation breakpoint regions have
identified very short spans of identical base pairs (often in the form of repeats) which lie
within the critical breakpoint regions on both chromosomes involved in the
translocation, and may actually serve to stabilize the translocation. Repetitive regions in
particular have been strongly implicated as they are genomically unstable and
susceptible to the double-stranded breakage associated with translocations, as well as
leaving chromosomal “ends” which can more easily undergo interchromosomal
recombination than unique sequence (Bodrug et al., 1991; Giacalone and Francke, 1992;
van Bakel et al., 1995; Kehrer-Sawatzki et al., 1997; Ishikawa-Brush et al., 1997;
Edelmann et al., 1999; Masuno et al., 1995, Budarf et al., 1995; Chernova et al., 2001).
Other observed “markers” for translocations which hint at recombination mechanisms
include the C-like octamer (Krowczynska et al., 1990; Sowerby et al., 1993), Z-DNA
derived from alternating purine/pyrimidine residues (Boehm et al., 1989; Love et al.,
1989), topoisomerase I and II consensus recognition sites (Bae et al., 1988; Laemmli et
al., 1987; Spitzner and Muller,1988; Sander and Hsieh, 1989), immunoglobulin
heptamers (Chen et al., 1989) or a-protein recognition sites (Sowerby et al., 1993).
Another interesting point to note is related to the sequence at the actual breakpoint
junction. In the vast majority of breakpoints in the human constitutional translocations
that have undergone analysis, there is a small loss of DNA and the common
accompaniment of a small addition of DNA from a source other than the breakpoint
region. Presumably, this occurs because of an initial degradation of the free ends
generated upon double-stranded breakage of the chromosomes, followed by a repair
mechanism which would have used the additional nucleotides to “fill in” the gap during
repair of the break (Richardson and Jasin, 2000; Bodrug et al., 1991). The additions are
rarely over 100 bp, in good agreement with the repair theory. These deletions, while
typically less than 100 bp, do not always follow this model: at least two recorded cases
have reported larger deletions of 518 bp (Krebs et al., 1997) and 5000 bp (Giacalone and
Francke, 1992).
The sequence of the t(9;4) breakpoint region is now known, and as of current
analysis, does not appear to contain any of the aforementioned elements to indicate
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possible mechanisms for translocation, nor does it indicate deletions or rearrangements.
However, because the cloned fragment is very small, further verification by PCR will be
needed to assess the integrity of the chromosome 9 DNA. The sequence of this fragment
did verify the occurrence of the chromosomal break in Abca1, in the intron between
exons 34 and 35. The sequence on the Mmu9 side of the breakpoint will need much
more scrutiny in order to determine the causative factors for the skeletal phenotype. The
sequence is not interrupted in the middle of a mapped gene, but this does not preclude
the separation of regulatory elements for either Tbx18 or Rock1 from the respective gene
by the chromosomal rearrangement, or that either gene does not exend futher into this
poorly mapped region. There are several methods available to test these theories. First
and foremost, embryonic expression may now be tested because sequence is available at
the breakpoint junction. Now that the means are available to screen embryos from
heterozygote crosses, experiments such as whole mount and/or section in situ
hybridization, Northern analysis, RT-PCR, and microarray analysis can be performed.
Second, if sequence analysis indicates the presence of a regulatory element, luciferase
assays may be used to test the expression driven by the regulatory element. The
indication that the break does not occur in an Mmu9 gene also assumes that current maps
are correct, and a gene does not map to this region. However, available mouse sequence
data is far from complete at this time, and the possibility of another gene mapping to this
region still exists. Generation and analysis of sequence data from this region should
provide more clues to support or refute the presence of a disrupted gene, which would be
subjected to similar expression analysis as mentioned for Tbx18 and Rock1.

Preliminary evidence for Abca1 as the candidate gene associated with the reduced
fitness of 12Gso/12Gso mice
In Abca1 knockout mice, homozygous mutant offspring of heterozygote crosses
are generated at a rate of 8.3%, much decreased from the expected Mendelian ratio
(McNeish et al., 2000; Christiansen-Weber et al., 2000). The same is true for 12Gso:
initial karyotyping results indicated that the homozygotes were either dying prenatally,
or dying just after birth so as not to be counted in initial litter tabulation. Further
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analysis of earlier, prenatal stages indicated that, at least on a B6C3 background, mutants
were being generated at expected rates through at least the last day of gestation. This
observation would indicate that mutants were indeed dying by some means shortly after
birth.
As PCR and cloning results indicated that the chromosomal break occurred
within the Abca1 transcription unit, and RT-PCR experiments indicated that a truncated
transcript is produced from this gene, closer scrutiny of Abca1 as a candidate for some
aspects of the 12Gso phenotype was therefore imperative. In studies of targeted mouse
Abca1 null mutations (Christiansen-Weber et al., 2000; Orso et al., 2000) the percentage
of homozygote mutants born live was significantly lower than expected, and postnatal
viability was also substantially decreased. In fact, survival rates for Abca1-/- offspring
correlate well with decreased 12Gso homozygote survival rates on a B6C3 background
(12Gso, B6C3 background: 7.4%; Abca1-/-, C57BL/6J background: 8.3%).

The

hypothesis presented as an explanation for the reduced viability was that altered
steroidogenesis caused severe placental malformation leading to embryonic runting and
fetal and neonatal loss. The aberrant steroidogenesis in Abca1-/- mice manifested as
levels of progesterone and estrogen levels that were each decreased more than 50% in
homozygous females. This information would implicate Abca1 as being associated with
the early death of 12Gso homozygous mice and could possibly correlate with the
infertility we have noted for all mutant mice of either sex.
Abca1 encodes a large transmembrane protein involved in cholesterol
homeostasis. Hydropathy plots of the protein indicate that ABCA1 and other members
of the ABC-A superfamily share common unique features, including the presence of two
ATP binding cassettes, a regulatory domain positioned between these two cassettes
flanked by two hydrophobic regions, and a highly conserved N-terminal hydrophobic
region (Schmitz and Langmann, 2001). The role of ABCA1 is thought to be involved in
the ATP-dependent transport of lipids to lipid-free apolipoprotein A-I (Fielding and
Fielding, 2001; Schmitz and Langmann, 2001) during a process called reverse
cholesterol transport. Reverse cholesterol transport begins with cholesterol efflux, one
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mechanism of which is ATP-dependent and facilitated, such as the microsolubilization
pathway of efflux mediated by ABCA1 and ApoA-I (Fielding and Fielding).
Apolipoprotein A-I (ApoA-I) is the major component of high-density lipoprotein
(HDL), the function of which is the removal of excess tissue cholesterol (Chiesa et al.,
1998; Oram, 2002). Evidence for a relationship between ABCA1 and ApoA-I is
confirmed in Tangier disease, which is linked to a mutation in the Abca1 gene. ApoA-I
is produced at consistent levels in Tangier disease patients, but is degraded much more
rapidly. This ability of ApoA-I to accept phospholipids is thus reduced, leading to the
serum HDL deficiency (Oram, 2002). Though originally the Tangier disease findings
indicated a direct role for Abca1 in phospholipid and free cholesterol transport out of the
cell, current data has alluded to an indirect transferal of phospholipids to ApoA-I,
without the necessity of direct binding of this protein to ABCA1 (Fielding and Fielding,
2001). However, the exact mechanism for ABCA1-dependent reverse cholesterol
transport has not been clearly elucidated.
Mutations in this gene that result in the encoding of a nonfunctional or truncated
protein result in defective lipid transport, which has pleiotropic effects on the rest of the
anatomy. As a result of aberrant lipid transport, Abca1 targeted null mutant mice exhibit
reduced platelet count, hemorrhagic diathesis, fat-soluble vitamin deficiency, impaired
leukocyte-platelet aggregation, increased production of macrophages, megakaryocytes,
and erythroid precursors, increased immune complexes, low serum cholesterol, lipid
deposition in specific tissues such as liver, bronchopulmonary dysplasia resulting in
respiratory distress, placental malformation, runting and fetal distress, aberrant female
steroidogenesis, cardiomegaly with hypertrophied ventricles, congested liver, spleen,
and thymus, and glomerulonephritis (McNeish et al., 2000; Orso et al., 2000;
Christiensen-Weber et al., 2000). When examining the array of genes for which
expression is significantly down-regulated or absent in the 12Gso homozygote bone
marrow, we can see that 12Gso presents the genetic hallmarks of thrombosis and
hemorrhaging, chronic inflammation, macrophage proliferation, and serum HDL
deficiency, a definite parallel to observations of Abca1-/- mice. Whether or not this gene
is related to the bone marrow hypercellularity remains to be seen. While Abca1 can
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cause an increase in the number of erythroid precursors, megakaryocytes, and
macrophages, excessive presence of these cell types have not been examined in the bone
marrow.
The microarray analysis on 12Gso/12Gso tissue provides preliminary evidence
for the notion that the absence of functional Abca1 plays a significant role in the lack of
fitness of 12Gso homozygous mice (Table 2). As has been noted in microarray studies
of Abca1-deficient mice (McNeish et al., 2000), several key genes involved in
cholesterol and lipid metabolism are significantly down-regulated in 12Gso mutant
tissues. Included in this group are several apolipoprotein genes (Table 4): Apoa1 and
Apoa2, the lack of which drastically decreases the serum levels of high density
lipoprotein (HDL; Franceschini et al., 1988; Yui et al., 1988; Warden et al., 1993), and
Apoa5, the lack of which is involved in increased very low density lipoprotein (VLDL)
and increased triglyceride production (Pennacchio et al., 2001). In patients of Tangier
disease, the human form of ABCA1 mutations, and the mouse targeted Abca1 mutations,
blood serum presents an almost complete lack of HDL components and increased
triglyceride production (Pietrini et al., 1985; Orso et al., 2000; McNeish et al., 2000).
The decreased expression of these genes in the 12Gso/12Gso tissue encourages the
hypothesis that Abca1 disruption is likely to be a cause in the lack of fitness exhibited by
12Gso homozygotes. As indicated in several cases of Tangier disease, the absence of
full-length transcripts for this gene are sufficient to eradicate the normal function of the
gene. This lack of function in a truncated product would explain the low survival rates
of 12Gso homozygous offspring (Bodzioch et al., 1999; Rust et al., 1999; BrooksWilson et al., 1999).
The initial microarray studies gave evidence of other genes with protein products
belonging to other functional categories that may also be significantly affected in
12Gso/12Gso tissue samples. A disturbance in inflammation response, as also seen in
examples of Abca1 deficiency, is evident by the severe decrease in alpha-1microglobulin/bikunin precursor (Ambp) expression. Lack of normal Ambp function
allows the chemotaxis of neutropils to endotoxin-activated blood sera, which eventually
spirals into a full-blown inflammation response. Another gene in this category, urate
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oxidase (Urox), is severely downregulated in 12Gso. The gene is by itself nonfunctional
in humans, but mice with this deficiency die before 4 weeks of age (Wu et al., 1994).
Although it is not known at the time whether this gene specifically relates to Abca1,
neither Urox gene expression or product levels were tested in mice deficient for Abca1,
though the similarity in offspring viability in the two mutations is striking. The
decreased expression levels of genes in the 12Gso/12Gso involved in thrombosis and
hemorrhage are in accordance with the data presented for Abca1 null mutations. These
Abca1-deficient mutations manifest bleeding disorders and myocardial infarction, both
of which could be induced by the same anti-thrombosis genes showing decreased
expression in 12Gso/12Gso bone samples: antithrombin III (At3), a-2 microglobulin,
thrombin, plasminogen, and vitronectin. The Cyp3 family of genes, also appearing
downregulated in 12Gso/12Gso bone, is involved in the catalysis of hydroxylation of
various steroids, including testosterone, progesterone, and cortisol (Wrighton and
Stevens, 1992).

Again, the appearance of the disregulation of these genes in

12Gso/12Gso tissue provides yet another parallel between affected genes in 12Gso and
the protein expression pattern in Abca1-deficient mice. The presence of the neurological
genes in the 12Gso/12Gso microarray data is also interesting. While careful analysis of
these genes must be performed because of the innervation of the tissue used in the
microarray, these genes could be indicative of the peripheral neuropathy seen in patients
with Tangier disease. The downregulation of numerous genes encoding liver enzymes is
also intriguing, as many of these enzymes can contribute to liver disease, as in the case
of glycine-N-methyltransferase (Gnmt), or to aberrant transport from the liver to
peripheral tissues (retinol binding protein 1, Rbp1). Although gross pathology of the
brain and liver has already been examined and appears normal in 12Gso homozygous
mice, these microarray data suggest that subtle abnormalities in the lungs, liver, thymus,
intestine, kidneys, adrenal glands, and reproductive tissues of the mutants may be noted
on more detailed examination. Such detailed analyses are presently under way.
While neither Abca1, nor the lack thereof, has been documented in the bone
marrow lymphocytes of patients or animals with Abca1 mutations, current knowledge
does not indicate a role for this gene in B-cell lymphoproliferative disorders. However,
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Abca1 deficiency has been associated with the recruitment and proliferation of
macrophages and the increase in cellularity of megakaryocytes and erythroid precursors
(Orso et al., 2000). Other studies have indicated not only an increase in these
leukocytes, but also an expansion of T-helper cells (van Eck et al., 2002). However, all
of these factors could be associated with inflammation, and not necessarily with
lymphoproliferative disease.
If Abca1 is responsible for the reduced fitness observed in 12Gso/12Gso mice,
the most obvious human diseases for which 12Gso can serve as a model are Tangier
disease and the allelic high-density lipoprotein deficiency, both of which derive from
mutations in Abca1. Just as in the families with these diseases, which exhibit a truncated
or null Abca1 protein due to point mutations, deletions, or frameshifts, the 12Gso/12Gso
mouse also presents a truncated transcript of the gene, one which separates the both the
two ATP-binding sites and the two transmembrane domains, and crude analyses estimate
the break is likely to map within or near the conserved regulatory domain.

This

disruption is further down stream in the coding sequence than the three knock out
mutations described; one of these mutations targeted the first ATP-binding cassette
(Orso et al., 2000), one disrupted exons 18 – 22 (Christiansen-Weber et al., 2000), and
the third deleted 5.7 kb of the 7.4 kb transcript produced by Abca1.
Just as speculations can be made in the comparison of 12Gso homozygotes with
targeted Abca1 mouse mutations, the same logic exists for comparison to Tangier
disease. Patients with Tangier disease report deposition of lipid in thymus and intestine,
enlarged liver, spleen, and lymph nodes, peripheral neuropathy, one documented case of
visual impairment, accumulation of cholesterol esters in the macrophages, and a case of
myocardial infarction (Engel et al., 1967; Pietrini et al., 1985; Pressly et al., 1987;
Chueng et al., 1993; Brooks-Wilson et al., 1999; Schmitz et al., 1999). The defects in
lymphatic tissues offer a possible link between Tangier disease and therefore, Abca1
deficiency, with the lymphoproliferative disorder we have observed in 12Gso
homozygous mice. While these defects may be due to an increase in T-helper cells in
these tissues (van Eck et al., 2002), there still exists the possibility that there is bone
marrow involvement as well. On a molecular level, patients with Tangier disease have
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low levels of plasma HDL and its components apolipoproteins A-I and A-II (Cheung et
al., 1993). When comparing these diagnostics to the preliminary expression data
presented in the microarray experiment, we see that downregulated 12Gso/12Gso gene
expression could indicate a correlation with genetic components of this disease.

Identification of a possible candidate gene for the 12Gso skeletal phenotype on Mmu9
As an association of Abca1 with bone marrow hypercellularity has not been
reported, and knockout-mutant mice or human mutations suggest no involvement of this
gene in somite determination or segmentation, it seems likely that that the candidate for
these phenotypes should lie on Mmu9. Mapping of the Mmu9 breakpoint also identified
an excellent candidate for the skeletal phenotype. This gene (Tbx18) is but one member
of a closely related family of transcriptional regulators containing T-box elements.
Transcriptional regulators in general play a prominent role in development, and this
family is no exception. Mutations in members of this family include the brachyury
phenotype (T), Holt-Oram disease (TBX5; Basson et al., 1997), and ulnar-mammary
syndrome (TBX3; Li et al., 1997; Bamshad et al., 1997). While mutations in this gene
have not been documented, expression patterns are consistent with the 12Gso phenotype.
The gene for Tbx18 was considered a particularly strong candidate, as it is
expressed most highly in the developing somitic tissue. Expression of Tbx18 is also
notably high in the developing heart and limb bud, and these structures do not provide
evidence of anomaly in 12Gso. However, there is a distinct possibility of functional
overlap between genes in the T-box family of transcription factors and it is possible that
some expression sites of the gene will not be reflected in mutant phenotypes associated
with the Tbx18 gene. Tbx18 and its paralogue, Tbx15, overlap in expression patterns
with respect to the appendicular skeleton; both genes are expressed at high levels in the
developing limb bud, with no apparent involvement of the apical ectodermal ridge
(Kraus et al., 2001; Agulnik et al., 1998). However, a distinct difference in expression
pattern between these genes is seen when examining the axial skeleton. Tbx18 exhibits a
distinct metameric expression pattern confined to the anterior compartment of the
developing somites, in contrast to a lack of expression of Tbx15 in any but the most
134

anterior somites, which develop into head structures.

To corroborate this data,

expression patterns of Tbx15 and Tbx18 in zebrafish were examined, and it was found
that Tbx15 was absent in tail somites at any developmental stage, but both were
expressed in the developing fin (Bengemann et al., 2002). Association of Tbx18 with a
developmental pathway has yet to be assigned, and cannot be determined by the
examination of family members. Tbx18 is closest in homology to family members Tbx8,
Tbx15, Tbx14, and Tbx22, and within the same phylogenetic branch as Tbx1 and Tbx13.
Little is known about the upstream and downstream genes for most of these, but Tbx1, a
DiGeorge syndrome candidate gene, is regulated by Shh in mouse and chick pharyngeal
arch development (Garg et al., 2001). Expression of the less similar brachyury (T) and
Tbx6 genes are each induced by Bmp4 (Finley et al., 1999) and by Wnt3a (Yamaguchi et
al., 1999) in paraxial mesoderm specification. T expression in the notochord is activated
by Suppressor of Hairless [Su(H); Corbo et al., 1997; Corbo et al., 1998], an
intermediary gene between Notch and the Enhancer of Split complex in Notch-Delta
signaling (Bailey and Posakony, 1995). While it cannot be assumed that Tbx18 may be a
member of one of these established pathways, the connection between these pathways
and other Tbx genes, especially those involved in somitogenesis, encourages the
hypothesis that a mutation in Tbx18 could certainly cause the skeletal phenotype
presented in 12Gso homozygotes.

Future experiments proposed for studying the 12Gso mouse
Phenotypic and molecular analysis of the Abca1 disruption
Our preliminary results have indicated that disruption of Abca1 is likely to play a
role in the 12Gso homozygous reduced fitness phenotype, suggesting many future
experiments for analysis of this mutation in impending studies. Initial experiments
would include analysis similar to those used for the current gene knockout models that
exist for this locus. Because of the lack of grossly abnormal tissues, sites which would
be most affected by the Abca1 mutation (e.g. thymus, kidney, and liver) will be closely
scrutinized for the types of subtle defects detected in Abca1 null mutant mice and in
human Tangier disease patients. Because of the indications presented in these data,
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sectioned tissues of both 12Gso/12Gso and 12Gso/+ mice will be analyzed for cellular
hyper- or hypoproliferation, abnormal cell differentiation, and changes in lipid content.
The presence of neurological-associated genes in the microarray data could correlate to
subtle changes in brain signaling, similar to the peripheral neuropathy observed in
Tangier disease (Engel et al., 1967; Pietrini et al., 1985). While general 12Gso/12Gso
behavior is counter indicative to brain involvement, the lack of available homozygotes,
abnormal skeletal morphology, and general failure to thrive makes comprehensive
behavioral tests difficult with 12Gso homozygous mice. Consequently, brain chemistry
may indeed be slightly altered; brain sections hybridized with various probes for
neurotransmitters and receptors such as those indicated in the microarray may be useful
in determining the extent of brain involvement. Analysis of blood plasma will be a
crucial aspect of the complete analysis of this mutation. As many of the components
affected by this mutation are expressed in the plasma (e.g. Apoa1), blood analysis would
indicate further possible protein interactions, as well as affected loci whose expression is
not located in the bone or bone marrow. Included in this blood analysis would be a
quantitation of HDL and triglyceride levels, as this is strong proof of Abca1 deficiency.
All these experiments should also include samples from heterozygote mice; serum data
reported for targeted mouse Abca1 heterozygotes and Tangier disease relatives make it
probable that expression levels could be altered in 12Gso heterozygotes as well.
A major area of future study, however, will be to determine whether or not
Abca1 has a role in the hypercellularity of the bone marrow. Though documented cases
of marrow involvement are scarce, the lack of information may only be due to lack of
observation. One way in which the role of Abca1 may be tested for contribution to
lymphoproliferation would be complementation testing, involving crosses of 12Gso
carriers to animals carrying Abca1 targeted null mutations. These animals are available
from Jackson Laboratories and complementation studies will soon be in progress.
Complete analysis of the marrow from animals that are homozygous Abca1 null, and
from offspring of a 12Gso x Abca1+ / - that have been determined to be doubly
heterozgyous for the two mutations should help determine the contribution of Abca1
gene truncation to this aspect of the 12Gso phenotype (see below). As a corollary to
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this, transgenic mice overexpressing the Abca1 gene are also available, and breeding
experiments with these mice should complement the genetic deficiencies indicated in
12Gso/12Gso lipid efflux. The bone marrow of the offspring from the crosses with the
transgenic strain can be examined for hyperplasia. The combination of these two
breeding experiments should confirm or refute the contribution of Abca1 to the
12Gso/12Gso bone marrow phenotype.

Determination of the root causes for the lack of viable male 12Gso mutants
Of the 14 12Gso homozygotes generated, only 3 of the offspring were male, and
both of these were sickly and died within a few weeks after birth (data not shown).
Though the sample size is too small to state conclusively that a gender bias does exist,
the current numbers could represent a general trend in which the reduced fitness is
further exacerbated in males. One clue to this puzzle may be given by the
downregulation of many genes encoding products involved in steroidogenesis
downstream of Abca1, including hydroxysteroid 17-b dehydrogenase 1 (less than 10-fold
decrease; data not shown), a gene associated with the processing of estrone into estradiol
(Tremblay et al., 1989), but is closely related to hydroxysteroid 17-b dehydrogenase 3,
the gene implicated in human pseudohermaphrodism (Geissler et al., 1994). This aspect
of the 12Gso phenotype has not been explored, and would certainly deserve some future
focus. While Abca1 could be involved in this process, it is also possible that a second
gene residing on Mmu9 may play a role, or it may derive from an artifact due to
breeding schemes, specifically the fact that maintenance of the stock always derives
from the male, which may be transmitting othe loci from the Y chromosome. A full
accounting of any possible gender bias in live-born mutants must therefore await both a
more complete molecular and genetic description of the 12Gso mutation and an increase
in numbers of 12Gso/12Gso produced.

Verification and specification of leukemic phenotype
We cannot yet point conclusively to Abca1 as the culprit for bone marrow
hypercellularity, and another disrupted gene may indeed play a role in this aspect of the
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12Gso phenotype. To clarify the role of Abca1 and other potentially contributing genes,
a thorough immunophenotyping of the 12Gso/12Gso bone marrow, thymus, fetal liver,
and blood will need to be carried out. Part of the reason that the current analysis is
incomplete is that only a small number of anti-mouse antibodies for the diagnostic set of
relevant CD antigens are available for use on paraffin sections. In addition, there is a
much greater danger of RNA degradation in bone samples than in softer tissue, and
difficulties may be encountered in RNA-based studies of the relevant marker genes. The
most accurate way to immunophenotype the bone marrow is by FACS analysis, for
which numerous anti-mouse antibodies are available. This analysis should be able to
determine B- and T- cell ratios, the presence or absence of hematopoietic cells, and the
developmental stage of the major lymphocyte population present in the tissue. Once
these diagnostics are analyzed and a determination is made as to the form of
hypercellularity, additional experiments can proceed. For example, determination of
which genes are up or down regulated can be tested using documented human cases of
leukemia as a guide.
A combination of antigenic markers is already available to examine the bone
marrow and liver for B and T cell lineages and stages. These markers include CD117,
CD18, CD5, CD23, CDw75, and CD45RO. CD117 is a marker for hematopoietic stem
cells and very early lymphocytic development, we can assume that the nucleated cells do
not derive from the undifferentiated cell populations. The second marker (CD18) is
expressed on all leukocytes, and has a role in cellular adhesion. The third marker (CD5)
is mostly expressed on T cells, but also on a small subpopulation of B-cells (termed B1a
cells) and in chronic lymphocytic leukemia. The CD23 antigen is expressed on mature
activated B-cells, the cellular stage whose population expands in B-CLL. CDw75 is also
expressed on mature B-cells and is involved in intercellular adhesion. The final antigen
(CD45RO) is expressed on most T-cell populations and thymocytes. Once alternative
forms of analysis are available, a more accurate description of the 12Gso bone marrow
phenotype can be made.
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Expression analysis of Mmu9 candidate genes in 12Gso homozygotes and determination
of developmental pathway partners
Future studies will also focus on the candidacy of Tbx18 with regard to the
skeletal, and possibly, the hematopoietic phenotypes. Because this gene has a limited
window of expression, like many other genes expressed in the early embryonic stages,
determination of aberrant expression has not been possible before breakpoint cloning
was completed. As the embryos produced in 12Gso carrier timed matings have mostly
appeared normal (LRC, unpublished), visual identification of mutants to use as templates
for expression studies has been impossible. Although some embryos appear runted and
developmentally delayed, and these are likely to be mutants (especially considering the
Abca1 embryonic phenotype), we cannot be certain that the delayed development and
growth is due to the mutation of Abca1. Now that breakpoint spanning sequences are
available, genotypic analysis of the embryos may be done using PCR analysis on yolk
sac DNA associated with each of the isolated embryos. A more reliable genotyping
scheme will involve detection of mutant Mmu4-Mmu9 junction fragments with PCR,
and this should be possible within the next several months now that Mmu4 breakpoint
sequences are cloned. By using two different sets of primers, one that crosses the
breakpoint and one that spans the region on either normal chromosome 4 or 9, genotype
of these embryos would be accessible. Wild type embryos should show a product only
from that primer set which spans the normal region, and not the breakpoint.
Heterozygotes should produce a product with both primer sets, and homozygotes should
produce a product only with the primer set that spans the breakpoint.
Once embryos have been genotyped, gene expression analysis can proceed either
in the form of whole mount or section ISH. While whole mount in situ hybridization can
provide a more global picture of gene expression and can be more visually striking to the
untrained eye, section in situ has many other advantages. The use of sections allows the
application of multiple probes to a single embryo, as well as the ability to zoom in the
exact cellular type that expresses the gene of interest. The difficult task in section in situ
hybridization, with regard to somitic development, is encompassing all of the different
structures involved in somitogenesis. Sagittal sections of an embryo that slice directly
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through the midline, and thus encompassing structures like the notochord, may be
difficult to come by. This can be at least partially addressed by transverse sections
through the midline of the body, thus including the neural tube and notochord. Each
form of in situ has pros and cons, and a mix of the two procedures would be most
informative.
Even if Tbx18 does not turn out to be the gene whose disruption is associated
with 12Gso skeletal phenotype, this same procedure should be followed with other genes
in the breakpoint region. The 12Gso skeletal phenotype, and all of the accumulated data
from mutants expressing similar phenotypes, predicts that the gene will be expressed
primarily, if not exclusively, during embryonic stages. To study the mechanism of
action of the candidate gene, it will be particularly valuable to study expression of
various somitogenesis markers. Members of the Notch-Delta pathway are excellent
candidates for analysis of segmentation and somitogenesis, as these genes are expressed
in a temporal spatial pattern that clearly defines anterior and posterior compartments of
the somites (e.g. Conlon et al., 1995; Dunwoodie et al., 1997; Hrabe de Angelis et al.,
1997; Kusimi et al., 1998; Zhang and Gridley, 1998; Evrard et al., 1998). In a similar
vein, markers in the Hh pathway would be useful in determining perturbance of
dorsoventral polarity (Marti et al., 1995). Other markers, such as Pax1, should be used to
determine whether or not the phenotype presents notochordal involvement (Timmons et
al., 1994; Wallin et al., 1994), and other markers, such as either MyoD (Hannon et al.,
1992) or Mesp (Sawada et al., 2000) should be used to analyze possible involvement of
the myotome. By using a series of these markers, a clear picture should evolve as to the
exact function and pathway of the 12Gso candidate gene.
The downstream genes regulated by this gene can also be determined in ways
very similar to those currently in use to elucidate the effects of Abca1 in 12Gso, such as
the use of microarrays and complementation testing.
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Generation and testing of alternate alleles to verify the phenotype as related to the
candidate genes
In order to provide conclusive evidence that a particular gene is the relevant one
with regard to the phenotype, other alleles of the gene such as those generated by
transgenesis, gene knockout, or targeted mutagenesis will need to be analyzed. While
gene knockout or transgenesis may be necessary for testing the skeletal candidate gene
for 12Gso, another option is available for providing solid evidence of the phenotypic
contribution of the Abca1 gene in 12Gso: complementation testing. Mice that carry a
null mutation in Abca1 are available from Jackson Laboratory, and by crossing these
mice with 12Gso, confirmation of the contribution provided by this gene to the 12Gso
phenotype (including the possible role of Abca1 in the bone marrow phenotype) can be
investigated. Compound heterozygotes would be tested as in the experiments listed for
further phenotypic characterization (p. 138, above). Crosses with transgenic
overexpressers of Abca1 (Cavalieri et al., 2001) can also be performed; the offspring
from these crosses should be complemented at the Abca1 locus. If all hypotheses put
forward for Abca1 are correct, that is, Abca1 is responsible for early lethality and biased
sex ratio, offspring homozygous for the translocation should exhibit the skeletal
phenotype in equivalent gender ratios, and the mutants should have increased longevity.
Because of complementation of the early phenotype, these mutants should also be
generated at the expected ratio of 1 in 6.
Alternate alleles of Tbx18, if more evidence points to the involvement of this
gene in the 12Gso homozygous phenotype, would need to be found or generated as well
to test and verify the candidacy of the putative role for this gene in the 12Gso/12Gso
skeletal phenotype. While knockouts or transgenics of this gene are not currently
available, experiments could be conducted to generate a knockout for complementation
crosses with 12Gso. By the same token, collections of mutagenized ES cells are
available for screening (Chen et al., 2000; Munroe et al., 2000), and it is possible to take
advantage of this resource to derive an allelic series of mutations by which the candidacy
of Tbx18 may be tested.
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Final considerations
Because 12Gso is the first translocation mutant in the LLNL collection to be
characterized so completely, it can serve as a prototype for the analysis of the other
uncharacterized mutants within the colony. More complete protocols have now been
established for the mouse translocation projects where a candidate gene is not readily
obvious or where tissues expressing candidate genes are difficult to access for
expression studies, as was the case with 12Gso. These features made 12Gso one of the
more challenging of the translocation mutants that we might have attempted to tackle.
The importance and excitement of finding novel genes associated with early lethality,
leukemia, and skeletal defects with likely roots in defective early somitogenesis made
the challenge worthwhile. With the influx of mouse sequence data into the public
databases, finding genes associated with other mouse mutants, including those in our
translocation colony, is rapidly being transformed. The pace of gene discovery has
changed remarkably over the course of this endeavor, even over the course of the past
year. When the 12Gso project began, many of the gene markers used in mapping were
yet to be mapped to mouse chromosomes, and were necessarily subjected to IB mapping
before ever being used to isolate BAC clones for FISH analysis. The rapidly changing
databases now have mapped contigs of BAC clones, which essentially eliminate the need
for BAC library screening. Much has changed in this aspect of translocation projects,
but the steps and precautions outlined by the 12Gso project will aid in specific recovery
of these breakpoints from mutant DNA and the more rapid recovery of affected genes.
The 12Gso mutation serves not only as a primary example for similar research
projects to follow, but also lays the foundation for the futures of these projects as well.
Work on this mouse mutation can now progress through the many channels outlined
above. These channels include analysis of the genomic regions surrounding the
breakpoint, complete characterization of the genes involved in the phenotype,
examination of the possible involvement of other organs, determination of interacting
pathway genes and modifier loci, and last but not least, the generation and/or testing of
an alternate allelic mutation, such as those in the form of a transgenic or knockout, to
verify or refute the direct association of the translocation with the phenotype.
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Because the 12Gso mutation is a translocation, we were consistently aware of the
fact that the mutation might disrupt the activities of genes in two different chromosomal
sites. The pleiotropic nature of the phenotype presented by 12Gso homozygotes made
the possibility of at least two affected genes - one on Mmu4 and one on Mmu9 - even
more likely. Our molecular analyses provide strong indication that this prediction is true
for 12Gso, as the known disorders associated with Abca1 mutations, including early
lethality and low live birth rates, steroid imbalance, and lymphatic defects, do not
include defects in development of the axial skeleton. The fact that genes in two
locations contribute to the 12Gso phenotype adds a complication to the study of this
mutant, but also has added some interest to the analysis of the animals and potentially, to
its utility as a model. In characterizing this mutation before the molecular basis of
lethality was known, we have uncovered some phenotypic manifestations of Abca1
deficiency that may have relevance to at least some Tangier disease patients.
Preliminary data collected on the 12Gso mouse indicate that additional aspects of the
phenotype associated with Abca1 mutations should be scrutinized and tested. The
lymphoproliferative phenotype detected in 12Gso homozygotes may also be a useful
finding with respect to understanding the causes of the human form of the disease.
Whether it is eventually traced to defects in Abca1 and lipid transport or to defects in a
second, unidentified gene, the 12Gso lymphatic defect is a novel finding with high
potential relevance to the study of leukemia in humans. The data suggest that the 12Gso
mouse represents a model for leukemia susceptibility, with striking similarities to the
phenotype associated with CLL. Our examination of the Mmu4 and Mmu9 breakpoint
regions have not identified any candidate genes that are known to be associated with
leukemia or that are closely related in sequence to CLL-associated genes. The Nipsnap
genes in the Mmu4 breakpoint region were originally suspected as candidates for this
aspect of the mutant phenotype because of their sequence similarity to HSPC299, which
is expressed on CD34+ cells in humans (Genbank, NCBI). However, though a potential
role cannot be excluded unequivocally at this time, preliminary data indicate that these
genes are normal in structure and expression in 12Gso/12Gso mice. Establishing a link
between any of the genes in this region and leukemia susceptibility will be a novel
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discovery and will highlight a new marker involved in the disease. Publicly documented
cases of the classic mechanisms for CLL have not reported linkage to human regions
homologous to the breakpoint sites of 12Gso, although deletions in the homologous
region have been found in numerous cases of many forms leukemia.
However, it is in the study of skeletal defects that 12Gso should become
particularly useful. Although Tbx18 is a known gene with appropriate patterns of
expression and represents an excellent candidate for further study, no gene located in the
Mmu4 or Mmu9 breakpoint regions has been associated with inherited skeletal
abnormalities. The link between this mutation and skeletal defects will therefore lead to
discovery of a new factor, and perhaps a new molecular pathway, associated with
inherited scoliosis and the more serious manifestations of abnormal development of the
axial skeleton in humans and mice. The mouse is a particularly useful model for
studying the events of skeletogenesis because of the relative accessibility of the relevant
early developmental stages in mice compared to developing human offspring. Mouse
mutations that are able to elucidate the pathways and mechanisms responsible for
development should provide insight into human prenatal development, and possibly aid
in an effort to prevent fetal abnormalities.

144

REFERENCES

145

Adinolfi M., Beck S., Embury S., Polani P. E., and Seller M. J. (1976). Levels of alphafetoprotein in amniotic fluids of mice (curly-tail) with neural tube defects. J Med
Genet 13: 511-3.
Agulnik S. I., Papaioannou V. E., and Silver L. M. (1998). Cloning, mapping, and
expression analysis of TBX15, a new member of the T-Box gene family.
Genomics 51: 68-75.
Akeson E. C., Lambert J. P., Narayanswami S., Gardiner K., Bechtel L. J., and Davisson
M. T. (2001). Ts65Dn -- localization of the translocation breakpoint and trisomic
gene content in a mouse model for Down syndrome. Cytogenet Cell Genet 93:
270-6.
Artavanis-Tsakonas S., Rand M. D., and Lake R. J. (1999). Notch signaling: cell fate
control and signal integration in development. Science 284: 770-6.
Ashley T. (1988). G-band position effects on meiotic synapsis and crossing over.
Genetics 118: 307-17.
Ashley T., and Cacheiro N. L. (1990). Correlation between meiotic behavior and
breakpoints with respect to G-bands in two X-4 mouse translocations: T(X;4)7R1
and T(X;4)8R1. Cytogenet Cell Genet 53: 178-84.
Aulehla A., and Johnson R. L. (1999). Dynamic expression of lunatic fringe suggests a
link between notch signaling and an autonomous cellular oscillator driving somite
segmentation. Dev Biol 207: 49-61.
Avner E. D., Sweeney W. E., Jr., Young M. C., and Ellis D. (1988). Congenital murine
polycystic kidney disease. II. Pathogenesis of tubular cyst formation. Pediatr
Nephrol 2: 210-8.
Bae Y. S., Kawasaki I., Ikeda H., and Liu L. F. (1988). Illegitimate recombination
mediated by calf thymus DNA topoisomerase II in vitro. Proc Natl Acad Sci U S
A 85: 2076-80.
Bailey A. M., and Posakony J. W. (1995). Suppressor of hairless directly activates
transcription of enhancer of split complex genes in response to Notch receptor
activity. Genes Dev 9: 2609-22.
Bamshad M., Lin R. C., Law D. J., Watkins W. C., Krakowiak P. A., Moore M. E.,
Franceschini P., Lala R., Holmes L. B., Gebuhr T. C., Bruneau B. G., Schinzel A.,

146

Seidman J. G., Seidman C. E., and Jorde L. B. (1997). Mutations in human TBX3
alter limb, apocrine and genital development in ulnar-mammary syndrome. Nat
Genet 16: 311-5.
Bartholomew C., and Ihle J. N. (1991). Retroviral insertions 90 kilobases proximal to the
Evi-1 myeloid transforming gene activate transcription from the normal promoter.
Mol Cell Biol 11: 1820-8.
Basson C. T., Bachinsky D. R., Lin R. C., Levi T., Elkins J. A., Soults J., Grayzel D.,
Kroumpouzou E., Traill T. A., Leblanc-Straceski J., Renault B., Kucherlapati R.,
Seidman J. G., and Seidman C. E. (1997). Mutations in human TBX5 [corrected]
cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 15: 305.
Bedell M. A., Jenkins N. A., and Copeland N. G. (1996). Good genes in bad
neighbourhoods. Nat Genet 12: 229-32.
Begemann G., Gibert Y., Meyer A., and Ingham P. W. (2002). Cloning of zebrafish Tbox genes tbx15 and tbx18 and their expression during embryonic development.
Mech Dev 114: 137-41.
Beier D. R., Dushkin H., and Telle T. (1995). Haplotype analysis of intra-specific
backcross curly-tail mice confirms the localization of ct to chromosome 4. Mamm
Genome 6: 269-72.
Bell J. A., Rinchik E. M., Raymond S., Suffolk R., and Jackson I. J. (1995). A highresolution map of the brown (b, Tyrp1) deletion complex of mouse chromosome
4. Mamm Genome 6: 389-95.
Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., and
Sultan C. (1989). Proposals for the classification of chronic (mature) B and T
lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin
Pathol 42: 567-84.
Bertrand F. E., Eckfeldt C. E., Lysholm A. S., and LeBien T. W. (2000). Notch-1 and
Notch-2 exhibit unique patterns of expression in human B-lineage cells. Leukemia
14: 2095-102.
Bessho Y., Miyoshi G., Sakata R., and Kageyama R. (2001). Hes7: a bHLH-type
repressor gene regulated by Notch and expressed in the presomitic mesoderm.

147

Genes Cells 6: 175-85.
Bhardwaj G., Murdoch B., Wu D., Baker D. P., Williams K. P., Chadwick K., Ling L. E.,
Karanu F. N., and Bhatia M. (2001). Sonic hedgehog induces the proliferation of
primitive human hematopoietic cells via BMP regulation. Nat Immunol 2: 172-80.
Bichi R., Shinton S. A., Martin E. S., Koval A., Calin G. A., Cesari R., Russo G., Hardy
R. R., and Croce C. M. (2002). Human chronic lymphocytic leukemia modeled in
mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A 99: 6955-60.
Bickmore W. A., and Sumner A. T. (1989). Mammalian chromosome banding--an
expression of genome organization. Trends Genet 5: 144-8.
Bitgood M. J., and McMahon A. P. (1995). Hedgehog and Bmp genes are coexpressed at
many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol 172:
126-38.
Blanco G., Coulton G. R., Biggin A., Grainge C., Moss J., Barrett M., Berquin A.,
Marechal G., Skynner M., van Mier P., Nikitopoulou A., Kraus M., Ponting C. P.,
Mason R. M., and Brown S. D. (2001). The kyphoscoliosis (ky) mouse is
deficient in hypertrophic responses and is caused by a mutation in a novel musclespecific protein. Hum Mol Genet 10: 9-16.
Blanco G., Nikitopoulou A., Kraus M., Mason R. M., Coulton G. R., and Brown S. D.
(1998). A STS content physical and transcription map across the ky,
kyphoscoliosis, nonrecombinant region. Genomics 54: 415-23.
Bodrug S. E., Holden J. J., Ray P. N., and Worton R. G. (1991). Molecular analysis of Xautosome translocations in females with Duchenne muscular dystrophy. Embo J
10: 3931-9.
Bodzioch M., Orso E., Klucken J., Langmann T., Bottcher A., Diederich W., Drobnik
W., Barlage S., Buchler C., Porsch-Ozcurumez M., Kaminski W. E., Hahmann H.
W., Oette K., Rothe G., Aslanidis C., Lackner K. J., and Schmitz G. (1999). The
gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.
Nat Genet 22: 347-51.
Boehm T., Mengle-Gaw L., Kees U. R., Spurr N., Lavenir I., Forster A., and Rabbitts T.
H. (1989). Alternating purine-pyrimidine tracts may promote chromosomal
translocations seen in a variety of human lymphoid tumours. Embo J 8: 2621-31.

148

Bonhomme F., Benmehdi F., Britton-Davidian J., and Martin S. (1979). [Genetic analysis
of interspecific crosses Mus musculus L. x Mus spretus Lataste: linkage of Adh-1
with Amy-1 on chromosome 3 and Es-14 with Mod-1 on chromosome 9]. C R
Seances Acad Sci D 289: 545-8.
Boyd Y., Cockburn D., Holt S., Munro E., Van Ommen G. J., Gillard B., Affara N.,
Ferguson-Smith M., and Craig I. (1988). Mapping of 12 translocation breakpoints
in the Xp21 region with respect to the locus for Duchenne muscular dystrophy.
Cytogenet Cell Genet 48: 28-34.
Brandt C. A., Ludecke H. J., Hindkjaer J., Stromkjaer H., Pinkel D., Herlin T., Bolund L.,
and Friedrich U. (1997). A de nevo complex t(7;13;8) translocation with a
deletion in the TRPS gene region. Hum Genet 100: 334-8.
Bronner-Fraser M., and Stern C. (1991). Effects of mesodermal tissues on avian neural
crest cell migration. Dev Biol 143: 213-7.
Brook F. A., Shum A. S., Van Straaten H. W., and Copp A. J. (1991). Curvature of the
caudal region is responsible for failure of neural tube closure in the curly tail (ct)
mouse embryo. Development 113: 671-8.
Brooks-Wilson A., Marcil M., Clee S. M., Zhang L. H., Roomp K., van Dam M., Yu L.,
Brewer C., Collins J. A., Molhuizen H. O., Loubser O., Ouelette B. F., Fichter K.,
Ashbourne-Excoffon K. J., Sensen C. W., Scherer S., Mott S., Denis M.,
Martindale D., Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J. J.,
Hayden M. R., and et al. (1999). Mutations in ABC1 in Tangier disease and
familial high-density lipoprotein deficiency. Nat Genet 22: 336-45.
Brown K. S. (1988). The comparative biology of chondrodysplasias in mice. Pathol
Immunopathol Res 7: 55-61.
Brown K. S. (1988). The comparative biology of chondrodysplasias in mice. Pathol
Immunopathol Res 7: 55-61.
Budarf M. L., Collins J., Gong W., Roe B., Wang Z., Bailey L. C., Sellinger B., Michaud
D., Driscoll D. A., and Emanuel B. S. (1995). Cloning a balanced translocation
associated with DiGeorge syndrome and identification of a disrupted candidate
gene. Nat Genet 10: 269-78.
Bugge M., Bruun-Petersen G., Brondum-Nielsen K., Friedrich U., Hansen J., Jensen G.,

149

Jensen P. K., Kristoffersson U., Lundsteen C., Niebuhr E., Rasmussen K. R.,
Rasmussen K., and Tommerup N. (2000). Disease associated balanced
chromosome rearrangements: a resource for large scale genotype-phenotype
delineation in man. J Med Genet 37: 858-65.
Bulman M. P., Kusumi K., Frayling T. M., McKeown C., Garrett C., Lander E. S.,
Krumlauf R., Hattersley A. T., Ellard S., and Turnpenny P. D. (2000). Mutations
in the human delta homologue, DLL3, cause axial skeletal defects in
spondylocostal dysostosis. Nat Genet 24: 438-41.
Bultman S. J., Michaud E. J., and Woychik R. P. (1992). Molecular characterization of
the mouse agouti locus. Cell 71: 1195-204.
Bultman S. J., Russell L. B., Gutierrez-Espeleta G. A., and Woychik R. P. (1991).
Molecular characterization of a region of DNA associated with mutations at the
agouti locus in the mouse. Proc Natl Acad Sci U S A 88: 8062-6.
Bunting K. D. (2002). ABC transporters as phenotypic markers and functional regulators
of stem cells. Stem Cells 20: 11-20.
Burda D. J., and Center E. M. (1969). Development of luxoid (lu) skeletal defects in
vitro. J Embryol Exp Morphol 21: 347-60.
Byers P. H., and Steiner R. D. (1992). Osteogenesis imperfecta. Annu Rev Med 43: 26982.
Cacheiro N. L., Rutledge J. C., Cain K. T., Cornett C. V., and Generoso W. M. (1994).
Cytogenetic analysis of malformed mouse fetuses derived from balanced
translocation heterozygotes. Cytogenet Cell Genet 66: 139-48.
Call K. M., Glaser T., Ito C. Y., Buckler A. J., Pelletier J., Haber D. A., Rose E. A., Kral
A., Yeger H., Lewis W. H., and et al. (1990). Isolation and characterization of a
zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.
Cell 60: 509-20.
Capdevila J., and Guerrero I. (1994). Targeted expression of the signaling molecule
decapentaplegic induces pattern duplications and growth alterations in Drosophila
wings. Embo J 13: 4459-68.
Carlson G. P., and Weaver P. M. (1985). Distribution and binding of [14C]acrylamide to
macromolecules in SENCAR and BALB/c mice following oral and topical

150

administration. Toxicol Appl Pharmacol 79: 307-13.
Cattanach B. M., and Kirk M. (1985). Differential activity of maternally and paternally
derived chromosome regions in mice. Nature 315: 496-8.
Cavalieri E. L., Kumar S., Todorovic R., Higginbotham S., Badawi A. F., and Rogan E.
G. (2001). Imbalance of estrogen homeostasis in kidney and liver of hamsters
treated with estradiol: implications for estrogen-induced initiation of renal tumors.
Chem Res Toxicol 14: 1041-50.
Cawthon R. M., Weiss R., Xu G. F., Viskochil D., Culver M., Stevens J., Robertson M.,
Dunn D., Gesteland R., O'Connell P., and et al. (1990). A major segment of the
neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point
mutations. Cell 62: 193-201.
Chakrabarti A., Onaivi E., Chittenden L., and Stubbs L. (1996). The gene encoding the
central cannabinoid receptor is located in proximal mouse Chromosome 4. Mamm
Genome 7: 165-6.
Chen S. J., Chen Z., Font M. P., d'Auriol L., Larsen C. J., and Berger R. (1989).
Structural alterations of the BCR and ABL genes in Ph1 positive acute leukemias
with rearrangements in the BCR gene first intron: further evidence implicating
Alu sequences in the chromosome translocation. Nucleic Acids Res 17: 7631-42.
Chen Y., Yee D., Dains K., Chatterjee A., Cavalcoli J., Schneider E., Om J., Woychik R.
P., and Magnuson T. (2000). Genotype-based screen for ENU-induced mutations
in mouse embryonic stem cells. Nat Genet 24: 314-7.
Chernova O. B., Hunyadi A., Malaj E., Pan H., Crooks C., Roe B., and Cowell J. K.
(2001). A novel member of the WD-repeat gene family, WDR11, maps to the
10q26 region and is disrupted by a chromosome translocation in human
glioblastoma cells. Oncogene 20: 5378-92.
Cheung M. C., Mendez A. J., Wolf A. C., and Knopp R. H. (1993). Characterization of
apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density
lipoprotein deficiency resembling Tangier disease and their effects on
intracellular cholesterol efflux. J Clin Invest 91: 522-9.
Chiesa G., Parolini C., Canavesi M., Colombo N., Sirtori C. R., Fumagalli R.,
Franceschini G., and Bernini F. (1998). Human apolipoproteins A-I and A-II in

151

cell cholesterol efflux: studies with transgenic mice. Arterioscler Thromb Vasc
Biol 18: 1417-23.
Chittenden L., Lu X., Cacheiro N. L., Cain K. T., Generoso W., Bryda E. C., and Stubbs
L. (2002). A new mouse model for autosomal recessive polycystic kidney disease.
Genomics 79: 499-504.
Christiansen-Weber T. A., Voland J. R., Wu Y., Ngo K., Roland B. L., Nguyen S.,
Peterson P. A., and Fung-Leung W. P. (2000). Functional loss of ABCA1 in mice
causes severe placental malformation, aberrant lipid distribution, and kidney
glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. Am
J Pathol 157: 1017-29.
Clarke A., Roberts S. H., Thomas N. S., Whitfield A., Williams J., and Harper P. S.
(1986). Duchenne muscular dystrophy with adrenal insufficiency and glycerol
kinase deficiency: high resolution cytogenetic analysis with molecular,
biochemical, and clinical studies. J Med Genet 23: 501-8.
Conlon R. A., Reaume A. G., and Rossant J. (1995). Notch1 is required for the
coordinate segmentation of somites. Development 121: 1533-45.
Conroy J. M., Grebe T. A., Becker L. A., Tsuchiya K., Nicholls R. D., Buiting K.,
Horsthemke B., Cassidy S. B., and Schwartz S. (1997). Balanced translocation
46,XY,t(2;15)(q37.2;q11.2) associated with atypical Prader-Willi syndrome. Am J
Hum Genet 61: 388-94.
Copeland N. G., and Jenkins N. A. (1991). Development and applications of a molecular
genetic linkage map of the mouse genome. Trends Genet 7: 113-8.
Corbo J. C., Fujiwara S., Levine M., and Di Gregorio A. (1998). Suppressor of hairless
activates brachyury expression in the Ciona embryo. Dev Biol 203: 358-68.
Corbo J. C., Levine M., and Zeller R. W. (1997). Characterization of a notochord-specific
enhancer from the Brachyury promoter region of the ascidian, Ciona intestinalis.
Development 124: 589-602.
Cotran, R. S., Kumar, V., and Collins, T. (1999). Robbins Pathologic Basis of Disease.
Philidelphia: W. B. Saunders Company. Pp.601 – 696
Culiat C. T., Carver E. A., Walkowicz M., Rinchik E. M., Cacheiro N. L., Russell L. B.,
Generoso W. M., and Stubbs L. (1997). Induced mouse chromosomal

152

rearrangements as tools for identifying critical developmental genes and
pathways. Reprod Toxicol 11: 345-51.
Culiat C. T., Stubbs L., Nicholls R. D., Montgomery C. S., Russell L. B., Johnson D. K.,
and Rinchik E. M. (1993). Concordance between isolated cleft palate in mice and
alterations within a region including the gene encoding the beta 3 subunit of the
type A gamma-aminobutyric acid receptor. Proc Natl Acad Sci U S A 90: 5105-9.
Culiat C. T., Stubbs L. J., Woychik R. P., Russell L. B., Johnson D. K., and Rinchik E.
M. (1995). Deficiency of the beta 3 subunit of the type A gamma-aminobutyric
acid receptor causes cleft palate in mice. Nat Genet 11: 344-6.
Dale L., and Jones C. M. (1999). BMP signalling in early Xenopus development.
Bioessays 21: 751-60.
Davies K. E., Pearson P. L., Harper P. S., Murray J. M., O'Brien T., Sarfarazi M., and
Williamson R. (1983). Linkage analysis of two cloned DNA sequences flanking
the Duchenne muscular dystrophy locus on the short arm of the human X
chromosome. Nucleic Acids Res 11: 2303-12.
Davis A. P., and Justice M. J. (1998). An Oak Ridge legacy: the specific locus test and its
role in mouse mutagenesis. Genetics 148: 7-12.
de Klein A., van Kessel A. G., Grosveld G., Bartram C. R., Hagemeijer A., Bootsma D.,
Spurr N. K., Heisterkamp N., Groffen J., and Stephenson J. R. (1982). A cellular
oncogene is translocated to the Philadelphia chromosome in chronic myelocytic
leukaemia. Nature 300: 765-7.
Dickinson A. G., and Meikle V. M. (1973). Genetic kyphoscoliosis in mice. Lancet 1:
1186.
DiLeone R. J., King J. A., Storm E. E., Copeland N. G., Jenkins N. A., and Kingsley D.
M. (1997). The Bmp8 gene is expressed in developing skeletal tissue and maps
near the Achondroplasia locus on mouse chromosome 4. Genomics 40: 196-8.
Dirks W. G., Zaborski M., Jager K., Challier C., Shiota M., Quentmeier H., and Drexler
H. G. (1996). The (2;5)(p23;q35) translocation in cell lines derived from
malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
Leukemia 10: 142-9.
Djabali M., Selleri L., Parry P., Bower M., Young B. D., and Evans G. A. (1992). A

153

trithorax-like gene is interrupted by chromosome 11q23 translocations in acute
leukaemias. Nat Genet 2: 113-8.
Dosch R., Gawantka V., Delius H., Blumenstock C., and Niehrs C. (1997). Bmp-4 acts as
a morphogen in dorsoventral mesoderm patterning in Xenopus. Development 124:
2325-34.
Duba H. C., Erdel M., Loffler J., Wirth J., Utermann B., and Utermann G. (1998). Nail
patella syndrome in a cytogenetically balanced t(9;17)(q34.1;q25) carrier. Eur J
Hum Genet 6: 75-9.
Dunwoodie S. L., Clements M., Sparrow D. B., Sa X., Conlon R. A., and Beddington R.
S. (2002). Axial skeletal defects caused by mutation in the spondylocostal
dysplasia/pudgy gene Dll3 are associated with disruption of the segmentation
clock within the presomitic mesoderm. Development 129: 1795-806.
Dunwoodie S. L., Henrique D., Harrison S. M., and Beddington R. S. (1997). Mouse
Dll3: a novel divergent Delta gene which may complement the function of other
Delta homologues during early pattern formation in the mouse embryo.
Development 124: 3065-76.
Edelmann L., Spiteri E., McCain N., Goldberg R., Pandita R. K., Duong S., Fox J.,
Blumenthal D., Lalani S. R., Shaffer L. G., and Morrow B. E. (1999). A common
breakpoint on 11q23 in carriers of the constitutional t(11;22) translocation. Am J
Hum Genet 65: 1608-16.
Eissenberg J. C. (1989). Position effect variegation in Drosophila: towards a genetics of
chromatin assembly. Bioessays 11: 14-7.
Elder J. T., Forrester W. C., Thompson C., Mager D., Henthorn P., Peretz M.,
Papayannopoulou T., and Groudine M. (1990). Translocation of an erythroidspecific hypersensitive site in deletion-type hereditary persistence of fetal
hemoglobin. Mol Cell Biol 10: 1382-9.
Embury S., Seller M. J., Adinolfi M., and Polani P. E. (1979). Neural tube defects in
curly-tail mice. I. Incidence, expression and similarity to the human condition.
Proc R Soc Lond B Biol Sci 206: 85-94.
Engel W. K., Dorman J. D., Levy R. I., and Fredrickson D. S. (1967). Neuropathy in
Tangier disease. Alpha-Lipoprotein deficiency manifesting as familial recurrent

154

neuropathy and intestinal lipid storage. Arch Neurol 17: 1-9.
Escribano L., Heinrichs B., Villarrubia J., Navas G., Cervero C., Velasco J. L., Cabezudo
E., and Roldan E. (1995). Juvenile chronic lymphocytic leukemia with unusual
intracisternal inclusions: an ultrastructural study. Leuk Lymphoma 17: 515-9.
Evrard Y. A., Lun Y., Aulehla A., Gan L., and Johnson R. L. (1998). lunatic fringe is an
essential mediator of somite segmentation and patterning. Nature 394: 377-81.
Fan C. M., and Tessier-Lavigne M. (1994). Patterning of mammalian somites by surface
ectoderm and notochord: evidence for sclerotome induction by a hedgehog
homolog. Cell 79: 1175-86.
Favor J. (1999). Mechanisms of mutation induction in germ cells of the mouse as
assessed by the specific locus test. Mutat Res 428: 227-36.
Feduccia, A., and McCrady, E. (1991). Torrey’s Morphogenesis of the Vertebrates, 5th
Ed. New York: John Wiley and Sons, Inc., p. 201-251.
Feingold E. A., and Forget B. G. (1989). The breakpoint of a large deletion causing
hereditary persistence of fetal hemoglobin occurs within an erythroid DNA
domain remote from the beta-globin gene cluster. Blood 74: 2178-86.
Felix C. A., and Poplack D. G. (1991). Characterization of acute lymphoblastic leukemia
of childhood by immunoglobulin and T-cell receptor gene patterns. Leukemia 5:
1015-25.
Fielding C. J., and Fielding P. E. (2001). Cellular cholesterol efflux. Biochim Biophys
Acta 1533: 175-89.
Finley M. F., Devata S., and Huettner J. E. (1999). BMP-4 inhibits neural differentiation
of murine embryonic stem cells. J Neurobiol 40: 271-87.
Fletcher C., Norman D. J., and Heintz N. (1991). Genetic mapping of meander tail, a
mouse mutation affecting cerebellar development. Genomics 9: 647-55.
Fletcher C., Norman D. J., and Heintz N. (1991). Genetic mapping of meander tail, a
mouse mutation affecting cerebellar development. Genomics 9: 647-55.
Foon K. A., and Todd R. F., 3rd (1986). Immunologic classification of leukemia and
lymphoma. Blood 68: 1-31.
Fountain J. W., Wallace M. R., Bruce M. A., Seizinger B. R., Menon A. G., Gusella J. F.,
Michels V. V., Schmidt M. A., Dewald G. W., and Collins F. S. (1989). Physical

155

mapping of a translocation breakpoint in neurofibromatosis. Science 244: 1085-7.
Franceschini G., Apebe P., Calabresi L., Busnach G., Minetti L., Vaccarino V., and
Sirtori C. R. (1988). Alterations in the HDL system after rapid plasma cholesterol
reduction by LDL-apheresis. Metabolism 37: 752-7.
Freedman M. H., Boyden M., Taylor M., and Skarf B. (1988). Neurotoxicity associated
with deferoxamine therapy. Toxicology 49: 283-90.
Friedrich U., Dalby M., Staehelin-Jensen T., and Bruun-Petersen G. (1982).
Chromosomal studies of children with developmental language retardation. Dev
Med Child Neurol 24: 645-52.
Garg V., Yamagishi C., Hu T., Kathiriya I. S., Yamagishi H., and Srivastava D. (2001).
Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog
during pharyngeal arch development. Dev Biol 235: 62-73.
Geissler W. M., Davis D. L., Wu L., Bradshaw K. D., Patel S., Mendonca B. B., Elliston
K. O., Wilson J. D., Russell D. W., and Andersson S. (1994). Male
pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid
dehydrogenase 3. Nat Genet 7: 34-9.
Generoso W. M., Bishop J. B., Gosslee D. G., Newell G. W., Sheu C. J., and von Halle E.
(1980). Heritable translocation test in mice. Mutat Res 76: 191-215.
Generoso W. M., Cain K. T., Krishna M., Cunningham E. B., and Hellwig C. S. (1981).
Evidence that chromosome rearrangements occur after fertilization following
postmeiotic treatment of male-mice germ cells with EMS. Mutat Res 91: 137-40.
Generoso W. M., Huff S. W., and Cain K. T. (1978). Tests on induction of chromosome
aberrations in mouse germ cells with sodium bisulfite. Mutat Res 56: 363-5.
Generoso W. M., Krishna M., Cain K. T., and Sheu C. W. (1981). Comparison of two
methods for detecting translocation heterozygotes in mice. Mutat Res 81: 177-86.
Germano G., Chen B. C., Huang S. C., Gambhir S. S., Hoffman E. J., and Phelps M. E.
(1992). Use of the abdominal aorta for arterial input function determination in
hepatic and renal PET studies. J Nucl Med 33: 613-20.
Giacalone J. P., and Francke U. (1992). Common sequence motifs at the rearrangement
sites of a constitutional X/autosome translocation and associated deletion. Am J
Hum Genet 51: 226.

156

Godin I. E., Garcia-Porrero J. A., Coutinho A., Dieterlen-Lievre F., and Marcos M. A.
(1993). Para-aortic splanchnopleura from early mouse embryos contains B1a cell
progenitors. Nature 364: 67-70.
Gofflot F., Hall M., and Morriss-Kay G. M. (1998). Genetic patterning of the posterior
neuropore region of curly tail mouse embryos: deficiency of Wnt5a expression.
Int J Dev Biol 42: 637-44.
Goldstein R. S., and Kalcheim C. (1992). Determination of epithelial half-somites in
skeletal morphogenesis. Development 116: 441-5.
Gorlin R. J. (1987). Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore) 66:
98-113.
Green, M.C. (1955). Luxoid, a new hereditary leg and foot abnormality in the house
mouse. J Hered 46:91-99
Greenberg C. R., Hamerton J. L., Nigli M., and Wrogemann K. (1987). DNA studies in a
family with Duchenne muscular dystrophy and a deletion at Xp21. Am J Hum
Genet 41: 128-37.
Greenfield A. J., and Brown S. D. (1987). Microdissection and microcloning from the
proximal region of mouse chromosome 7: isolation of clones genetically linked to
the pudgy locus. Genomics 1: 153-8.
Grindley J. C., Bellusci S., Perkins D., and Hogan B. L. (1997). Evidence for the
involvement of the Gli gene family in embryonic mouse lung development. Dev
Biol 188: 337-48.
Gruneberg, H. (1954). tk - tail kinks Mouse News Lett 11:29
Gruneberg, H. (1955). Genetical studies on the skeleton of the mouse. XVI. Tail-kinks. J
Genet 53:536-50
Gruneberg, H. (1961). Genetical studies on the skeleton of the mouse. XXIX. Pudgy,
Genet Res 2:384-93
Gu Y., Cimino G., Alder H., Nakamura T., Prasad R., Canaani O., Moir D. T., Jones C.,
Nowell P. C., Croce C. M., and et al. (1992). The (4;11)(q21;q23) chromosome
translocations in acute leukemias involve the VDJ recombinase. Proc Natl Acad
Sci U S A 89: 10464-8.
Gustavsson P., Skeppner G., Johansson B., Berg T., Gordon L., Kreuger A., and Dahl N.

157

(1997). Diamond-Blackfan anaemia in a girl with a de novo balanced reciprocal
X;19 translocation. J Med Genet 34: 779-82.
Hahn H., Christiansen J., Wicking C., Zaphiropoulos P. G., Chidambaram A., Gerrard B.,
Vorechovsky I., Bale A. E., Toftgard R., Dean M., and Wainwright B. (1996). A
mammalian patched homolog is expressed in target tissues of sonic hedgehog and
maps to a region associated with developmental abnormalities. J Biol Chem 271:
12125-8.
Hall, B. K. (1977). Chondrogenesis of the Somitic Skeleton . Springer-Verlag BerlinHeidelberg.
Handel M. A., Lane P. W., Schroeder A. C., and Davisson M. T. (1988). New mutation
causing sterility in the mouse. Gamete Res 21: 409-23.
Hannon K., Smith C. K., 2nd, Bales K. R., and Santerre R. F. (1992). Temporal and
quantitative analysis of myogenic regulatory and growth factor gene expression in
the developing mouse embryo. Dev Biol 151: 137-44.
Hawley R. S. (1980). Chromosomal sites necessary for normal levels of meiotic
recombination in Drosophila melanogaster. I. Evidence for and mapping of the
sites. Genetics 94: 625-46.
Heim S., and Mitelman F. (1986). Chromosome abnormalities in the myelodysplastic
syndromes. Clin Haematol 15: 1003-21.
Henikoff S. (1990). Position-effect variegation after 60 years. Trends Genet 6: 422-6.
Herman R. K. (1978). Crossover suppressors and balanced recessive lethals in
Caenorhabditis elegans. Genetics 88: 49-65.
Hidalgo A., and Ingham P. (1990). Cell patterning in the Drosophila segment: spatial
regulation of the segment polarity gene patched. Development 110: 291-301.
Hollander W. F. (1976). Genetic spina bifida occulta in the mouse. Am J Anat 146: 1739.
Hollander W. F., and Waggie K. S. (1977). Meander tail: a recessive mutant located in
chromosome 4 of the mouse. J Hered 68: 403-6.
Hollander W. F., and Waggie K. S. (1977). Meander tail: a recessive mutant located in
chromosome 4 of the mouse. J Hered 68: 403-6.
Hui C. C., Slusarski D., Platt K. A., Holmgren R., and Joyner A. L. (1994). Expression of

158

three mouse homologs of the Drosophila segment polarity gene cubitus
interruptus, Gli, Gli-2, and Gli-3, in ectoderm- and mesoderm-derived tissues
suggests multiple roles during postimplantation development. Dev Biol 162: 40213.
Imai K., Nass S. J., Olowson M., and Balling R. (1993). The genetic map around the tail
kinks (tk) locus on mouse chromosome 9. Mamm Genome 4: 560-4.
Ingham P. W., Taylor A. M., and Nakano Y. (1991). Role of the Drosophila patched gene
in positional signalling. Nature 353: 184-7.
Ishikawa-Brush Y., Powell J. F., Bolton P., Miller A. P., Francis F., Willard H. F.,
Lehrach H., and Monaco A. P. (1997). Autism and multiple exostoses associated
with an X;8 translocation occurring within the GRPR gene and 3' to the SDC2
gene. Hum Mol Genet 6: 1241-50.
Izon D. J., Punt J. A., and Pear W. S. (2002). Deciphering the role of Notch signaling in
lymphopoiesis. Curr Opin Immunol 14: 192-9.
Jacobs P. A., Hunt P. A., Mayer M., and Bart R. D. (1981). Duchenne muscular
dystrophy (DMD) in a female with an X/autosome translocation: further evidence
that the DMD locus is at Xp21. Am J Hum Genet 33: 513-8.
Jarcho, S and Levin, P. M. (1938). Hereditary malformation of the vertebral bodies. Bull
Johns Hopkins Hosp 62: 216-226.
Jiang Y. J., Aerne B. L., Smithers L., Haddon C., Ish-Horowicz D., and Lewis J. (2000).
Notch signalling and the synchronization of the somite segmentation clock.
Nature 408: 475-9.
Johnson D. K., Hand R. E., Jr., and Rinchik E. M. (1989). Molecular mapping within the
mouse albino-deletion complex. Proc Natl Acad Sci U S A 86: 8862-6.
Johnson D. K., Stubbs L. J., Culiat C. T., Montgomery C. S., Russell L. B., and Rinchik
E. M. (1995). Molecular analysis of 36 mutations at the mouse pink-eyed dilution
(p) locus. Genetics 141: 1563-71.
Johnson, D. R. (1986). The Genetics of the Skeleton. New York: Oxford University
Press, p. 199-231.
Johnson D. R., and Wallace M. E. (1979). Crinkly-tail, a mild skeletal mutant in the
mouse. J Embryol Exp Morphol 53: 327-33.

159

Johnson E. F., Mitchell R., Berryman H., Cardoso S., Ueal O., and Patterson D. (1986).
Secretory cells in the nucleus pulposus of the adult human intervertebral disc. A
preliminary report. Acta Anat (Basel) 125: 161-4.
Jones P., May G., Healy L., Brown J., Hoyne G., Delassus S., and Enver T. (1998).
Stromal expression of Jagged 1 promotes colony formation by fetal hematopoietic
progenitor cells. Blood 92: 1505-11.
Jouve C., Palmeirim I., Henrique D., Beckers J., Gossler A., Ish-Horowicz D., and
Pourquie O. (2000). Notch signalling is required for cyclic expression of the
hairy-like gene HES1 in the presomitic mesoderm. Development 127: 1421-9.
Kalderon D. (1997). Hedgehog signalling: Ci complex cuts and clasps. Curr Biol 7:
R759-62.
Kaufman, M. H. (1991). Critical role of the yolk sac in erythropoiesis and the formation
of the primordial germ cells in mammals. Int. J. Radiat. Biol. 60: 544-547.
Kaufman, M. H. and Bard, J. B. L.

(1999).

The Anatomical Basis of Mouse

Development. Academic Press, san Diego, CA, pp. 4 - 46, 51 - 59.
Kawamata S., Du C., Li K., and Lavau C. (2002). Overexpression of the Notch target
genes Hes in vivo induces lymphoid and myeloid alterations. Oncogene 21: 385563.
Kehrer-Sawatzki H., Haussler J., Krone W., Bode H., Jenne D. E., Mehnert K. U.,
Tummers U., and Assum G. (1997). The second case of a t(17;22) in a family
with neurofibromatosis type 1: sequence analysis of the breakpoint regions. Hum
Genet 99: 237-47.
Klebig M. L., Russell L. B., and Rinchik E. M. (1992). Murine fumarylacetoacetate
hydrolase (Fah) gene is disrupted by a neonatally lethal albino deletion that
defines the hepatocyte-specific developmental regulation 1 (hsdr-1) locus. Proc
Natl Acad Sci U S A 89: 1363-7.
Kleinman H. K., Pennypacker J. P., and Brown K. S. (1977). Proteoglycan and collagen
of "achondroplastic" (cn/cn) neonatal mouse cartilage. Growth 41: 171-7.
Koenig M., Hoffman E. P., Bertelson C. J., Monaco A. P., Feener C., and Kunkel L. M.
(1987). Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA
and preliminary genomic organization of the DMD gene in normal and affected

160

individuals. Cell 50: 509-17.
Konyukhov B. V., and Paschin Y. V. (1970). Abnormal growth of the body, internal
organs and skeleton in the achondroplastic mice. Acta Biol 21: 347-54.
Kraus F., Haenig B., and Kispert A. (2001). Cloning and expression analysis of the
mouse T-box gene Tbx18. Mech Dev 100: 83-6.
Krebs I., Weis I., Hudler M., Rommens J. M., Roth H., Scherer S. W., Tsui L. C.,
Fuchtbauer E. M., Grzeschik K. H., Tsuji K., and Kunz J. (1997). Translocation
breakpoint maps 5 kb 3' from TWIST in a patient affected with Saethre-Chotzen
syndrome. Hum Mol Genet 6: 1079-86.
Kristoffersen L., Howitz P., Nathan E., and Lundsteen C. (1974). [The clinical
importance of chromosome abnormalities. Some problems illustrated by 2
examples]. Ugeskr Laeger 136: 1628-30.
Krowczynska A. M., Rudders R. A., and Krontiris T. G. (1990). The human minisatellite
consensus at breakpoints of oncogene translocations. Nucleic Acids Res 18: 11217.
Kuslich C. D., Kobori J. A., Mohapatra G., Gregorio-King C., and Donlon T. A. (1999).
Prader-Willi syndrome is caused by disruption of the SNRPN gene. Am J Hum
Genet 64: 70-6.
Kusumi K., Sun E. S., Kerrebrock A. W., Bronson R. T., Chi D. C., Bulotsky M. S.,
Spencer J. B., Birren B. W., Frankel W. N., and Lander E. S. (1998). The mouse
pudgy mutation disrupts Delta homologue Dll3 and initiation of early somite
boundaries. Nat Genet 19: 274-8.
Lane, P.W. (1987) Abnormal feet and tail (Aft). Mouse News Lett 78:56-57
Lane P. W., and Dickie M. M. (1968). Three recessive mutations producing
disproportionate dwarfing in mice: achondroplasia, brachymorphic, and stubby. J
Hered 59: 300-8.
Lavy, N. W., Palmer, C. G., and Merritt, A. D. (1966). A syndrome of bizarre vertebral
anomalies. J Pediat 69: 1121-1125.
Lebovitz R. M. (1986). Oncogenes as mediators of cell growth and differentiation. Lab
Invest 55: 249-51.
Leimeister C., Dale K., Fischer A., Klamt B., Hrabe de Angelis M., Radtke F., McGrew

161

M. J., Pourquie O., and Gessler M. (2000). Oscillating expression of c-Hey2 in
the presomitic mesoderm suggests that the segmentation clock may use
combinatorial signaling through multiple interacting bHLH factors. Dev Biol 227:
91-103.
Letts V. A., Schork N. J., Copp A. J., Bernfield M., and Frankel W. N. (1995). A curlytail modifier locus, mct1, on mouse chromosome 17. Genomics 29: 719-24.
Levine A., Yeivin A., Ben-Asher E., Aloni Y., and Razin A. (1993). Histone H1mediated inhibition of transcription initiation of methylated templates in vitro. J
Biol Chem 268: 21754-9.
Li Q. Y., Newbury-Ecob R. A., Terrett J. A., Wilson D. I., Curtis A. R., Yi C. H., Gebuhr
T., Bullen P. J., Robson S. C., Strachan T., Bonnet D., Lyonnet S., Young I. D.,
Raeburn J. A., Buckler A. J., Law D. J., and Brook J. D. (1997). Holt-Oram
syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene
family. Nat Genet 15: 21-9.
Lindenbaum R. H., Clarke G., Patel C., Moncrieff M., and Hughes J. T. (1979). Muscular
dystrophy in an X; 1 translocation female suggests that Duchenne locus is on X
chromosome short arm. J Med Genet 16: 389-92.
Litz, C. E., McClure, J. S., and Brunning, R. D. (1996). “Blood and Bone Marrow” in
Anderson’s Pathology, Vol.1. Damjanov, I., and Linder, J., Eds. St. Louis:
Mosby-Year Book, Inc. Pp 1063 – 1114.
Loken M. R., Shah V. O., Dattilio K. L., and Civin C. I. (1987). Flow cytometric analysis
of human bone marrow: I. Normal erythroid development. Blood 69: 255-63.
Look A. T. (1997). Oncogenic transcription factors in the human acute leukemias.
Science 278: 1059-64.
Love E. M., Yin J. A., Harrison C. J., Narayanan M. N., and Bhavnani M. (1989). Acute
monocytic leukaemia and t(2;6) (p21;q26) translocation. Clin Lab Haematol 11:
277-80.
Lyon M. F., King T. R., Gondo Y., Gardner J. M., Nakatsu Y., Eicher E. M., and Brilliant
M. H. (1992). Genetic and molecular analysis of recessive alleles at the pink-eyed
dilution (p) locus of the mouse. Proc Natl Acad Sci U S A 89: 6968-72.
Ma Q., Alder H., Nelson K. K., Chatterjee D., Gu Y., Nakamura T., Canaani E., Croce C.

162

M., Siracusa L. D., and Buchberg A. M. (1993). Analysis of the murine All-1
gene reveals conserved domains with human ALL-1 and identifies a motif shared
with DNA methyltransferases. Proc Natl Acad Sci U S A 90: 6350-4.
Maniatis A., Tsakanikas S., Stamatellou M., and Papanastasiou K. (1989). Intermediatedose melphalan for refractory myeloma. Blood 74: 1177.
Manley N. R., O'Connell M., Sun W., Speck N. A., and Hopkins N. (1993). Two factors
that bind to highly conserved sequences in mammalian type C retroviral
enhancers. J Virol 67: 1967-75.
Marti E., Takada R., Bumcrot D. A., Sasaki H., and McMahon A. P. (1995). Distribution
of Sonic hedgehog peptides in the developing chick and mouse embryo.
Development 121: 2537-47.
Masuno M., Imaizumi K., Nishimura G., Nakamura M., Saito I., Akagi K., and Kuroki Y.
(1995). Shwachman syndrome associated with de novo reciprocal translocation
t(6;12)(q16.2;q21.2). J Med Genet 32: 894-5.
McKim K. S., and Rose A. M. (1990). Chromosome I duplications in Caenorhabditis
elegans. Genetics 124: 115-32.
McNeish J., Aiello R. J., Guyot D., Turi T., Gabel C., Aldinger C., Hoppe K. L., Roach
M. L., Royer L. J., de Wet J., Broccardo C., Chimini G., and Francone O. L.
(2000). High density lipoprotein deficiency and foam cell accumulation in mice
with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad
Sci U S A 97: 4245-50.
Mercer J. F., Livingston J., Hall B., Paynter J. A., Begy C., Chandrasekharappa S.,
Lockhart P., Grimes A., Bhave M., Siemieniak D., and et al. (1993). Isolation of a
partial candidate gene for Menkes disease by positional cloning. Nat Genet 3: 205.
Metallinos D. L., Oppenheimer A. J., Rinchik E. M., Russell L. B., Dietrich W., and
Tilghman S. M. (1994). Fine structure mapping and deletion analysis of the
murine piebald locus. Genetics 136: 217-23.
Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu
Q., Cochran C., Bennett L. M., Ding W., and et al. (1994). A strong candidate for
the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71.

163

Miyoshi H., Kon Y., Seo K. W., Jin H. K., Hasegawa A., and Watanabe T. (1999).
Jumbled spine and ribs (Jsr): a new mutation on mouse chromosome 5. Mamm
Genome 10: 213-7.
Muller R. (1986). Cellular and viral fos genes: structure, regulation of expression and
biological properties of their encoded products. Biochim Biophys Acta 823: 20725.
Mundlos S., and Olsen B. R. (1997). Heritable diseases of the skeleton. Part II: Molecular
insights into skeletal development-matrix components and their homeostasis.
Faseb J 11: 227-33.
Mundlos S., and Olsen B. R. (1997). Heritable diseases of the skeleton. Part I: Molecular
insights into skeletal development-transcription factors and signaling pathways.
Faseb J 11: 125-32.
Munroe R. J., Bergstrom R. A., Zheng Q. Y., Libby B., Smith R., John S. W., Schimenti
K. J., Browning V. L., and Schimenti J. C. (2000). Mouse mutants from
chemically mutagenized embryonic stem cells. Nat Genet 24: 318-21.
Nesbitt M. N., and Francke U. (1973). A system of nomenclature for band patterns of
mouse chromosomes. Chromosoma 41: 145-58.
Nielsen L., and Nielsen I. M. (1984). Turner's syndrome and Duchenne muscular
dystrophy in a girl with an X; autosome translocation. Ann Genet 27: 173-7.
Niswander L., Yee D., Rinchik E. M., Russell L. B., and Magnuson T. (1989). The
albino-deletion complex in the mouse defines genes necessary for development of
embryonic and extraembryonic ectoderm. Development 105: 175-82.
Nusse R. (1999). WNT targets. Repression and activation. Trends Genet 15: 1-3.
O'Brien T. P., Metallinos D. L., Chen H., Shin M. K., and Tilghman S. M. (1996).
Complementation mapping of skeletal and central nervous system abnormalities
in mice of the piebald deletion complex. Genetics 143: 447-61.
O'Connell P., Leach R., Cawthon R. M., Culver M., Stevens J., Viskochil D., Fournier R.
E., Rich D. C., Ledbetter D. H., and White R. (1989). Two NF1 translocations
map within a 600-kilobase segment of 17q11.2. Science 244: 1087-8.
Oram J. F. (2002). Molecular basis of cholesterol homeostasis: lessons from Tangier
disease and ABCA1. Trends Mol Med 8: 168-73.

164

Orso E., Broccardo C., Kaminski W. E., Bottcher A., Liebisch G., Drobnik W., Gotz A.,
Chambenoit O., Diederich W., Langmann T., Spruss T., Luciani M. F., Rothe G.,
Lackner K. J., Chimini G., and Schmitz G. (2000). Transport of lipids from golgi
to plasma membrane is defective in tangier disease patients and Abc1-deficient
mice. Nat Genet 24: 192-6.
Osborne B., and Miele L. (1999). Notch and the immune system. Immunity 11: 653-63.
Pai J. T., Tsai S. F., Horng C. J., Chiu P. C., Cheng M. Y., Hsiao K. J., and Wuu K. D.
(1994). Absence of FMR-1 gene expression can be detected with RNA extracted
from dried blood specimens. Hum Genet 93: 488-93.
Papaioannou V. E., and Silver L. M. (1998). The T-box gene family. Bioessays 20: 9-19.
Parker J. D., Rabinovitch P. S., and Burmer G. C. (1991). Targeted gene walking
polymerase chain reaction. Nucleic Acids Res 19: 3055-60.
Pear W. S., Aster J. C., Scott M. L., Hasserjian R. P., Soffer B., Sklar J., and Baltimore
D. (1996). Exclusive development of T cell neoplasms in mice transplanted with
bone marrow expressing activated Notch alleles. J Exp Med 183: 2283-91.
Peeters M. C., Shum A. S., Hekking J. W., Copp A. J., and van Straaten H. W. (1996).
Relationship between altered axial curvature and neural tube closure in normal
and mutant (curly tail) mouse embryos. Anat Embryol (Berl) 193: 123-30.
Pennacchio L. A., Olivier M., Hubacek J. A., Cohen J. C., Cox D. R., Fruchart J. C.,
Krauss R. M., and Rubin E. M. (2001). An apolipoprotein influencing
triglycerides in humans and mice revealed by comparative sequencing. Science
294: 169-73.
Pietrini V., Rizzuto N., Vergani C., Zen F., and Ferro Milone F. (1985). Neuropathy in
Tangier disease: A clinicopathologic study and a review of the literature. Acta
Neurol Scand 72: 495-505.
Potter M. D., Klebig M. L., Carpenter D. A., and Rinchik E. M. (1995). Genetic and
physical mapping of the fitness 1 (fit1) locus within the Fes-Hbb region of mouse
chromosome 7. Mamm Genome 6: 70-5.
Pourquie O., Coltey M., Teillet M. A., Ordahl C., and Le Douarin N. M. (1993). Control
of dorsoventral patterning of somitic derivatives by notochord and floor plate.
Proc Natl Acad Sci U S A 90: 5242-6.

165

Pressly T. A., Scott W. J., Ide C. H., Winkler A., and Reams G. P. (1987). Ocular
complications of Tangier disease. Am J Med 83: 991-4.
Pringle E. M., Young W. F., and Haworth E. M. (1968). Syndrome of pancreatic
insufficiency, blood dyscrasia and metaphyseal dysplasia. Proc R Soc Med 61:
776-7.
Psychoyos D., and Stern C. D. (1996). Fates and migratory routes of primitive streak
cells in the chick embryo. Development 122: 1523-34.
Pui J. C., Allman D., Xu L., DeRocco S., Karnell F. G., Bakkour S., Lee J. Y., Kadesch
T., Hardy R. R., Aster J. C., and Pear W. S. (1999). Notch1 expression in early
lymphopoiesis influences B versus T lineage determination. Immunity 11: 299308.
Qiu Y., Cavelier L., Chiu S., Yang X., Rubin E., and Cheng J. F. (2001). Human and
mouse ABCA1 comparative sequencing and transgenesis studies revealing novel
regulatory sequences. Genomics 73: 66-76.
Rabbitts T. H. (1994). Chromosomal translocations in human cancer. Nature 372: 143-9.
Rabbitts T. H. (2001). Chromosomal translocation master genes, mouse models and
experimental therapeutics. Oncogene 20: 5763-77.
Rasmussen K., Nielsen J., and Dahl G. (1982). The prevalence of chromosome
abnormalities among mentally retarded persons in a geographically delimited area
of Denmark. Clin Genet 22: 244-55.
Restrepo D., Teeter J. H., and Schild D. (1996). Second messenger signaling in olfactory
transduction. J Neurobiol 30: 37-48.
Ribeiro R. C., Abromowitch M., Raimondi S. C., Murphy S. B., Behm F., and Williams
D. L. (1987). Clinical and biologic hallmarks of the Philadelphia chromosome in
childhood acute lymphoblastic leukemia. Blood 70: 948-53.
Richardson C., and Jasin M. (2000). Frequent chromosomal translocations induced by
DNA double-strand breaks. Nature 405: 697-700.
Ries L. A., Wingo P. A., Miller D. S., Howe H. L., Weir H. K., Rosenberg H. M., Vernon
S. W., Cronin K., and Edwards B. K. (2000). The annual report to the nation on
the status of cancer, 1973-1997, with a special section on colorectal cancer.
Cancer 88: 2398-424.

166

Ries P. (1991). Characteristics of persons with and without health care coverage: United
States, 1989. Adv Data: 1-11.
Rinchik E. M. (2000). Developing genetic reagents to facilitate recovery, analysis, and
maintenance of mouse mutations. Mamm Genome 11: 489-99.
Rinchik E. M., Bangham J. W., Hunsicker P. R., Cacheiro N. L., Kwon B. S., Jackson I.
J., and Russell L. B. (1990). Genetic and molecular analysis of chlorambucilinduced germ-line mutations in the mouse. Proc Natl Acad Sci U S A 87: 141620.
Rinchik E. M., Bell J. A., Hunsicker P. R., Friedman J. M., Jackson I. J., and Russell L.
B. (1994). Molecular genetics of the brown (b)-locus region of mouse
chromosome 4. I. Origin and molecular mapping of radiation- and chemicalinduced lethal brown deletions. Genetics 137: 845-54.
Rinchik E. M., and Carpenter D. A. (1999). N-ethyl-N-nitrosourea mutagenesis of a 6- to
11-cM subregion of the Fah-Hbb interval of mouse chromosome 7: Completed
testing of 4557 gametes and deletion mapping and complementation analysis of
31 mutations. Genetics 152: 373-83.
Rinchik E. M., Carpenter D. A., and Johnson D. K. (2002). Functional annotation of
mammalian genomic DNA sequence by chemical mutagenesis: a fine-structure
genetic mutation map of a 1- to 2-cM segment of mouse chromosome 7
corresponding to human chromosome 11p14-p15. Proc Natl Acad Sci U S A 99:
844-9.
Rinchik E. M., Carpenter D. A., and Selby P. B. (1990). A strategy for fine-structure
functional analysis of a 6- to 11-centimorgan region of mouse chromosome 7 by
high-efficiency mutagenesis. Proc Natl Acad Sci U S A 87: 896-900.
Rinchik E. M., Machanoff R., Cummings C. C., and Johnson D. K. (1989). Molecular
cloning and mapping of the ecotropic leukemia provirus Emv-23 provides
molecular access to the albino-deletion complex in mouse chromosome 7.
Genomics 4: 251-8.
Roberts P. A. (1970). Screening for x-ray-induced crossover suppressors in Drosophila
melanogaster: prevalence and effectiveness of translocations. Genetics 65: 42948.

167

Romao L., Osorio-Almeida L., Higgs D. R., Lavinha J., and Liebhaber S. A. (1991).
Alpha-thalassemia resulting from deletion of regulatory sequences far upstream of
the alpha-globin structural genes. Blood 78: 1589-95.
Rosenbluth R. E., and Baillie D. L. (1981). The genetic analysis of a reciprocal
translocation, eT1(III; V), in Caenorhabditis elegans. Genetics 99: 415-28.
Rowley J. D. (1998). The critical role of chromosome translocations in human leukemias.
Annu Rev Genet 32: 495-519.
Rowley J. D., Diaz M. O., Espinosa R., 3rd, Patel Y. D., van Melle E., Ziemin S.,
Taillon-Miller P., Lichter P., Evans G. A., Kersey J. H., and et al. (1990).
Mapping chromosome band 11q23 in human acute leukemia with biotinylated
probes: identification of 11q23 translocation breakpoints with a yeast artificial
chromosome. Proc Natl Acad Sci U S A 87: 9358-62.
Russell L. B., Montgomery C. S., Cacheiro N. L., and Johnson D. K. (1995).
Complementation analyses for 45 mutations encompassing the pink-eyed dilution
(p) locus of the mouse. Genetics 141: 1547-62.
Russell L. B., Montgomery C. S., and Raymer G. D. (1982). Analysis of the albino-locus
region of the mouse: IV. Characterization of 34 deficiencies. Genetics 100: 42753.
Russell L. B., and Shelby M. D. (1985). Tests for heritable genetic damage and for
evidence of gonadal exposure in mammals. Mutat Res 154: 69-84.
Russell W. L., Kelly E. M., Hunsicker P. R., Bangham J. W., Maddux S. C., and Phipps
E. L. (1979). Specific-locus test shows ethylnitrosourea to be the most potent
mutagen in the mouse. Proc Natl Acad Sci U S A 76: 5818-9.
Rust S., Rosier M., Funke H., Real J., Amoura Z., Piette J. C., Deleuze J. F., Brewer H.
B., Duverger N., Denefle P., and Assmann G. (1999). Tangier disease is caused
by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet
22: 352-5.
Rutledge J. C., Cain K. T., Cacheiro N. L., Cornett C. V., Wright C. G., and Generoso W.
M. (1986). A balanced translocation in mice with a neurological defect. Science
231: 395-7.
Rutledge J. C., Cain K. T., Kyle J., Cornett C. V., Cacheiro N. L., Witt K., Shelby M. D.,

168

and Generoso W. M. (1990). Increased incidence of developmental anomalies
among descendants of carriers of methylenebisacrylamide-induced balanced
reciprocal translocations. Mutat Res 229: 161-72.
Saga Y., and Takeda H. (2001). The making of the somite: molecular events in vertebrate
segmentation. Nat Rev Genet 2: 835-45.
Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory
Manual. Cold Spring Harbor Laboratory Press, USA.
Santamarina-Fojo S., Remaley A. T., Neufeld E. B., and Brewer H. B., Jr. (2001).
Regulation and intracellular trafficking of the ABCA1 transporter. J Lipid Res 42:
1339-45.
Sato E., and Saito I. (1996). Risk of clot formation with ionic and nonionic contrast
media in cerebral angiography. Tama Contrast Media Study Group. Acad Radiol
3: 925-8.
Sato Y., Kobori S., Sakai M., Yano T., Higashi T., Matsumura T., Morikawa W., Terano
T., Miyazaki A., Horiuchi S., and Shichiri M. (1996). Lipoprotein(a) induces cell
growth in rat peritoneal macrophages through inhibition of transforming growth
factor-beta activation. Atherosclerosis 125: 15-26.
Sawada A., Fritz A., Jiang Y., Yamamoto A., Yamasu K., Kuroiwa A., Saga Y., and
Takeda H. (2000). Zebrafish Mesp family genes, mesp-a and mesp-b are
segmentally expressed in the presomitic mesoderm, and Mesp-b confers the
anterior identity to the developing somites. Development 127: 1691-702.
Schmitz G., Kaminski W. E., Porsch-Ozcurumez M., Klucken J., Orso E., Bodzioch M.,
Buchler C., and Drobnik W. (1999). ATP-binding cassette transporter A1
(ABCA1) in macrophages: a dual function in inflammation and lipid metabolism?
Pathobiology 67: 236-40.
Schmitz G., and Langmann T. (2001). Structure, function and regulation of the ABC1
gene product. Curr Opin Lipidol 12: 129-40.
Schulze A., Hansen C., Skakkebaek N. E., Brondum-Nielsen K., Ledbeter D. H., and
Tommerup N. (1996). Exclusion of SNRPN as a major determinant of PraderWilli syndrome by a translocation breakpoint. Nat Genet 12: 452-4.

169

Seemayer, T. A. and Nezelof, C. (1996). “Primary Immunodeficiencies” in Anderson’s
Pathology, Vol.1. Damjanov, I., and Linder, J., Eds. St. Louis: Mosby-Year
Book, Inc pp. 615 – 625.
Sega G. A. (1991). Adducts in sperm protamine and DNA vs. mutation frequency. Prog
Clin Biol Res 372: 521-30.
Sega G. A., Alcota R. P., Tancongco C. P., and Brimer P. A. (1989). Acrylamide binding
to the DNA and protamine of spermiogenic stages in the mouse and its
relationship to genetic damage. Mutat Res 216: 221-30.
Sega G. A., and Generoso E. E. (1990). Measurement of DNA breakage in specific germcell stages of male mice exposed to acrylamide, using an alkaline-elution
procedure. Mutat Res 242: 79-87.
Selby P. B. (1998). Major impacts of gonadal mosaicism on hereditary risk estimation,
origin of hereditary diseases, and evolution. Genetica 102-103: 445-62.
Semina E. V., Reiter R., Leysens N. J., Alward W. L., Small K. W., Datson N. A., SiegelBartelt J., Bierke-Nelson D., Bitoun P., Zabel B. U., Carey J. C., and Murray J. C.
(1996). Cloning and characterization of a novel bicoid-related homeobox
transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet 14: 3929.
Sharan S. K., Holdener-Kenny B., Ruppert S., Schedl A., Kelsey G., Rinchik E. M., and
Magnuson T. (1991). The albino-deletion complex of the mouse: molecular
mapping of deletion breakpoints that define regions necessary for development of
the embryonic and extraembryonic ectoderm. Genetics 129: 825-32.
Shelby M. D., Cain K. T., Cornett C. V., and Generoso W. M. (1987). Acrylamide:
induction of heritable translocation in male mice. Environ Mutagen 9: 363-8.
Shelby M. D., Cain K. T., Hughes L. A., Braden P. W., and Generoso W. M. (1986).
Dominant lethal effects of acrylamide in male mice. Mutat Res 173: 35-40.
Shelby M. D., and Tindall K. R. (1997). Mammalian germ cell mutagenicity of ENU,
IPMS and MMS, chemicals selected for a transgenic mouse collaborative study.
Mutat Res 388: 99-109.
Silahtaroglu A., Hol F. A., Jensen P. K., Erdel M., Duba H. C., Geurds M. P., Knoers N.
V., Mariman E. C., Tumer Z., Utermann G., Wirth J., Bugge M., and Tommerup

170

N. (1999). Molecular cytogenetic detection of 9q34 breakpoints associated with
nail patella syndrome. Eur J Hum Genet 7: 68-76.
Silberberg R., Hasler M., and Lesker P. (1976). Ultrastructure of articular cartilage of
achondroplastic mice. Acta Anat (Basel) 96: 162-75.
Silver, L. M. (1995). Mouse Genetics: Concepts and Applications. Oxford University
Press, New York, NY.
Skovby F., and Niebuhr E. (1974). Presumably balanced translocations involving the
same band of chromosome No. 4 found in two mentally retarded, dysmorphic
individuals. Ann Genet 17: 243-9.
Smith J. (1999). T-box genes: what they do and how they do it. Trends Genet 15: 154-8.
Smith O. P., Hann I. M., Chessells J. M., Reeves B. R., and Milla P. (1996).
Haematological abnormalities in Shwachman-Diamond syndrome. Br J Haematol
94: 279-84.
Solari A. J. (1980). Synaptosomal complexes and associated structures in microspread
human spermatocytes. Chromosoma 81: 315-37.
Solomon J. J., Fedyk J., Mukai F., and Segal A. (1985). Direct alkylation of 2'deoxynucleosides and DNA following in vitro reaction with acrylamide. Cancer
Res 45: 3465-70.
Sowerby S. J., Kennedy M. A., Fitzgerald P. H., and Morris C. M. (1993). DNA
sequence analysis of the major breakpoint cluster region of the BCR gene
rearranged in Philadelphia-positive human leukemias. Oncogene 8: 1679-83.
Spitz F., Montavon T., Monso-Hinard C., Morris M., Ventruto M. L., Antonarakis S.,
Ventruto V., and Duboule D. (2002). A t(2;8) Balanced Translocation with
Breakpoints Near the Human HOXD Complex Causes Mesomelic Dysplasia and
Vertebral Defects. Genomics 79: 493-8.
Spitzner J. R., and Muller M. T. (1988). A consensus sequence for cleavage by vertebrate
DNA topoisomerase II. Nucleic Acids Res 16: 5533-56.
Stack S. M. (1984). Heterochromatin, the synaptonemal complex and crossing over. J
Cell Sci 71: 159-76.
Stern C. D., and Keynes R. J. (1987). Interactions between somite cells: the formation
and maintenance of segment boundaries in the chick embryo. Development 99:

171

261-72.
Stone D. M., Hynes M., Armanini M., Swanson T. A., Gu Q., Johnson R. L., Scott M. P.,
Pennica D., Goddard A., Phillips H., Noll M., Hooper J. E., de Sauvage F., and
Rosenthal A. (1996). The tumour-suppressor gene patched encodes a candidate
receptor for Sonic hedgehog. Nature 384: 129-34.
Stubbs L., Carver E. A., Cacheiro N. L., Shelby M., and Generoso W. (1997). Generation
and characterization of heritable reciprocal translocations in mice. Methods 13:
397-408.
Stubbs L., Poustka A., Baron A., Lehrach H., Lonai P., and Duboule D. (1990). The
murine genes Hox-5.1 and Hox-4.1 belong to the same HOX complex on
chromosome 2. Genomics 7: 422-7.
Sun Y., Nicholls R. D., Butler M. G., Saitoh S., Hainline B. E., and Palmer C. G. (1996).
Breakage in the SNRPN locus in a balanced 46,XY,t(15;19) Prader-Willi
syndrome patient. Hum Mol Genet 5: 517-24.
Sutherland D. R., and Keating A. (1992). The CD34 antigen: structure, biology, and
potential clinical applications. J Hematother 1: 115-29.
Taub R., Kirsch I., Morton C., Lenoir G., Swan D., Tronick S., Aaronson S., and Leder P.
(1982). Translocation of the c-myc gene into the immunoglobulin heavy chain
locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl
Acad Sci U S A 79: 7837-41.
Tavtigian S. V., Simard J., Rommens J., Couch F., Shattuck-Eidens D., Neuhausen S.,
Merajver S., Thorlacius S., Offit K., Stoppa-Lyonnet D., Belanger C., Bell R.,
Berry S., Bogden R., Chen Q., Davis T., Dumont M., Frye C., Hattier T.,
Jammulapati S., Janecki T., Jiang P., Kehrer R., Leblanc J. F., Goldgar D. E., and
et al. (1996). The complete BRCA2 gene and mutations in chromosome 13qlinked kindreds. Nat Genet 12: 333-7.
Telenius H., Carter N. P., Bebb C. E., Nordenskjold M., Ponder B. A., and Tunnacliffe A.
(1992). Degenerate oligonucleotide-primed PCR: general amplification of target
DNA by a single degenerate primer. Genomics 13: 718-25.
Telenius H., Pelmear A. H., Tunnacliffe A., Carter N. P., Behmel A., Ferguson-Smith M.
A., Nordenskjold M., Pfragner R., and Ponder B. A. (1992). Cytogenetic analysis

172

by chromosome painting using DOP-PCR amplified flow-sorted chromosomes.
Genes Chromosomes Cancer 4: 257-63.
Theiler K., Varnum D. S., Southard J. L., and Stevens L. C. (1975). Malformed
vertebrae: a new mutant with the "wirbel-rippen syndrom" in the mouse. Anat
Embryol (Berl) 147: 161-6.
Thurston M. N., Johnson D. R., and Kember N. F. (1985). Cell kinetics of growth
cartilage of achondroplastic (cn) mice. J Anat 140 ( Pt 3): 425-34.
Timmons P. M., Wallin J., Rigby P. W., and Balling R. (1994). Expression and function
of Pax 1 during development of the pectoral girdle. Development 120: 2773-85.
Tkachuk D. C., Kohler S., and Cleary M. L. (1992). Involvement of a homolog of
Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias.
Cell 71: 691-700.
Tommerup N., Brandt C. A., Pedersen S., Bolund L., and Kamper J. (1993). Sex
dependent transmission of Beckwith-Wiedemann syndrome associated with a
reciprocal translocation t(9;11)(p11.2;p15.5). J Med Genet 30: 958-61.
Tommerup N., and Nielsen F. (1983). A familial reciprocal translocation t(3;7)
(p21.1;p13) associated with the Greig polysyndactyly-craniofacial anomalies
syndrome. Am J Med Genet 16: 313-21.
Townes T. M., and Behringer R. R. (1990). Human globin locus activation region (LAR):
role in temporal control. Trends Genet 6: 219-23.
Tremblay Y., Ringler G. E., Morel Y., Mohandas T. K., Labrie F., Strauss J. F., 3rd, and
Miller W. L. (1989). Regulation of the gene for estrogenic 17-ketosteroid
reductase lying on chromosome 17cen----q25. J Biol Chem 264: 20458-62.
van Bakel I., Holt S., Craig I., and Boyd Y. (1995). Sequence analysis of the breakpoint
regions of an X;5 translocation in a female with Duchenne muscular dystrophy.
Am J Hum Genet 57: 329-36.
van Eck M., Bos I. S., Kaminski W. E., Orso E., Rothe G., Twisk J., Bottcher A., Van
Amersfoort E. S., Christiansen-Weber T. A., Fung-Leung W. P., Van Berkel T. J.,
and Schmitz G. (2002). Leukocyte ABCA1 controls susceptibility to
atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci U S
A 99: 6298-303.

173

van Straaten H. W., and Copp A. J. (2001). Curly tail: a 50-year history of the mouse
spina bifida model. Anat Embryol (Berl) 203: 225-37.
van Zeeland A. A., de Groot A., and Neuhauser-Klaus A. (1990). DNA adduct formation
in mouse testis by ethylating agents: a comparison with germ-cell mutagenesis.
Mutat Res 231: 55-62.
Varnum-Finney B., Purton L. E., Yu M., Brashem-Stein C., Flowers D., Staats S., Moore
K. A., Le Roux I., Mann R., Gray G., Artavanis-Tsakonas S., and Bernstein I. D.
(1998). The Notch ligand, Jagged-1, influences the development of primitive
hematopoietic precursor cells. Blood 91: 4084-91.
Verkerk A. J., Pieretti M., Sutcliffe J. S., Fu Y. H., Kuhl D. P., Pizzuti A., Reiner O.,
Richards S., Victoria M. F., Zhang F. P., and et al. (1991). Identification of a gene
(FMR-1) containing a CGG repeat coincident with a breakpoint cluster region
exhibiting length variation in fragile X syndrome. Cell 65: 905-14.
Viskochil D., Buchberg A. M., Xu G., Cawthon R. M., Stevens J., Wolff R. K., Culver
M., Carey J. C., Copeland N. G., Jenkins N. A., and et al. (1990). Deletions and a
translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell
62: 187-92.
Vogler L. B., Crist W. M., Sarrif A. M., Pullen D. J., Bartolucci A. A., Falletta J. M.,
Dowell B., Humphrey G. B., Blackstock R., van Eys J., Metzgar R. S., and
Cooper M. D. (1981). An analysis of clinical and laboratory features of acute
lymphocytic leukemias with emphasis on 35 children with pre-B leukemia. Blood
58: 135-40.
Wagner T., Wirth J., Meyer J., Zabel B., Held M., Zimmer J., Pasantes J., Bricarelli F.
D., Keutel J., Hustert E., and et al. (1994). Autosomal sex reversal and
campomelic dysplasia are caused by mutations in and around the SRY-related
gene SOX9. Cell 79: 1111-20.
Walker L., Carlson A., Tan-Pertel H. T., Weinmaster G., and Gasson J. (2001). The notch
receptor and its ligands are selectively expressed during hematopoietic
development in the mouse. Stem Cells 19: 543-52.
Walkowicz M., Ji Y., Ren X., Horsthemke B., Russell L. B., Johnson D., Rinchik E. M.,
Nicholls R. D., and Stubbs L. (1999). Molecular characterization of radiation- and

174

chemically induced mutations associated with neuromuscular tremors, runting,
juvenile lethality, and sperm defects in jdf2 mice. Mamm Genome 10: 870-8.
Wallace M. R., Marchuk D. A., Andersen L. B., Letcher R., Odeh H. M., Saulino A. M.,
Fountain J. W., Brereton A., Nicholson J., Mitchell A. L., and et al. (1990). Type
1 neurofibromatosis gene: identification of a large transcript disrupted in three
NF1 patients. Science 249: 181-6.
Wallin J., Wilting J., Koseki H., Fritsch R., Christ B., and Balling R. (1994). The role of
Pax-1 in axial skeleton development. Development 120: 1109-21.
Warden C. H., Hedrick C. C., Qiao J. H., Castellani L. W., and Lusis A. J. (1993).
Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science
261: 469-72.
Weichert, C. K., and Presch, W. (1975). Elements of Chordate Anatomy, 4th Ed.
McGraw-Hill, p. 189-221.
Wellington C. L., Walker E. K., Suarez A., Kwok A., Bissada N., Singaraja R., Yang Y.
Z., Zhang L. H., James E., Wilson J. E., Francone O., McManus B. M., and
Hayden M. R. (2002). ABCA1 mRNA and protein distribution patterns predict
multiple different roles and levels of regulation. Lab Invest 82: 273-83.
Wilson A., MacDonald H. R., and Radtke F. (2001). Notch 1-deficient common
lymphoid precursors adopt a B cell fate in the thymus. J Exp Med 194: 1003-12.
Woychik R. P., Generoso W. M., Russell L. B., Cain K. T., Cacheiro N. L., Bultman S.
J., Selby P. B., Dickinson M. E., Hogan B. L., and Rutledge J. C. (1990).
Molecular and genetic characterization of a radiation-induced structural
rearrangement in mouse chromosome 2 causing mutations at the limb deformity
and agouti loci. Proc Natl Acad Sci U S A 87: 2588-92.
Wrighton S. A., and Stevens J. C. (1992). The human hepatic cytochromes P450 involved
in drug metabolism. Crit Rev Toxicol 22: 1-21.
Wrighton S. A., and Vandenbranden M. (1989). Isolation and characterization of human
fetal liver cytochrome P450HLp2: a third member of the P450III gene family.
Arch Biochem Biophys 268: 144-51.
Wu M., Rinchik E. M., and Johnson D. K. (2000). An integrated deletion and physical
map encompassing l71Rl, a chromosome 7 locus required for peri-implantation

175

survival in the mouse. Genomics 67: 228-31.
Wu X., Wakamiya M., Vaishnav S., Geske R., Montgomery C., Jr., Jones P., Bradley A.,
and Caskey C. T. (1994). Hyperuricemia and urate nephropathy in urate oxidasedeficient mice. Proc Natl Acad Sci U S A 91: 742-6.
Yamaguchi T. P., Takada S., Yoshikawa Y., Wu N., and McMahon A. P. (1999). T
(Brachyury) is a direct target of Wnt3a during paraxial mesoderm specification.
Genes Dev 13: 3185-90.
Yu B. D., Hess J. L., Horning S. E., Brown G. A., and Korsmeyer S. J. (1995). Altered
Hox expression and segmental identity in Mll-mutant mice. Nature 378: 505-8.
Yui Y., Aoyama T., Morishita H., Takahashi M., Takatsu Y., and Kawai C. (1988).
Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I).
A novel function of Apo A-I. J Clin Invest 82: 803-7.
Zhang N., and Gridley T. (1998). Defects in somite formation in lunatic fringe-deficient
mice. Nature 394: 374-7.
Zhou S. L., Stump D., Sorrentino D., Potter B. J., and Berk P. D. (1992). Adipocyte
differentiation of 3T3-L1 cells involves augmented expression of a 43-kDa
plasma membrane fatty acid-binding protein. J Biol Chem 267: 14456-61.
Zon L. I. (1995). Developmental biology of hematopoiesis. Blood 86: 2876-91.

176

APPENDIX

177

FORWARD

REVERSE

ABCA1209

ABCA1211

ABCA1210

ABCA1213

ABCA1214

ABCA1214

ABCA1215

ABCA1215

ABCA1216

ABCA1216

ABCA1219

ABCA1219

ABCA1219

ABCA1220

ABCA1220

ABCA1220

ABCA1220

ABCA12232

ABCA1236

N2363

ABCA1236

NIP2RELUTR28

ABCA1A-F

ABCA1A-R

ABCA1B-F

ABCA1B-R

ABCA1C-F

ABCA1C-R

ABCA1D-F

ABCA1D-R

ABCA1E-F

ABCA1E-R

ABCA1EXON 31-F

ABCA1EXON31-R

ABCA1EXON2

ABCA1EXON2

ABCA1EXON32-F

ABCA1EXON33-R

ABCA1EXON33-F

ABCA1EXON33-R

ABCA1EXON34-F

ABCA1EXON34-R

ABCA1EXON50

ABCA1EXON50

ABCA1F-F

ABCA1F-R

ABCA1G-F

ABCA1G-R

ABCA1H-F

ABCA1H-R

ABCA1I-F

ABCA1I-R

ABCA1J-F

ABCA1J-R

ABCA1K-F

ABCA1K-R

ABCA1L-F

ABCA1L-R

ABCA1M-F

ABCA1M-R

CONTIG1.1

CONTIG1.1

SEQUENCE-F

SEQUENCE-R

TTGCCAAGGACCAAAGTGA
TGATGA
ACCAGTGCTCAATGTCATCC
GTCTTC
CTTCGAGAACACACCTTAA
ACATGGAGTA
GAAGAGGCACAAACGTGTC
AAACACTAG
GGTCTCCACCTCTAAATATC
ATTACATTCG
TGCAAACGATCTATGCTACT
ATGTGAACCT
TGCAAACGATCTATGCTACT
ATGTGAACCT
CACTTCGGTGATTAAATGTG
CCACGGAG
CACTTCGGTGATTAAATGTG
CCACGGAG
CCAATATGGCTGGGAGTGC
TACAGTGCA
CCAATATGGCTGGGAGTGC
TACAGTGCA
TCAACAACTTTCAAGATGCT
GACTGGAGACA
CAGTGTGAACCTCTTCATCG
GCATCAATGG
CTGGCATGCTATCAGTTCGT
TCTTGAATGT
ATCGTGGACCTCTTCCAGAA
TGGAAACTGG
TTGTGGAACTCTTCCATGAG
ATTGATGACC
ACCGCAGACATCCTTCAGA
ATCTGACAGGA
AGTCACAGCTCTGTGCTCTG
G
AAAGAATAAGATCTGGGTG
AACGAGTTTCG
CCTGGGTGTCAGTAATTCTC
AAGCACTTCCT
GAAGGTTCATGGCAGGGCT
GGATACGAA
GTGAACTTTGCCAAGGACC
A
AAACCAGTTGGGAACGGGT
TACTATCTGAC
GCTCAACTTTTACGAAGGCC
AGATTACCTC
GTTTGCCATGGTGACCATCC
TACAGTGCTT
AAGAAAACGGGTGTCTACG
TGCAACAGATG
AATGGCTCTGTGTATACCTG
GAGAGAAGCT
GTACGAGGATAACAACTAC
AAAGCCCTCTT
CTGCAGCACAATTTGTCCCT
TCCAAGATCT
AAGTCCATCGTGTCTCGCCT
GTTCTCAGAC
CCATGTAGATCCTAAACCTG
AACGATG

AGGGCTGTACATGGT
GATAATGGACTG
GATTTCATTCGATATA
ACATCCCCTGAATCA
CCTGTCATACACGCCA
GAGTCCTAACAT
CTAGCACCATGATGCC
ATCTTCCATGAAC
TACCAGCTTTTCTTCT
TTGACTTATTGTCT
TGACGTGTTCTTTGTC
TGTGATCTCATGAC
AGCGCAGACCATGAA
GGCCTTTCAAAGA
AGCGCAGACCATGAA
GGCCTTTCAAAGA
ACAGCTAACTTATGAT
CTACTTCTGCAG
CTGGTCCCATTAGATA
TGGCTGTGCCAC
CTTTCTACAGGGAATA
CTCTCTGTAGACTC
CACTGCCAAGGCACC
TGAACCTTCCATTGA
TGTCTCCAGTCAGCAT
CTTGAAAGTTGTTGA
CACTGCCATTGATGCC
GATGAAGAGGTTCA
GACATTCAAGAACGA
ACTGATAGCATGCCA
CCAGTTTCCATTCTGG
AAGAGGTCCACGAT
TCTTCCTGTCAGATTC
TGAAGGATGTCTGC
GTTTGTCTCCTTCGAA
ATGTCA
CTCGGAGGAAGTGCT
TGAGAATTACTGACA
CTCGGAGGAAGTGCT
TGAGAATTACTGACA
TTCGTATCCAGCCCTG
CCATGAACCTTC
AGGCTACAAAGGCAC
TGCC
GGTCATCAATCTCATG
GAAGAGTTCCACAA
GGTCAGATAGTAACC
CGTTCCCAACTGGTT
GAGGTAATCTGGCCTT
CGTAAAAGTTGAGC
GGAAGCACTGTAGGA
TGGTCACCATGGCAA
GCACGTAGACACCCG
TTTTCTTCTCAGATC
AGCTTCTCTCCAGGTA
TACACAGAGCCATT
CTCCAAAGAGGGCTTT
GTAGTTGTTATCCT
AGTAGATCTTGGAAG
GGACAAATTGTGCTG
CTCCTTCTTTTAGGCT
TCAAAACATCG
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CONTIG1.1

CONTIG1.3

CONTIG1.2

CONTIG1.2

CONTIG1.3

CONTIG1.3

CONTIG1.3

CONTIG1.5

CONTIG1.4

CONTIG1.4

CONTIG1.5

CONTIG1.5

CONTIG1.5

CONTIG1.6

CONTIG1.5

CONTIG1.7

CONTIG1.6

CONTIG1.6

CONTIG1.6

CONTIG1.7

CONTIG1.7

CONTIG1.7

CONTIG1.7

CONTIG1.8

CONTIG1.8

CONTIG1.8

CONTIG6.1

CONTIG6.1

CONTIG6.1

CONTIG6.2

CONTIG6.2

CONTIG6.2

CONTIG6.2

CONTIG6.3

CONTIG6.3

CONTIG6.3

CONTIG6.3

CONTIG6.4

CONTIG6.4

CONTIG6.4

CONTIG6.4

CONTIG6.5

CONTIG6.5

CONTIG6.5

CONTIG6.6

CONTIG6.6

CONTIG6.6END

CONTIG6.7BEGIN

CONTIG6.7

CONTIG6.7

CONTIG6.7

CONTIG6.8

CONTIG6.8

CONTIG6.8

KY

KY

KY

KY

N2217

N2232

N2217

N2240

N2237

N2240

SEQUENCE-F

SEQUENCE-R

CCATGTAGATCCTAAACCTG
AACGATG
CTGCCACAGATACTCTGGA
AAATCAGC
AAGAGCATCCACCTTTCTGG
ACCTACT
AAGAGCATCCACCTTTCTGG
ACCTACT
TTCTAGGTAAGACAAAGAA
CGCTTCGTG
CACTCACTGAAGACCCAGA
GCTGGTTA
CACTCACTGAAGACCCAGA
GCTGGTTA
CACTCACTGAAGACCCAGA
GCTGGTTA
AGCCATTGTGGTCTGTCTTC
ATATCAC
AGCCATTGTGGTCTGTCTTC
ATATCAC
AGATAATGTGTGCATATCCA
CGTGACC
AGATAATGTGTGCATATCCA
CGTGACC
GGTTCTTATTTCCTCCTGGG
CTATAGC
GAAGCTTGGCTGTCTTACCT
TATGGAC
GAAGCTTGGCTGTCTTACCT
TATGGAC
ATATGTCAACTAGCCACCTC
CCTACTCTT
ATATGTCAACTAGCCACCTC
CCTACTCTT
CTCAGACTTTGTGTGGATGC
TATGGTC
CTCAGACTTTGTGTGGATGC
TATGGTC
GTGGGAGATAAGATGACAG
AATGGACG
GTGGGAGATAAGATGACAG
AATGGACG
GTTCTCACATGAAGTCAACA
GTTGAGC
GTGAAGCTGGGTGAGTATA
ACGGTCAA
GTGACAACCACTGAAGAAT
TCGTGCTA
GAGGGGCATCTTTTTCTTTT
AGAATATCA
GAGGGGCATCTTTTTCTTTT
AGAATATCA
ACCCAGCTGAGGAGAAATT
GGATCTAA
ATTCCAAGGTGTCAGAAAC
GGAATC
CTATCATAGCCATTTTCCCT
CCTGTCTT
TTCACACAAGCACACATTGT
ACAGTGAGTT
TTCACACAAGCACACATTGT
ACAGTGAGTT
CTCTTCCAGTTTCTAAACAA
CTGTTATCC

GCTTTGACCTTTCCTT
TACCTTGTAGC
GGTGACTGACGACGT
GGAAAACTTAAG
GCTTTGACCTTTCCTT
TACCTTGTAGC
CTGTTTCCTTAGCTTG
GCTGTAGTGAC
AGATAATAAAAACCA
GGTCCCCGTCAA
CTGTTTCCTTAGCTTG
GCTGTAGTGAC
ACCTTAAAGTCCTGGG
GATAAGAGACG
TCAAAAGAGAGCTCT
GTGAACCTTGATAG
ACCTTAAAGTCCTGGG
GATAAGAGACG
TCAAAAGAGAGCTCT
GTGAACCTTGATAG
TCAAAAGAGAGCTCT
GTGAACCTTGATAG
TTTACAAACTCAAATC
AATTACCCGAAGA
TTTACAAACTCAAATC
AATTACCCGAAGA
TGAGGCAGATTAGAG
CATAAACATAACG
CCTGATACATCTTCCC
TCTTTTAAATCG
CCTGATACATCTTCCC
TCTTTTAAATCG
GCTGATCATCAATAGC
CAATTGTTTAATC
GCTGATCATCAATAGC
CAATTGTTTAATC
GAAACTGGTGTTCTTG
TCCATTTCGAT
GAAACTGGTGTTCTTG
TCCATTTCGAT
CCAGCTTGGAGACAA
GAACATCAGTAG
CCAGCTTGGAGACAA
GAACATCAGTAG
TGAACTATCCATGAG
AAGACAGGATAAGTC
TTCTAAAAGAAAAAG
ATGCCCCTCAAG
TTACAAACACCAGCT
AAGACCACATGT
GGCTGTAAAGTTGAA
TAAGCAATAGGTGAC
GGCTGTAAAGTTGAA
TAAGCAATAGGTGAC
GGTGGATTTCCACAGT
CAGCTGAGTA
GGATGCTACTGCAGG
AACCTCTTGTC
ACAGCTAACTTATGAT
CTACTTCTGCAG
CAGCTCTGTGGGGTA
ATGCATTTAAAAG
CAGCTCTGTGGGGTA
ATGCATTTAAAAG
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N2237

N2263

N2248

N2253

N2256

N2263

N2256

N2274

N2270

N2274

N2270

N2294

N2270

N2307

N2280

N2294

N2280

N2307

N2294

N2307

N2294

N2331

N2294

N2363

N2310

N2331

N2310

N2348

N2339

N2348

N2339

N2363

N2352

N2363

N2352

NIP2RELUTR28

N2576

N2580

N2576

N2589

N2576

N2612

N2591

N2612

N2591

N2623

N2614

N2618

N2614

N2639

N2621

N2623

N2621

N2651

N2626

N2639

N2626

N2651

N2641

N2651

N2657F

N2670R

N2681F

N2683R

SEQUENCE-F

SEQUENCE-R

CTCTTCCAGTTTCTAAACAA
CTGTTATCC
GGGTCATCTGCAGATACAG
TTTTATGCA
CCTAGATTTGACACTGCAAG
AGATGGCA
CCTAGATTTGACACTGCAAG
AGATGGCA
CTCACTTAACAGCTGAACAT
TTTCAGTC
CTCACTTAACAGCTGAACAT
TTTCAGTC
CTCACTTAACAGCTGAACAT
TTTCAGTC
GCACTGTGAACTGAATATAT
GTGCAATC
GCACTGTGAACTGAATATAT
GTGCAATC
GGTAACTGCTTGCAAGTGTG
GTAAGAAG
GGTAACTGCTTGCAAGTGTG
GTAAGAAG
GGTAACTGCTTGCAAGTGTG
GTAAGAAG
CCAGATCAAAAAGGAAACA
TGGCAGACT
CCAGATCAAAAAGGAAACA
TGGCAGACT
GCTGACATTATGTTATGAGC
ACATAATG
GCTGACATTATGTTATGAGC
ACATAATG
GGAGCTTCTGATAGAGGTA
AACTTGATT
GGAGCTTCTGATAGAGGTA
AACTTGATT
TGCAACACAGGGTGCCATT
AAGAGCTGAT
TGCAACACAGGGTGCCATT
AAGAGCTGAT
TGCAACACAGGGTGCCATT
AAGAGCTGAT
GCTTTCAGGGTACTTTTGTC
TTGGATTT
GCTTTCAGGGTACTTTTGTC
TTGGATTT
ACTAGTAAGCCCCACACTTG
GGAGACTGA
ACTAGTAAGCCCCACACTTG
GGAGACTGA
TCCCACCTTGCTTCCTTGAG
GCAGCACTTT
TCCCACCTTGCTTCCTTGAG
GCAGCACTTT
GCTCTCAATACCTAGGAAC
ACATTTTAC
GCTCTCAATACCTAGGAAC
ACATTTTAC
CCTGATTTCCCTAACTTTGA
GGACAAAT
TTAGGTCACTTTCTAGAGTC
GTAATGCTAC
GCTGAATAGCAGGAATATG
GTGTTCAGCAT

CTGGCATTGTCAAGGT
ACACTGCAGTTA
CTATCAGATCTACTTA
TCCTCCAGTTTC
CTGGCATTGTCAAGGT
ACACTGCAGTTA
CCCTGAAGACTGTGAT
TTGATGCAGATA
CCCTGAAGACTGTGAT
TTGATGCAGATA
CTTCTTACCACACTTG
CAAGCAGTTACC
CACCTGCAGTGTGTTT
TATAGGAAGCTT
CTTCTTACCACACTTG
CAAGCAGTTACC
CACCTGCAGTGTGTTT
TATAGGAAGCTT
CACCTGCAGTGTGTTT
TATAGGAAGCTT
CGTTAGGAGTTTAAA
GGCTAACAGGATT
CTGGTCCCATTAGATA
TGGCTGTGCCAC
CGTTAGGAGTTTAAA
GGCTAACAGGATT
CTTCTCCAAAGAGTAT
GAATCCAGAAGG
CTTCTCCAAAGAGTAT
GAATCCAGAAGG
CTGGTCCCATTAGATA
TGGCTGTGCCAC
CTGGTCCCATTAGATA
TGGCTGTGCCAC
CTTTCTACAGGGAATA
CTCTCTGTAGACTC
TAGAAATGCCTTAGA
GAAAGGCCCTGGAGG
GGCTACAAGAAATAG
CACACTGACACACAA
GACTGGGAGAACGAG
ATGAATGGGGAAA
GACTGGGAGAACGAG
ATGAATGGGGAAA
CTGAGAATATGCTAA
GGGGATCCACAGGAT
CATAATGAAGGTTTCC
ATGAGAAAGTCC
ACCTACTTCTCTCCAG
ACCTACTTCCTC
CTGAGAATATGCTAA
GGGGATCCACAGGAT
GCCATGCCTAATAAA
GTATGTTGTGACT
ACCTACTTCTCTCCAG
ACCTACTTCCTC
GCCATGCCTAATAAA
GTATGTTGTGACT
GCCATGCCTAATAAA
GTATGTTGTGACT
CTTAATAGGTACTTAC
AACTCTTGCAAGTG
AAGACAGCTATAAAT
GAATACTAATGAACC
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SEQUENCE-F

SEQUENCE-R

N2692F

N2695R

AAGCCTCAGGGTTGGTGGT
ACACACAAAAG
TGCACACATATAGCAAACA
AGTACATGCAA
GTGCTGAACTTGAGAGTTTT
AACAGCTCTT
CTTGATGAGCATCCTCAAGG
GGCTGATTCG
TACTAGGCTAGTGTCAGTTA
GCAAAGTGAG

CAGTGTCACTTAATGG
ATGCAACTACTGCA
TCTCCTCTGACCTCAA
GTGCTGTTACCACT
GCTGAGGGGTATTCAT
ATATTCCTGGAATC
CGAATCAGCCCCTTGA
GGATGCTCATCAAG
CCTCACTTTGCTAACT
GACACTAGCCTAGT
TTCATCACATACAAAA
GCTTCATAGCACAAG
C
CATAAGATAGCATAT
GCATTGTCTTTCCTTA
C
TAGGTCTAAATTACCA
CAAGTTTACATTAAGA
C
ACCTTCCAGGATTAAT
GAGTGCCAAACTGC
CTTTCTACAGGGAATA
CTCTCTGTAGACTC
TACCTAGTCCATTGTG
GCACCACAGTGG
GGCTACAAGAAATAG
CACACTGACACACAA
CTCTGTCAATTCTACT
GGATATCCAGCCAT
CATAATGAAGGTTTCC
ATGAGAAAGTCC
GGAGCTGATGTGACA
TGTGT
GGAGCTGATGTGACA
TGTGT
CATAGTAGGAAGTCA
TACAGTTTGGGTCTTG
AAGTGTTAAAAGCTG
CAAACCTGGAAGCTG
AACTGGCTACTTTTCT
GATGAAACCTGG
AAGTGTTAAAAGCTG
CAAACCTGGAAGCTG
CCTAATTGATTCTCTC
GCACAAGAGACT
GTGCATATGTACCGAC
ACATACTCAAGG
GGAATGCACTGAAGG
GAGAAAATTGTAT
TAGTGCATTTTCCAAA
TACACACTCACTC
TACCAACCACTACACT
ACGAGTGTAGCA
CTCAAGGCTGAAAAA
GCATTCTAAGTGA
ACATTTCCCAGGGGTG
AAGACCATCCAGGA
TACCAACCACTACACT
ACGAGTGTAGCA
TAGAAATGCCTTAGA
GAAAGGCCCTGGAGG
AACTTACAAGCCAAC
AACTCCACTCCTGGG

N2697F

N2700R

N2709F

N2715R

N2725F

N2725R

N2739F

N2739R

N2750F

N2750R

CTTGTGCTATGAAGCTTTTG
TATGTGATGAA

N2761F

N2765R

TGTGCGAACAGAGTCTGTGT
AGAATGGCAG

N2770F

N2770R

GTCTTAATGTAAACTTGTGG
TAATTTAGACCTA

N2778F

N2782R

NIP2RELUTR28

NIP2RELUTR28

NIP4P1

NIP4P1

NIP4P10

N2589

NIP4P10

NIP4P10

NIP4P10

N2618

NIP4P1RVS

NIP4P2

NIP4P2

NIP4P2

NIP4P3

NIP4P3RNEW

NIP4P3

NIP4P5RNEW

NIP4P4FNEW

NIP4P4RNEW

NIP4P5FNEW

NIP4P5RNEW

NIP4P6FNEW

N2505

NIP4P6FNEW

NIP4P6

NIP4P7

N2518

NIP4P7

NIP4P7

NIP4P7

N2573

NIP4P8

N2559

NIP4P8

NIP4P8

NIP4P9

N2573

NIP4P9

N2580

NIP4P9

NIP4P9

AGCAGACAGATCTATACAG
CTTCAATTACG
CCAGATGTACTTGACACAG
GAACTTATTG
CTAAGTCTTCGTGGCTTTGA
CCTTTCTC
CCCAGGAGTGGAGTTGTTG
GCTTGTAAGTT
CCCAGGAGTGGAGTTGTTG
GCTTGTAAGTT
CCCAGGAGTGGAGTTGTTG
GCTTGTAAGTT
CCACTGTGGTGCCACAATG
GACTAGGTA
GCTGAGGTACAGACAATGG
A
GGGTTGTCTTACAGAAGAG
G
GGGTTGTCTTACAGAAGAG
G
CAAGACCCAAACTGTATGA
CTTCCTACTATG
AGAAGATGAATAAGTCACC
AACATACACGGA
AACCTGGAGCATGCAAGTC
CACCATGTTGT
AACCTGGAGCATGCAAGTC
CACCATGTTGT
CCTTGAGTATGTGTCGGTAC
ATATGCAC
CCTTGAGTATGTGTCGGTAC
ATATGCAC
CCTTGAGTATGTGTCGGTAC
ATATGCAC
GAGTGAGTGTGTATTTGGA
AAATGCACTA
GAGTGAGTGTGTATTTGGA
AAATGCACTA
TCCTGGATGGTCTTCACCCC
TGGGAAATGT
TCCTGGATGGTCTTCACCCC
TGGGAAATGT
TCCTGGATGGTCTTCACCCC
TGGGAAATGT
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NIPSNAP33'

NIPSNAP33'

NIPSNAP3CDNA–
F

NIPSNAP3CDNAR

NIPSNAP43'

NIPSNAP43'

TBX18

TBX18

SEQUENCE-F

SEQUENCE-R

CAGAATACGTTCCTGATTCC
AACATCA
TATGGAGCCCTCAACAGAG
TTCATGTTCTG
TGGTCACAAACTTGGAAAC
ACGAT
CTCCAGGACCCTAGGACGTT
TAAC

AATGAAGTACCAGGG
CACGGAGTA
AGCTCAGCCCGTCCTT
CAGACAATGAACTG
CCACTGAAATAGTTTC
CTAACGACTGT
GCATCCTTACCAACTT
TCAAGTGTACC
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